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Summary 
Artificial nucleosides and nucleotides are used in therapy,[1-2] biotechnology (e.g. DNA sequencing)[3] 
and fundamental research.[4] Compared to their natural congeners, these compounds differ at the 
nucleobase,[5] the sugar[6] or the phosphate moiety.[7] In course of this work, several artificial nucleotides 
with nucleobase or phosphate modifications were synthesized and studied for their ability to be 
incorporated by enzymes. 
The expansion of the genetic code, to allow coding of additional non-canonical amino acids and thus the 
creation of novel biocatalysts, is one major goal in synthetic biology. One strategy aims at the creation of 
an additional artificial base pair, which can be replicated, transcribed and translated by the existing 
enzyme machinery. In order to achieve this extremely challenging goal, the design of the novel base pair 
candidate is crucial. Most approaches rely on shape complementarity and -stacking,[8-10] while hydrogen 
bonds are not necessary for selective interstrand interaction.[11] A completely different strategy, the 
interaction via reversible covalent bonding and metal complexation had been developed by Clever et 
al.[12] Based on the salen catalyst, a DNA metal base pair had been prepared, which was dependent on 
Cu2+ and could be amplified in the polymerase chain reaction.[13] 
In this research project efforts towards transcription and translation of the salen base pair were analyzed 
for which several compounds were required. The phosphoramidite of the salicylaldehyde 
deoxynucleoside was synthesized. A synthesis route to the salicylaldehyde ribonucleoside was 
established and its triphosphate 1 was prepared successfully. In order to study the role of the ortho-
hydroxyl group for the imine formation, a benzaldehyde nucleoside 5’-triphosphate (AldTP) and its 
phosphoramidite were synthesized. Transcription of the salicylaldehyde base pair by T7 RNA 
polymerase was analyzed, but resulted in transcription termination prior to incorporation of the artificial 
base or mutation of the artificial salicylaldehyde to an adenine. Neither T7 RNA polymerase mutants nor 
solid-phase synthesis using a salicylaldehyde ribophosphoramidite could provide RNA containing the 
salicylaldehyde.  
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Scheme 0-1. Transcription of the salicyladehyde nucleoside by T7 RNA polymerase results in transcription stop or 
mutation to a natural adenosine. 
Since transcription of the salicylaldehyde metal-base pair was not possible, redesign of the artificial base 
pair was elaborated. The aim was to develop a base pair, which solely relied on reversible covalent imine 
chemistry without the need for additional metal chelation. The existing salicylaldehyde was used as the 
starting point and it provided the aldehyde subunit. A set of different amine nucleoside phosphoramidites 
was designed and synthesized. Amine nucleoside and aldehyde nucleoside containing DNA strands were 
produced and employed in melting temperature experiments. The combination of an aromatic amine (To) 
with the salicyladehyde (S) provided a melting temperature increase of up to 31 K compared to the 
control strand with a central adenine:thymine (A:T) pair (Figure 0-1, C). Notably, the duplex containing 
this aldehyde-aromatic base combination displayed a strong hysteresis effect. Comparison between 
salicylaldehyde and benzaldehyde containing DNA strands proved that the hydroxyl group directly 
adjacent to the aldehyde is crucial for imine stability.  
5‘-dATAATACGACTCACTATAGGG
3‘-dTATTATGCTGAGTGATATCCCTTAGGGCTCSTCACTGAT
T7 RNA polymerase, 
NTPs, STP, Cu2+
ethylenediamine
Template DNA
Transcript RNA 
5‘-pppGGGAATCCCGAGAAGTGACTA
STP =
5‘-pppGGGAATCCCGAG
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Figure 0-1. (A) Reversible chemistry enables salicylaldehyde: aromatic amine (S:To) base pair formation. (B) DNA 
strands containing different base pairs (X:Y) were studied in melting temperature analysis (C). 
Enzymatic incorporation of the novel, unnatural base pair candidate by DNA polymerases was studied. 
Therefore, the salicylaldehyde (dSTP) and aromatic amine triphosphate (dToTP) were synthesized. DNA 
templates containing the aromatic amine or the salicyladehyde nucleoside in the template strand were 
prepared and different DNA polymerases were studied for their ability to incorporate the artificial 
nucleotides. Using a polymerase mixture, dSTP incorporation opposite the aromatic amine and full 
elongation of the primer was achieved. Klenow fragment polymerase was able to synthesize the base pair 
in the reverse case, but subsequent elongation was inefficient after dToTP addition.  
In order to gain insight into the structure of the base pair, S:To containing strands were co-crystallized in 
complex with the DNA polymerase I from Geobacillus stearothermophilus. Well-diffracting crystals 
were obtained within several days and the X-ray structure was solved. The S:To base pair was found 
completely isosteric in comparison to a natural base pair. 
Based on the structure, the aromatic amine was changed to a naphthalene amine. A naphthalene amine 
triphosphate (dNaaTP) was synthesized and used in primer extension experiments. Single nucleotide 
incorporations using various polymerases revealed that the naphthalene nucleotide is accepted more 
readily by the enzymes. Even full elongation of the primer was achieved in the presence of five dNTPs 
and dNaaTP was incorporated opposite the templating salicylaldehyde. In summary, a reversible 
covalent base pair was developed which site-specifically crosslinks DNA and thereby stabilizes the 
5’-CACATTAXTGTTGTA-3’
3’-GTGTAATYACAACAT-5’
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duplex. The base pair can be formed by DNA polymerases and does not disturb the structure of the DNA 
double strand. 
Terminally phosphate modified nucleotides are important substrates in next-generation sequencing[3] and 
real-time methods.[14] Despite the increasing importance of these molecules, their synthesis is 
challenging.[7] 
A short and efficient synthesis of -modified triphosphates was developed based on the Cu(I)-catalyzed 
alkyne azide cycloaddition (CuAAC). Starting from nucleotides, alkyne labels were selectively 
introduced on the -phosphate with 70-86% yield for all eight major nucleoside triphosphates (Figure 
0-2). Subsequent CuAAC with different fluorescent dye azides allowed access to -fluorophore labeled 
nucleotides with 70-77% isolated yield. 
 
Figure 0-2. Click chemistry based synthesis of -modified nucleoside triphosphates. 
The modified deoxynucleotides were accepted by DNA polymerases in primer extension experiments. 
T7 RNA polymerase mediated labeling of RNA transcripts was achieved in vitro. By supplementation of 
natural GTP with -alkyne and -fluorescein GTP, 5’-labeling of the RNA transcript was possible. 
Therefore, -labeled nucleotides synthesized by this new method are potential substrates for real-time 
enzymatic studies and labeling. Efforts to expand the enzymatic labeling strategy and the application of 
-modified nucleotides were yet unsuccessful. 
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1 Introduction 
1.1 DNA 
Despite the biological diversity of organisms, life on the molecular level is surprisingly uniform.[15] Many 
of the biomolecules are biopolymers, which consist of a set of relatively few monomer building blocks. 
Proteins consist of 20 amino acids, lipids consist of fatty acids and DNA consists of four major 
nucleotides. DNA is the central molecule of life and the genetic code is universal for all organisms.[15] 
In 1869, Friedrich Miescher isolated a phosphorus rich substance from leukozyte nuclei, which he called 
“nuclein”.[16] This term has been preserved in todays’ name for the molecule: deoxyribonucleic acid, DNA 
(Figure 1-1, A). More than 50 years were needed since the initial isolation until the components of DNA 
were isolated and identified by Levene,[17] Klein and Thannhauser.[18] Unambigous structural elucidation of 
the monomers was strongly aided by chemical synthesis in the group of Todd.[19-20] DNA is a polymer of 
four different monomers comprising the bases adenine (A), cytosine (C), guanosine (G) and thymine (T). 
Each of these bases is connected to deoxyribose via an hemiaminal to form a nucleoside (Figure 1-1, B). 
Phosphate diester bonds join the monomers (nucleotides) at the 5’- and 3’- hydroxylgroup of the sugar.[19] 
 
 
Figure 1-1. (A) DNA is located in the nucleus of eucaryotes. (B) Exemplary DNA monomer: 2‘-deoxyadenosine 5‘-
monophosphate.  
A major breaktrough was the identification of DNA as the carrier of genetic information by Avery et al. in 
1944.[21] A few years later (1953), the structure of the DNA was deciphered.[22-24] A helical structure is 
adopted from two pairing strands. A sugar-phosphate backbone connects the bases, which selectively base 
pair via hydrogen bonds: A pairs with T and C pairs with G. 
DNA is the prime example of the structure-function relation, which is found in many 
biomacromolecules.[15] The order of bases in the DNA strand (primary structure) encodes the genetic 
information and the reversibility of the base pairs allows replication.[24-25] A “transient copy” of this 
information is generated by transcription of DNA into messenger RNA (mRNA), which is needed for 
protein synthesis. Three base pairs, the so-called triplet, encodes one amino acid (or stop codon).[26-27] 
DNA
A B
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Genomic DNA is mostly found in the right-handed B-conformation and has ten base pairs per turn.[28] The 
major and the minor groove are two areas of the DNA helix that are exposed to the solvent and allow 
interaction of base pairs with proteins for selective sequence recognition.[29] 
 
 
Figure 1-2. (A) Hydrogen bonds mediate the base pairing in double stranded DNA. Two base pairs are formed 
selectively between A:T and G:C. R = oligonucleotide (B) B-DNA structure, generated from pdb entry: 3OPI.[30] 
 
1.2 Nucleoside Chemistry 
Nucleoside chemistry is the key to study DNA, RNA, nucleosides and nucleotides. It enables the targeted 
preparation of nucleosides and oligonucleotides to investigate their physicochemical properties and their 
role in biological systems. Before chemical synthesis of nucleosides was possible, progress depended on 
isolation of molecules from natural sources and subsequent chemical or enzymatic decomposition.[26-27]  
Protecting group strategies are an essential part in nucleoside chemistry.[31-32] Since the nucleosides contain 
a variety of functional groups in close proximity, chemo-, regio- and stereoselectivity are serious issues. 
Protection of functional groups, to prevent side reactions is a common method to obtain the desired 
selectivity.[31, 33] 
Two major retrosynthetic strategies are applied: the glycosidic bond formation or construction of the 
nucleobase on 1’-substituted sugars. The first one being the key step in most nucleoside syntheses. 
Efficient reaction to a single anomer ( or ) and regioselective reaction with the sugar derivative is highly 
desirable. Several efficient N-glycosylation methods have been established, which have been optimized to 
provide mostly the natural -anomers at C1’.[34-35] 
A B
major groove
minor groove
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The synthesis of C-nucleosides was crucial for this project, therefore some synthetic methods for the 
preparation of these nucleosides are presented briefly. A typical synthesis strategy for C-nucleosides is 
attack of a nucleophilic base on a sugar electrophile (Scheme 1-1, a-c). Depending on the 
prefunctionalization of base and sugar, several C-glycosylation methods can be distinguished. Halosugars 
are reacted with organometallic nucleobase derivatives or deprotonated nucleobase precursors (Scheme 
1-1, a).[36-37] Alternatively, a lactone derivative of the sugar (Scheme 1-1, b)[38-39] or the C1’-unprotected 
sugar (Scheme 1-1, c) is attacked by an organometallic nucleobase. In the first case, the resulting hydroxyl 
group is removed in a subsequent reduction (Scheme 1-1, b),[39] for the latter a Mitsunobu reaction is used 
for cyclization (Scheme 1-1, c). Cross couplings are a completely different strategy for C-nucleoside 
synthesis: e.g. a Heck reaction between a 1’-2’ glycal and a Pd-activated aryl halide (Scheme 1-1, d).[40] 
 
Scheme 1-1. Overview of common retrosynthetic strategies for C-glycosylation. Abbreviations: PG = protecting 
group, R = base derivative, M = metal, X = halogen. 
The key step for the synthesis of the salicylaldehyde nucleoside developed by Clever et al. is an example 
for the first approach.[12] A protected bromo base building block 2 was lithiated using tBuLi and 
subsequently transmetalated to a homocuprate (Scheme 1-2). This homocuprate is added to an -chloro 
deoxynucleoside derivative, Hoffer’s chlorosugar 3, and the desired -nucleoside is obtained with 31% 
yield. 
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Scheme 1-2. C-glycosidation in the synthesis of the salicylaldehyde deoxnucleoside. 
C-nucleosides containing (deoxy)ribose are usually prepared by the first three presented synthesis 
strategies (Scheme 1-1, a-c), despite the relatively low yields during C-glycosylation.[12, 41-42] Global 
deprotection of the compound after the glycosylation is often the only required transformation to obtain the 
nucleoside. Since the stereogenic centres at the sugar moiety (apart from C1’) are preinstalled, additional 
reactions are mostly obsolete. Therefore, synthesis routes feature only few reaction steps. 
Pd-catalyzed reactions like Tsuji-Trost[43] and Heck reactions[44] have been employed in the C-
glycosylations as well. For example, the Tsuji-Trost reaction was applied in the total synthesis of L-
showdomycin (Scheme 1-3).[43] After the glycosylation, five reaction steps were necessary to install the 
functional groups of the sugar. These approaches usually obtain higher yields for the C-glycosylation than 
alternative reactions without Pd, but are often less attractive as they increase the number of reaction steps. 
 
Scheme 1-3. Example of a Tsuji-Trost C-glycosylation using a chiral Pd catalyst.[43] 
 
1.3 Chemical (Tri)phosphorylation Methods 
Nucleotides are important compounds in the cellular metabolism, since they act as building blocks for 
enzymatic DNA and RNA synthesis. Moreover, they comprise chemically bound energy,[45] which is 
required for enzymatic reactions (ATP, UTP) and are involved in signal transduction[46] processes (ATP, 
GTP). Key to these functions is the charged phosphate group and the energy-rich phosphoanhydride bond. 
Whereas the most common eight nucleotides (dATP, dCTP, dGTP, dTTP, ATP, CTP, GTP, UTP) are 
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abundant in natural sources and can be obtained from isolated RNA and DNA of microorganism,[47] the 
preparation of modified nucleotides that at best have low natural abundance requires different strategies. 
Several synthetic methods exist, which provide access to nucleoside triphosphates with reasonable effort. 
However, low yields and tedious purifications are common problems. Despite major achievements, by 
Ludwig,[48] Ruth,[49] Eckstein,[33] Hoard and Ott[50] several decades ago, the chemical synthesis of 
triphosphate (derivates) still has potential for improvement. Numerous recent publications[51-54] 
demonstrate the ongoing need for improved methodology, as the number and diversity of applications 
involving (modified) nucleotides keeps growing. Some important chemical methods are highlighted in this 
chapter, since synthesis of artificial and modified triphosphates was essential for this work. 
One of the first feasible chemical nucleotide synthesis was developed by Yoshikawa and coworkers in 
1967. Guanosine monophosphate (4) was prepared from the corresponding nucleoside 5 using phosphorus 
oxytrichloride (POCl3) in trimethylphosphate (Scheme 1-4).[55] Applying contemporary analytical methods 
of that time, the protocol states 90% yield of the desired monophosphate and 5% additionally 
phosphorylated side products. In addition, 5’-monophosphates of inosine, adenosine, xanthosine, uridine 
and cytidine were obtained in yields of 80-91%. The excellent regioselectivity and yield is probably 
attributed to several factors. Addition of water generates HCl in situ and thereby decreases the 
nucleophilicity of the nucleoside after protonation and the effective amount of POCl3 present in the 
reaction. Trimethylphosphate as the solvent generates a homogenous solution and presumbably reacts with 
POCl3 to form an active phosphorylation intermediate 6 similar to reactions of DMF with POCl3 or 
phosphoro-dichloridates.[56]  
 
Scheme 1-4. Chemical monophosphate synthesis by Yoshikawa et al. and suggested phosphorylation 
intermediate 6.[55] 
It was assumed that nucleoside dichlorophosphates are formed using this method, before hydrolysis during 
work-up. Apart from H2O, this electrophilic intermediate could react with further nucleophiles. 
Consideration of this fact, prompted the concomitant development of nucleoside triphosphate syntheses by 
Ludwig and Ruth.[48-49] Based on the method from Yoshikawa and coworkers, nucleoside 
dichlorophosphates were prepared in situ and then reacted with bis(tri-n-butylammonium) pyrophosphate 
((TBA)2PPi). The reaction was quenched by addition of triethylammonium bicarbonate before work-up. In 
this way, Ludwig obtained the 5’-triphosphates of adenosine 7 and 2’-deoxyadenosine 8 in 86% and 78% 
yield (determined by paper TLC), respectively (Scheme 1-5). In contrast to the Yoshikawa protocol, water 
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was omitted in the reaction to the nucleoside dichlorophosphate and addition of a base in the second step 
was found to improve the yield of the nucleoside triphosphates. Despite these changes, the selectivity for 
the 5’-triphosphate was excellent, as less than 0.5% of the 3’-analog from dATP were stated.[48]  
 
 
Scheme 1-5. Chemical triphosphate synthesis by Ludwig.[48] TBA = tributylamine, (TBA)2PPi = bis(tri-n-
butylammonium) pyrophosphate. 
At the same time Ruth and Cheng developed a protocol which was practically identical to the procedure 
published by Ludwig.[49] Several thymidine and 2’-deoxycytidine analogs were converted into the 
corresponding 5’-triphosphates (Figure 1-3) and studied for their ability to inhibit human polymerases ( 
and ) and Herpes simplex virus polymerases. Isolated triphosphate yields of 8-46% (mainly 20-35%) were 
obtained for seven different nucleoside analogs in 95-99% purity (according to HPLC). Lack of an 
additional base during the second reaction step was the only difference to the method from Ludwig. The 
small set of artificial nucleotide analogs already indicated a wide applicability of the chemical 
triphosphorylation method. 
 
Figure 1-3. Nucleotide analogs synthesized by Ruth and Cheng from the corresponding nucleosides. Reaction 
conditions: i) POCl3, (MeO)3PO, –10 °C to rt, 3–15 h, ii) (TBA)2PPi, DMF, –10 °C to rt, 2–3 h, iii) Et3N(aq) to pH 7. 
Over the intervening years, numerous other artificial nucleotides were prepared by this “one-pot, three 
step” method.[8, 13, 42, 57-58] Despite its popularity, this nucleoside triphosphate synthesis method is not 
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universally applicable. For some substrates no 5’-triphosphate or only low yields were obtained, probably 
due to regio- and chemoselectivity issues.[13] 
Preparation of the 5’-monophosphate (including isolation) and subsequent reaction to the triphosphate 
circumvents some of the problems encountered in the one-pot method. In 1959, reaction of 1,1’-
carbonyldiimidazole (CDI) with nucleotide monophosphates to the corresponding imidazolides in mostly 
quantitive yield was published. It was noted that the resulting phosphorimidazolidates represent valuable 
intermediates, which readily react with phosphates, alcohols, amines and carboxylic acids.[59] This enabled 
the synthesis of 5’-diphosphates and even dinucleotide phosphates from monophosphates.[60] By addition 
of bis(tri-n-butylammonium) pyrophosphate to the in situ formed phosphorimidazolidate 9, triphosphates 
were prepared from the four 2’-deoxynucleoside-5’-monophosphates in 36-59% isolated yield (Scheme 
1-6) by Hoard and Ott.[50] Even the 5’-phosphate of di- and trinucleotides was converted to the 
corresponding 5’-triphosphate in 20-70% isolated yield.[50] 
Scheme 1-6. Activation of nucleotide monophosphates to phosphorimidazolides 9 and reaction to triphosphates. 
The formation of 2’,3’-cyclic carbonates with ribonucleoside-5’-monophosphates is one disadvantage of 
CDI which reduces the triphosphate yield.[61] A sulfonyl imidazolium derivative, as an alternative to CDI, 
provides isolated triphosphate yields of 84-90% starting from ribonucleoside monophosphates.[53] The 
suggested reaction mechanism of this more recent approach is discussed in a subsequent chapter (Scheme 
3-22, p. 92). 
A completely different strategy, relying on phosphites as electrophilic intermediates, was developed by 
Ludwig and Eckstein in 1989.[33] Using the salicylphosphite reagent 10,[62] a nucleoside phosphite 11 is 
formed within 10 min, which results in a cyclic phosphate intermediate 12 upon addition of bis(tri-n-
butylammonium). Oxidation and hydrolysis of this intermediate gives the corresponding triphosphate 
(Scheme 1-7). The proposed reaction mechanism was supported by 31P NMR of the crude reaction 
intermediates.[33] To achieve good yields and sufficient 5’-selectivity, protection of the 3’-hydroxyl group 
is required. In situ deprotection by aqueous ammonia after triphosphate formation yielded, e.g. thymidine 
5’-triphosphate from 3’-acetylthymidine in 72% yield. Notably, all reaction steps are performed in one 
flask, without isolation of intermediates and provide moderate to good yields even of modified nucleotides 
(22-72%). A slight modification of the oxidation protocol, using S8 instead of I2, gives 5’-O-(1-
thiotriphosphate)s 13 as R/S-diastereoisomer mixtures. Incorporation of these -sulfur-modified 
triphosphates 13 by polymerases produces DNA and RNA molecules containing phosphorothioate 
backbones. This improves the resistance of these macromolecules towards nucleases.[63] 
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Scheme 1-7. Chemical triphosphorylation method by Ludwig and Eckstein.[33] R1 = ester protecting group, R2 = H, or 
OR (OH in the triphosphate product). B = nucleobases A, C, G, T, U. 
A key variation of the protocol from Ludwig and Eckstein, is based on a changed order of reagent addition. 
Thereby, protecting group-free synthesis of all eight major nucleotides and also an artificial nucleotide was 
achieved from the corresponding nucleosides in yields ranging from 10-50%.[51, 64] The selectivity ratio for 
triphosphorylation of the 5’-hydroxyl over the 3’- or 2’-positions was determined to 85:15.[64] Detailed 
discussion and application of this alternative protocol can be found in chapter 3.1, Scheme 3-4. 
The phosphoramidite group is the synthetic equivalent of an electrophilic phosphate, therefore its 
application in chemical phosphorylations seems obvious. In analogy to the recurring synthesis cycle in 
oligonucleotide synthesis, an iterative phosphorylation protocol was developed by Jessen and 
coworkers.[54, 65] First, a fluorenylmethyl-protected P(III) amidite 14 is coupled to a nucleoside 5’-
monophosphate in 10 min (Scheme 1-8). Notably, the reaction is chemoselective under the applied 
conditions and no protecting groups are necessary on the nucleobase and the sugar. Moreover, anhydrous 
solvents and reagents are obsolete, thus simplifying the protocol. The resulting mixed P(III)-P(V) 
anhydride 15 is oxidized to the P(V)-form 16 by mCPBA in 1 min and the product is precipitated from 
solution. Treatment with 5-10% piperidine deprotects the terminal phosphate group and yields the 5’-
diphosphate after an additional precipitation. The reaction cycle can be started again by coupling of a 
phosphoramdite, oxidation and deprotection to the triphosphate.[54] This iterative procedure provided the 
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diphosphates of the canonical nucleotides in 75-93% isolated yield from the corresponding 
monophosphates. The whole procedure is complete within 30 min and was also used to prepare the 
tetraphosphate from ATP in 50% isolated yield, thus demonstrating its general applicability. In addition, 
this method was successfully transferred to a solid-phase protocol, preparing dGTP from commercially 
available protected 2’-deoxyguanosine CPG support.[54] 
 
Scheme 1-8. Principle of the iterative oligophosphate synthesis developed by Jessen and coworkers.[54] 
1.4 Cu(I)-Catalyzed Alkyne-Azide Cycloaddition 
The concept of “click” chemistry was introduced in 2001 by Kolb, Finn and Sharpless. So-called “click” 
reactions are used to connect two molecular building blocks selectively and are characterized by high 
yields under ambient conditions (water-tolerant) in the presence of many functional groups.[66] The 
bioorthogonal Cu(I)-catalyzed alkyne/azide cycloaddition (CuAAC) is arguably the most widely used click 
reaction.[67] 
Thermally and light-induced reactions between alkynes and azides have been known since 1893, when the 
first synthesis of a 1,2,3-triazoles was described by Arthur Michael.[68] Due to detailed systematic studies 
of 1,3-dipolar cycloadditions in the mid-20th century by R. Huisgen, the alkyne-azide cycloaddition became 
known as the Huisgen reaction.[69-70] Based on his investigations, Huisgen proposed a concerted pericyclic 
mechanism for the reaction between a 1,3-dipole (here: azide 17) and a dipolarophile (here: alkyne 18). A 
stepwise mechanisms for the thermally induced reaction (Scheme 1-9, top) was excluded. Despite its 
applicability for a variety of substrates in the synthesis of five-membered heterocycles, the need for 
elevated temperature (about 100 °C) and the resulting mixture of 1,4 19 and 1,5 regioisomers 20, have 
limited the practical scope of the reaction. In 2002, two research groups independently discovered that 
Cu(I) catalysis provides selectively 1,4-disubstituted 1,2,3-triazoles from alkynes and azides using ambient 
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conditions (Scheme 1-9, bottom).[71-72] Various alkynes and azides were efficiently reacted to triazoles in 
good to excellent yields in water containing solvent mixtures and in the presence of many functional 
groups.[71-72] The simplicity, efficiency and the broad applicability of the CuAAC has led to more than 
1000 research articles within the first decade after the original discovery by the groups of Fokin, Sharpless 
and Meldal.[67] 
 
Scheme 1-9. Overview of the Huisgen reaction and the Cu(I)-catalyzed version (CuAAC). 
In contrast to the concerted Huisgen reaction, the Cu(I)-catalyzed version is a stepwise non-concerted 
reaction.[71] Kinetic studies and DFT calculations were performed to further investigate the mechanism of 
the CuAAC.[73-76] The results suggest a complex multi-step mechanism that starts by initial formation of a 
Cu(I)-alkyne -complex 21 (Scheme 1-10). This complex lowers the pKa of the terminal alkyne by 10 
units, which allows more facile deprotonation and results in a Cu(I)-acetylide 22. Then, the azide 17 binds 
to the copper to form intermediate 23 by replacing one of the ligands (here: H2O or MeCN assumed). The 
distal nitrogen of the azide is attacked, generating a six-membered metallacycle 24 containing a Cu(III) 
species. DFT calculations suggest that this intermediate is very important for the rate acceleration of the 
catalyzed reaction in comparison to the uncatalyzed concerted reaction.[75] Subsequent ring contraction to 
the triazolyl-copper 25 is accompanied by reduction of Cu(III) to Cu(I) and ligand addition. The following 
proteolysis releases the triazole and completes the catalytic cycle.  
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Scheme 1-10. Proposed mechanism of the CuAAC adapted according to Himo et al.  and Rostovtsev et al.[71, 75] B = 
generic base, L = generic ligand, R1 and R2 = any residue except H. 
Experimental data provided evidence for the transition of the alkyne-azide copper complex 23 to the 
triazolyl-copper 25 as the rate-determining step of the CuAAC reaction.[77] Alternative proposals for the 
catalytic cycle involve bimetallic structures and more complicated mechanisms.[74, 76, 78] 
One key finding, which has contributed to the wide applicability of the CuAAC, was a reaction rate 
increase in the presence of some amine-containing compounds.[79] These molecules posess polydentate 
nitrogen donors which can become ligands of Cu(I), thus preventing the formation of unreactive Cu(I) 
aggregates[80] and disproportionation to Cu(0) and Cu(II).[81] Examples of favorable ligands are TBTA 
26,[79-80] THPTA 27[82] and BTTAA 28,[83] which can increase the reaction rate up to 10-100-fold as 
compared to the ligand-free CuAAC. These ligands are azide-alkyne click products and thus contain 
triazoles. Moreover, they posess a tris(triazolylmethyl)amine-motif and only differ in the residues of the 
former azides (Figure 1-4). 
Especially bioconjugations profit from ligand-accelerated CuAACs, as high amounts of copper salts have a 
toxic effect and can hinder in vivo applications.[84] For example the ligands BTTAA 28 and BTTES 29 
were successfully applied for CuAAC-promoted labeling in live zebrafish embryos.[83-84] Due to the 
enormous rate-accelerating effect of the ligand molecules, only 40 µM CuSO4 precatalyst was needed 
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(instead of 500 µM), which did not cause developmental defects in the click-labeled zebrafish embryos.[83] 
Also compounds without nitrogen donors can have a rate-accelerating effect on the CuAAC, like e.g. 
carboxylates and triphenyl phosphine PPh3.[85] Furthermore, solvent ligand effects have been reported.[86]  
 
 
Figure 1-4. Structural formulas of common ligands used in CuAAC. TBTA = tris[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]amine (26), THPTA = tris[(1-hydroxypropyl-1H-1,2,3-triazol-4-yl)methyl]amine (27), BTTAA = 2-[4-
{(bis[(1-tert-butyl-1H-1,2,3-tri-azol-4-yl)methyl]amino)methyl}-1H-1,2,3-triazol-1-yl]acetic acid (28), BTTES = 2-
[4-{(bis[(1-tert-butyl-1H-1,2,3-tri-azol-4-yl)methyl]amino) methyl}-1H-1,2,3-triazol-1-yl]ethyl hydrogen sulfate 
(29). 
Using CuAAC for the modification of oligonucleotides has been particularly fruitful.[87-89] Cu(I)-stabilizing 
ligands were important to the application of CuAAC with DNA, as non-chelated copper ions can damage 
DNA by strand scission.[90] Nucleotides and DNA were prepared containing alkyne groups, which were 
subsequently functionalized with azide-containing reporter molecules by CuAAC.[87] This approach 
enabled the efficient and selective introduction of many modifications, like e.g. fluorophores,[91] sugars,[92-
93] dendrimers,[94] affinity-tags,[95] and aldehydes for metallization.[96] 
Pioneering work from the Carell group established the CuAAC as efficient method to post-synthetically 
modify DNA.[91,96] Therefore, alkyne labels were introduced in the 5-position of the pyrimidine nucleobase. 
The phosphoramidites of the alkyne-uridine analog were synthesized and applied in the solid-phase 
synthesis of alkyne-labeled DNA strands. Varying label densities and two alkyne linker length were 
studied for their ability to undergo efficient CuAAC with fluorophore- and sugar azides 30 (Scheme 1-11). 
Up to six consecutive labels were introduced by click chemistry for the uridine analog 31 containing an 
alkyne on a flexible spacer.[91,96] Notably, the corresponding alkyne-modified deoxynucleoside 
triphosphates (uridine and cytosine analogs) were even accepted as a substrate in polymerase chain 
reactions (PCR). Sequencing proved that the uridine and cytosine derivatives were faithfully incorporated 
opposite a templating A and G, respectively. More than 800 alkyne modifications were introduced into a 
2000 bp long PCR product, of which at least 95% reacted with a sugar azide in a subsequent click 
reaction.[93]  
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Scheme 1-11. CuAAC between an alkyne-modified DNA strand and a glucosyl/galactosyl azide 30 as performed by 
Gierlich et al. [91, 93] R = oligonucleotide 
Several methods have been developed to provide DNA with a “clickable” backbone.[97-100] For example an 
alkynyl phosphinoamidite reagent was developed, which allowed introduction of an alkynyl-phosphonate 
by solid-phase synthesis and subsequent modification by CuAAC.[98] 3’-Azide and 5’-alkyne-modified 
nucleosides were introduced into oligonucleotides by solid-phase synthesis and post-synthetic activated 
ester modification.[97, 100] The efficiency of CuAAC was then exploited to selectively join azide- with 
alkyne-containing DNA strands. This form of “chemical ligation” was even capable of joining non-
templated DNA strands with good efficiency. If both modifications were within a single strand, even non-
templated circularization was achieved at low DNA concentrations (0.4 µM).[97] Remarkably, the templates 
generated by chemical ligation, which contain a triazole in the backbone, can be used for PCR[100] and even 
for in vivo transcription.[101]  
As many molecular-based diagnostic methods require photometrical readouts, fluorophores are the most 
common modification in reporter molecules.[102] The most important applications of fluorescently-labeled 
(oligo)nucleotides are arguably sequencing approaches[103] and probes for fluorescent in situ hybridization 
(FISH) in genome analysis.[104] Nucleotides with fluorophores on the terminal phosphates are suitable 
substrates in single-molecule real-time sequencing methods.[3,7] Despite numerous applications of the 
CuAAC on oligonucleotides, it had not been used for the synthesis of phosphate-modified nucleotides.  
1.5 Application of Artificial Nucleosides and Nucleotides 
1.5.1 Therapeutic Nucleosides and Nucleotides 
The first nucleosides and nucleotides that were prepared by chemical synthesis were essential for the 
structural elucidation of natural nucleosides.[20] In order to study their biological role, a sufficient supply of 
these compounds was necessary. By developing the chemical methods of nucleoside chemistry, several 
non-natural nucleosides were prepared as model substrates.[105] Thereafter, the first non-natural nucleosides 
and nucleotides were studied for their ability to be accepted as substrates for nucleoside-converting 
enzymes in vitro.[106] This provided insight into biocatalysis of these enzymes and ultimately yielded 
candidates for antiviral therapy. Several artificial nucleosides have become efficacious antiviral agents for 
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treatment of retroviral diseases. The most common agents arguably are acyclovir 32[107] and penciclovir 
33[108] used in labial Herpes simplex infections (Figure 1-5). Notably, acyclovir is non-toxic to normal cells 
and only displays its antiviral effect in infected cells.[109] Even severe retroviral diseases like AIDS and 
hepatitis infections are treated by nucleoside analogs. One example is emtricitabine 34 (Figure 1-5), which 
is a reverse transcriptase inhibitor used for the treatment against human immuno deficiency virus.[1] Many 
of these compounds are antimetabolites of the natural nucleosides (and nucleotides) and terminate the viral 
RNA and DNA polymerisation upon incorporation of the nucleotide analog. 
 
Figure 1-5. Structural formulas of selected nucleoside analogs used in antiviral therapy.  
It is noteworthy that most of these nucleoside drugs must be transformed into the corresponding 
triphosphate whithin the cell in order to display an inhibitory effect. Especially the first phosphorylation 
step to the monophosphate can be slow and thus lower the efficacy of the drug, as the intracellular 
triphosphate amount becomes limiting.[110] In order to circumvent this problem, the more recently 
developed sofosbuvir 35 (Figure 1-5) represents a monophosphate prodrug with good bioavailability, 
which is quickly reacted to the corresponding triphosphate intracellularly.[111] This uridine analog 35 is 
used in the treatment against hepatitis C viral infections. Moreover, artificial nucleosides are used for the 
treatment of Ebola virus disease (BCX4430)[112] and cancer (e.g. gemcitabine),[2] thus demonstrating the 
importance of this compound class for human health. 
1.5.2 Unnatural Base Pairs – Alternative Hydrogen Bonding 
Instead of inhibiting the nucleotide-consuming enzymes, the creation of artificial nucleotides, which 
cooperate with the enzyme machinery like a natural nucleotide represents an even greater challenge. Since 
natural DNA consists of four major bases which form two different base pairs, a triplet codon is necessary 
to provide 43 = 64 combinations. Living organisms encode with 61 codons 20 canonical amino acids and 
they utilize three stop codons within these 64 combinations.[113] By adding a single base pair to the natural 
bases the number of potential codons could be increased to 63 = 216, thus providing new codons for non-
canonical amino acids. This expansion of the genetic code is one major goal in synthetic biology and has 
the potential to provide access to novel biocatalysts by semi-synthetic organisms in the future.[4] 
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More than 50 years ago, the idea of an unnatural base pair was proposed, which could provide DNA with 
novel functionality and expand the genetic code.[114] In the late 1980s, the first studies on unnatural base 
pairs were performed in the groups of Rappaport[115] and Benner,[116] using the concept of alternative 
hydrogen bonding patterns. These unnatural nucleobases represented only slight modifications of the 
natural G:C pair 36:37 (Figure 1-6). Rappaport observed that his 6-thioguanine:5-methyl-2-pyrimidinone 
pair (GS:TH, 38:39) was about as stable as a natural A:T base pair.[115] Subsequent studies involving the 
large Klenow fragment (KF) polymerase I from Escherichia coli (E. coli) observed mutation of GS:TH to 
G:C.[117] Benner and coworkers demonstrated sufficient fidelity of in vitro replication and transcription for 
their iso-G:iso-C base pair 40:41.[118] Moreover, ribosomal translation of this unnatural base pair into a 
non-canonical amino acid was achieved in vitro.[119] These early efforts represented a first proof-of-concept 
that an expansion of the genetic code by unnatural base pairs is possible. 
 
Figure 1-6. Structural formula of the natural G:C base pair compared to the unnatural iso-G:iso-C and GS:TH base 
pairs, which interact via an alternative hydrogen bonding pattern. R = Sugar and phosphate residues. 
Despite these outstanding results, the iso-G:iso-C base pair 40:41 has several shortcomings. The tautomeric 
enol-form of the iso-G 40 (iso-G*) forms a mispair with T, the deamination product of iso-C 41 is 
misinserted opposite of A and finally the transcription is inefficient.[120] By replacing the natural thymidine 
triphosphate (dTTP) with a 2-thiothymidine variant, the iso-G*:T misinsertion is destabilized, while the 
A:T pair remains unaltered, thus improving the fidelity of the iso-G:iso-C replication. This improvement is 
sufficient to allow PCR amplification of DNA containing the unnatural base pair.[121] A fidelity of 98% was 
determined for each replication of the iso-G:iso-C pair 40:41 under these conditions, leading to a loss of 
32.2% (1-0.9820) of the unnatural base pairs after 20 PCR cycles. Redesign of the iso-G:iso-C 40:41 
recently resulted in the P:Z pair 42:43, which does not tautomerize and which is formed with better 
selectivity (Figure 1-7). The fidelity in PCR amplification was improved to 99.8% per cycle[122] and even 
transcription and reverse transcription was performed.[123] 
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Figure 1-7. Structural formula of the P:Z, x:y and s:y pair. R = Sugar and phosphate residues. 
Hirao and coworkers developed artificial base pairs, which also relied on hydrogen bonding for 
interaction. The design especially of the initial x:y pair 44:45 (Figure 1-7) closely ressembled the GS:TH 
38:39 (Figure 1-6) reported by Rappaport a decade earlier. Therefore, it was not so surprising that the x:y 
base pair 44:45 was mutated during replication by polymerases.[58, 124] In order to decrease the mispair 
formation, a sterically more demanding thiophenyl group was installed at the 6-position of the purine 
nucleobase 46.[125] This modification improved the selective enzymatic pairing and transcription of the s:y 
pair 46:45 (Figure 1-7). Although transcription of s 46 into y 45 was faithfully possible, transcription of y 
45 into s 46 was not satisfying. Hence, an artificial tRNA had to be prepared by a combination of chemical 
synthesis and enzymatic ligation, containing s 46 in the anticodon loop, to circumvent the selectivity issue. 
This allowed in vitro transcription and translation of the s:y unnatural base pair 46:45 into a 3-
chlorotyrosine containing protein.[126] 
1.5.3 Hydrophobic Unnatural Base Pairs 
Already in 1958, experimental and theoretical results by Sturtevant et al. indicated that hydrogen bonds are 
not the sole force of DNA stability.[127] Several factors have been identified which contribute to the non-
hydrogen bonding interactions. Among these, geometrical selection, the hydrophobic effect and packing 
forces between aromatic systems, also known as -stacking, have been identified to be most important.[4]  
In 1997, Kool and coworkers prepared the thymidine analog, 2,4-difluorotoluene nucleoside F 47, which 
was incorporated selectively opposite a templating adenine by KF polymerase in vitro.[128] In addition, an 
isosteric adenine variant Q 48, lacking all interstrand hydrogen bond donating and accepting groups was 
developed. It was demonstrated that Q 48 was an efficient template for F 47 insertion.[11] The absence of 
any hydrogen bond between the F:Q pair 47:48 (Figure 1-8) clearly demonstrated that alternative 
interactions are sufficient for selective pairing and that hydrogen bonding is not essential to form base 
pairs.[11, 129]  
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Figure 1-8. Structural formulas of unnatural base pairs from the Kool group (F:Q) and from the Hirao group (Pa:Ds 
and Px:Ds). R = Sugar and phosphate residues. R1 = HNCO(CH2)5-NH2, 51* was used to introduce modifications 
after PCR. 
Using the concept of predominately hydrophobic pairing, Hirao and coworkers developed the Pa:Ds 
unnatural base pair 49:50 (Figure 1-8). PCR amplification with a fidelity of more than 99% per cycle was 
achieved, when -amidotriphosphates of Ds and dA were used and transcription succeeded with less than 
5% mutation of the Pa:Ds 49:50 pair.[130] Replacing the aldehyde of the Pa 49 with a nitro group and 
introducing a conjugated alkyne resulted in the Px:Ds pair 51:50 (Figure 1-8). This variant improved the 
fidelity during PCR to more than 99.9% per cycle and allowed introduction of a fluorophore after 
enzymatic amplification if a modified Px 51* was used.[10] 
The Romesberg group has extensively studied the concept of unnatural base pairs, which rely on 
hydrophobic effect and -stacking.[4] Early studies majorly focussed on bicyclic self-pairs, featuring 
naphthyl and indole derivatives. Several potential unnatural base pairs were identified, which were 
incorporated by polymerases at rates one to three orders of magnitude slower than the natural nucleotides 
and possessed acceptable selectivities.[131] However, synthesis after the incorporation of the unnatural bases 
was inefficient. NMR structure of a DNA containing the PICS-PICS self-pair 52:52 (Figure 1-9) revealed 
that the large aromatic areas pair in an intercalative manner, which might misplace the 3’-OH terminus for 
the subsequent nucleotide addition.[132] In order to circumvent this problem, monocyclic aromatic systems, 
like pyridine and benzene derivatives were studied as unnatural base pair candidates.[44, 133-135] Some of 
these candidates were incorporated and extended by DNA polymerase with reasonable efficiency.[134] The 
key observations from these studies were conflicting with a rational design approach: Hydrophobic 
interactions favor fast formation of the unnatural base pair, but hinder further extension. Minor groove 
hydrogen bond acceptors favor subsequent elongation, yet decrease the efficiency of initial unnatural base 
pair formation. Therefore, a screening effort comprising more than 3600 possible artificial base pairs was 
undertaken to investigate formation and extension of unnatural base pairs. This screen found the 
MMO2:SICS pair 53:54 (Figure 1-9) to perform best.[136] Moreover, the two nucleobases possess minor 
groove hydrogen bond acceptors ortho to the glycosidic bond. Both hydrogen bond acceptors (methoxy 
and thiocarbonyl) are rather hydrophobic, thus combining the “contradictory” properties required for 
efficient enzymatic replication. 
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Figure 1-9. Structural formulas of selected unnatural base pairs from the Romesberg group. R = Sugar and phosphate 
residues. 
Introduction of a methyl group to the SICS, further improved the unnatural base pair and resulted in the 
5SICS base 55, which still paired with MMO2 53. This MMO2:5SICS pair 53:55 was replicated by several 
different DNA polymerases.[137] The NaM:5SICS pair 56:55 (Figure 1-9) was obtained from further 
optimization efforts and enzymatic replication efficiency was within 6- to 490-fold lower than a natural 
base pair.[9] Massive PCR amplification of NaM:5SICS containing DNA without significant mutation of 
the unnatural base pair demonstrated a fidelity of at least 99.9% independent of the sequence context. The 
error rates of 10–3 to 10–4 per nucleotide calculated for the unnatural base pair are similar to the 10–4 to 10–7 
observed for natural base pair amplification.[138] Despite this achievement, reoptimization of 5SICS 55 
resulted in NaM:TPT3 56:57 as a further improved base pair.[5] A PCR-based screen of about 6000 
unnatural base pair candidates, confirmed NaM:TPT3 56:57 as the “best” unnatural base pair known to 
date, but also found several other pairs, which performed better than the NaM:5SICS pair 56:55. Some of 
these alternative candidates are shown in Figure 1-10.[8] 
 
Figure 1-10. Structural formulas of unnatural base pairs with a better efficiency and fidelity in PCR than the 
NaM:5SICS base pair 56:55. R = Sugar and phosphate residues. 
Nevertheless, in vivo replication and propagation of the NaM:5SICS unnatural base pair 56:55 was 
achieved in E. coli.[139] The artificial nucleotide supply within the host cell was a major obstacle, as 
intracellular nucleotide biosynthesis from the unnatural nucleosides provided in the medium was 
insufficient. Finally, a nucleotide transporter was overexpressed in E. coli, which allowed uptake of 
dNaMTP and d5SICS from the medium. A plasmid containing a single NaM:TPT3 base pair 56:57 was 
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transformed into the cells and was isolated from the culture after 20 h growth. LC-MS/MS analysis of free 
nucleosides from the digested plasmid detected a single unnatural base pair per plasmid and thus 
demonstrated the successful in vivo replication. In addition, Sanger sequencing and biotin-label based 
amplification assays were in accordance with mass spectrometry data.[139]  
1.5.4 Metal-Base Pairs 
Metal-base pairs represent the third class of unnatural base pairs, which have been studied. Such base pairs 
incorporate a central metal cation serving as a ligand for coordination. Viscosity changes in thymidine-rich 
DNA-containing samples in the presence of Hg(II)-ions were already observed in 1952, which prompted 
the proposal of a thymidine-mercury-thymidine complex (58 Figure 1-11) by Katz.[140] More than 50 years 
later, Ono and coworkers showed that a thymidine-thymidine mismatch was thermodynamically stabilized 
by Hg(II)-ions[141] and proved the metal-base pair structure by NMR spectroscopy.[142] In the meantime, 
several natural mismatches have been discovered to serve as a scaffold for metal-cations. For example, C-
C (37, Figure 1-11),[143] C-T,[144] and C-A[145] mismatches are stabilized by Ag(I)-ions. These findings have 
led to several DNA-based applications.[146-147] For example, selective binding of mercury ions by T-T 
mismatches has been used to construct a DNA-based Hg(II) sensor.[146] Remarkably, the Ag(I)-mediated 
mismatch formation between C-T or C-C and the T-Hg(II)-T base were selectively formed and elongated 
by KF or Thermus aquaticus polymerase, the latter just for elongation.[148-149] 
 
 
Figure 1-11. Structural formula of the T-Hg(II)-T and the C-Ag(I)-C base pair. R = Sugar and phosphate residues. 
The first metal-base pair between two artificial nucleobases inside DNA was reported by Meggers et al. in 
2000.[150] A DNA duplex containing a central Dipic:Py pair (59:60, Figure 1-12) was thermally stabilized 
in the presence of Cu(II) ions. Therefore, it was suggested that metal-ligand coordinative bonds can 
potentially replace the hydrogen-bonding for interstrand interaction in unnatural base pairs.[150-151] Shionoya 
and coworkers developed a hydroxypyridone variant H 61, which forms H-Cu(II)-H pairs (Figure 1-12) 
and was used to stack several metal-ions inside the DNA helix. Despite these major changes compared to 
natural DNA double strands, CD-spectroscopy indicated B-form DNA for a duplex containing five 
consecutive metal-base pairs.[152] In the presence of Fe(III) even triple-helix complexes were reported for 
the H ligandoside 61 in adequately designed DNA strands.[153] Some structural insight was provided by 
Johannsen et al. for a silver-ion mediated imidazole self-pair (62, Figure 1-12). A DNA duplex containing 
20  Introduction 
 
three consecutive Im-Ag(I)-Im metal-base pairs was analysed by NMR spectroscopy. The structure 
revealed only minor structural changes compared to normal B-form DNA.[154]  
 
Figure 1-12. Selected metal-base pairs, which form inside DNA double strands and involve artificial nucleobases. 
R = Sugar and phosphate residues. 
Inspired by the famous salen ligand from homogenous catalysis,[155] Clever et al. developed a 
salicylaldehyde nucleoside S 63. Imine formation upon addition of ethylenediamine crosslinks two 
opposing salicylaldehydes and the resulting scaffold forms a Cu(II) salen complex 64 (Figure 1-13, A). 
Due to the properties of the imine bond and the metal complexation, this reaction is reversible in aqueous 
solutions. In the presence of ethylenediamine and Cu2+, DNA double strands containing a single central 
salicylaldehyde pair displayed a 30 K increase in the melting temperature in comparison to a natural 
duplex. Compared to other published metal-base pairs this was the strongest thermal duplex stabilization 
reported at that time.[12] Moreover, DNA salen metal complexes for Mn(III), Fe(III), Ni(II) and VO(II) 
were observed by electrospray ionization mass spectrometry[156] and a full helical turn of metal ions, i. e. 
ten consecutive base pairs, was stacked inside DNA (Figure 1-13, B).[157] More recently, electron transfer 
through a single DNA double-strand containing the salen metal-base pair was studied and displayed an 
increased conductivity in the presence of the Cu(II) complex.[158] 
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Figure 1-13. (A) Two salicyladehyde bases 63 form the copper salen base pair 64 in the presence of ethylenediamine 
and a Cu(II)-salt. R = Sugar and phosphate residues. (B) Computer model of the duplex containing ten consecutive 
Mn(III)-salen complexes from Clever et al.[157] 
Most remarkably, the Cu(II) complexing salen self-pair 64 is capable of being amplified by PCR. In 
addition, even a X-ray crystal structure was obtained of a DNA polymerase with the salen complex-
containing DNA.[13] The structure proved that the salicylaldehyde bases were covalently cross-linked by 
ethylenediamine with a copper ion sequestered in the centre. In comparison to a natural base pair, the 
Cu(II)-salen duplex was widened (Figure 1-14). Since replication of the salen base pair 64 was faithfully 
possible in the presence of Cu(II)-ions and ethylenediamine, the next step aimed for is transcription and 
translation.  
 
Figure 1-14.[13] Crystal structure of the binary complex between Geobacillus stearothermophilus polymerase I and a 
DNA with a central salen base pair (yellow), with ethylenediamine and copper (bottom) and without (top). 
A
B
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2 Aim of the Project 
Many modified nucleosides have been introduced into DNA and RNA by the solid-phase synthesis 
technique using phosphoramidite chemistry. However, this method is limited to provide oligonucleotides 
of up to 150-200 bases length at its best.[159] Longer DNA strands can be obtained by biochemical methods, 
like the polymerase chain reaction[160] based assembly of numerous synthesized oligonucleotides.[161] The 
enzyme machinery involved in handling of oligonucleotides was selected for hundreds of million years to 
minimize mutation to an acceptable rate.[162] As a result, the efficient enzymatic incorporation of non-
canonical nucleotides represents a tremendous challenge. 
To date a variety of artificial base pairs were described which are independent from hydrogen bonds for 
base pair formation and rely on hydrophobic interactions.[8, 11, 138-139, 163] Notably, metal-complexation has 
been used as an alternative strategy for unnatural base pair formation. Several nucleobase-metal complexes 
have been reported inside DNA.[12, 150-152, 154] Very few of these so-called metal-base pairs can be formed or 
extended by polymerases.[13, 145, 149] The salen metal-base pair was developed by Clever et al. and provides 
DNA with a highly increased thermal stability.[12] Recently, faithful replication of the salen base pair in 
polymerase chain reactions (PCR) was demonstrated in the presence of Cu2+ and ethylenediamine.[13] Next 
to the incorporation in PCR, the transcription of artificial base pairs is required for the expansion of the 
genetic code. Whether a metal-base pair can be transcribed into RNA and even translated into proteins was 
so far unknown. This research project focussed at the study of transcription and translation of the salen-
metal base pair. Therefore, generation of RNA strands with the salicylaldehyde base was to be studied 
using T7 RNA polymerase as well as solid-phase synthesis. In order to achieve this very challenging goal 
mutation of the corresponding enzymes was to be analyzed as well. 
One drawback of the salen metal-base pair is its dependence on metal complexation for bond formation, 
which greatly complicates in vivo applications. Thus, a novel base pair, independent of metal complexation 
and external amines, was of interest. A novel base pair was to be developed in allusion to the sterical 
properties of the salen base pair. Therefore, a set of different amine nucleosides was to be designed, 
synthesized and analyzed for reversible base pair formation with the salicylaldehyde nucleoside. The effect 
of such an amine-aldehyde base pair on the DNA duplex stability and structure was to be studied by 
temperature-dependent UV- and CD-spectroscopy. Candidate base pairs, which stabilize the double strand 
were to be used for primer extension and X-ray structural analysis.  
Fluorophore-modified nucleotides are an important part of modern sequencing methods, since they allow 
facile imaging of the enzyme reaction.[103] Depending on the sequencing method, fluorescent dyes are 
either introduced to the nucleobase[164] or the terminal phosphate.[3] Modifications at the terminal phosphate 
are cleaved upon nucleotide incorporation and thus allow real-time detection of the sequencing reaction.[7, 
165] Synthesis of phosphate-modified nucleotides can be cumbersome.[7] Therefore, another goal of the 
thesis was the development of a modular strategy relying on Cu(I)-catalyzed azide-alkyne cylcloadditions 
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(CuAAC)[71-72]. Introduction of short alkyne chains to the -phosphate of nucleoside triphosphates, was 
supposed to allow facile modification with different azido-flurophores using CuAACs. The resulting 
labeled nucleotides could be substrates in real-time experiments involving polymerases, like e.g. next-
generation sequencing. Therefore, enzymatic acceptance of the labeled nucleotides by DNA, RNA 
polymerases and kinases had to be studied. In addition, chemoenzymatic introduction of bioorthogonal 
labels to oligonucleotides was attempted. 
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3 Results and Discussion 
In course of this PhD thesis, three major projects were investigated, centered around the chemical synthesis 
of artificial nucleotides and their application in enzymatic reactions. From the chemical point of view, the 
synthesis of C-nucleosidation was challenging, as there is no established general method and the yields are 
often lower in comparison to the corresponding N-nucleosides. Also, the chemical formation of 
triphosphates is cumbersome, due to regio- and chemoselectivity issues. Since the subsequent biochemical 
assays require only small amounts of the nucleotides and oligonucleotides, low-yielding steps in the 
synthesis were tolerable to a certain extent and tedious optimization was neglected. From the biological 
side, the specificity of the enzymes for their natural substrates was the greatest obstacle we needed to 
overcome with respect to the design of the artificial nucleotides. Many DNA and RNA polymerases were 
optimized during millions of years of evolution to faithfully replicate the oligonucleotide template. 
Therefore, variation of the in vitro conditions during enzymatic assays was crucial, to force incorporation 
of the artificial substrates. In addition, the consequences of mutagenesis on substrate selection and 
processivity were investigated in the case of the T7 RNA polymerase. The outcome of the enzymatic 
reaction was evaluated by polyacrylamide gel electrophoresis and MALDI-TOF mass spectrometry. 
Part I – Efforts Towards Faithful Transcription and Translation of a Metal 
Base Pair 
3.1 Synthesis of a Salicylaldehyde Ribonucleotide 
The initial focus of this work was to analyze whether the salicylaldehyde base (S) pair is capable of being 
transcribed into RNA. Therefore, the phosphoramidite of the deoxyribose salicylaldehyde was synthesized 
according to published methods and used to generate the DNA template.[12] In addition, a ribonucleotide 
form of the salicylaldehyde base was needed for the incorporation by the RNA polymerase. Moreover, a 
salicylaldehyde RNA phosphoramidite was to be synthesized to allow solid-phase synthesis of RNA 
strands that could be used as authentic standards for the enzymatic experiments. 
The synthesis of the salicylaldehyde triphosphate 1 (STP) was designed to have a final triphosphorylation 
step of a salicyladehyde nucleoside 65 ( 
Scheme 3-1), which could be accessed from its protected nucleoside 66 by silyl ether and acetal cleavage. 
In a convergent reaction, this nucleoside 66 was synthesized by nucleophilic addition of a protected bromo 
salicylaldehyde 2 to the carbonyl of a TBS-protected ribolactone 67 and subsequent reduction following a 
method described by Štefko et al.[39] The TBS-ribolactone 67 could be obtained in a two-step one-pot 
sequence from natural D-ribose according to published protocols.[166-167] To provide multigram amounts of 
the protected bromo salicylaldehyde 2, which was also needed for the synthesis of the corresponding DNA 
compound, a three-step procedure starting with 3-bromophenol was performed as described by Clever et 
al.[12] 
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Scheme 3-1. Retrosynthetic analysis of salicylaldehyde triphosphate 1 (STP). 
The key step of the salicylaldehyde triphosphate 1 synthesis was the C-glycosylation reaction. After a 
bromide-lithium exchange at the protected salicylaldehyde 2 using tBuLi at ‒78 °C, the TBS-ribolactone 
67 was added and the resulting deprotonated hemiketal 68 was trapped with acetic anhydride (Scheme 
3-2). Despite the sensitivity of the acetylated nucleoside 69 towards heat and acid, modifications of the 
initial protocol enabled synthesis of the nucleoside precursor 69 with 77% isolated yield. In contrast to this, 
the non-acetylated hemiketal 68 was chemically stable under neutral and slightly acidic conditions and 
could be isolated in 84% yield, when the acetylation step was omitted. Based on NMR data, both 
hemiketals were exclusively isolated as the  anomer, as reported for the synthesis of related C-
ribonucleosides.[39] 
 
 
Scheme 3-2. Synthesis of acetylated nucleoside 69 from protected salicylaldehyde 2 and TBS-protected 
ribolactone 67. 
In order to eliminate the additional functional group and to obtain the nucleoside 66, a subsequent 
reduction using a hydride source under Lewis acid conditions was necessary. Therefore, the procedure 
from Štefko et al. was adapted with regards to temperature and solvent. The reaction starts with a 
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deoxygenation to an oxonium intermediate that is subsequently reduced by the hydride source. In the final 
protocol Et3SiH and BF3∙OEt2 in toluene at ‒20 °C provided the desired protected -nucleoside 66 in 74% 
yield (Scheme 3-3). The quality of the reagents and a strict temperature control was crucial for the success 
of the reaction. Moreover, only the chemically unstable acetylated hemiketal 69 was reasonably converted 
under the reaction conditions, whereas no conditions were found to provide more than traces of 
nucleoside 66 from the reduction of the non-acetylated hemiketal 68. Instead, Lewis acid-mediated 
deprotections of the acetal and silyl ether groups were observed. This illustrates the role of the leaving 
group on the speed of the oxonium intermediate formation. Also, no  anomer of the protected nucleoside 
66 could be isolated when using toluene as a solvent. 
 
Scheme 3-3. Synthesis of the salicylaldehyde nucleoside 65 from acetylated hemiketal 69. 
For the subsequent global deprotection to the salicylaldehyde nucleoside 65 HF∙pyridine was used in a 
THF/H2O mixture. This enabled the cleavage of all silyl ether groups and hydrolysis of the acetal with a 
moderate isolated yield of 55%. Unfortunately, flash column chromatography and the work-up procedure 
could not separate the 1,3-propanediol released from the acetal deprotection completely. After HPLC-
purification the desired nucleoside 65 was pure enough to be used in the triphosphate reaction setups. 
In contrast to the enzyme-catalyzed biosynthesis of triphosphates, the chemical synthesis of these charged 
and highly functionalized molecules can be cumbersome. Even famous methods like the one by Ludwig 
and Ruth from the early eighties (Scheme 1-5, p. 6),[48-49] which represented the only feasible protocol for 
many years that was widely used, proved to be incompatible with the synthesized artificial nucleotides and 
resulted in only minor triphosphate yields. The application of this method to the salicylaldehyde 
deoxynucleoside provided only 2% yield of the corresponding triphosphate after several rounds of RP-
HPLC purification.[13] In 2011 a further improved protocol of the Ludwig and Ruth method was published 
by J. Caton-Williams et al.,[51] which relied on a salicylic phosphite reagent 10 instead of POCl3 (Scheme 
3-4). This phosphite 10 reacts with tributylammonium pyrophosphate to generate a “triphosphate reagent” 
70 in situ (Scheme 3-4), which is less reactive and displays a better regioselectivity when applied to a 
nucleoside. Subsequent oxidation and hydrolysis is followed by NaCl-ethanol precipitation, which yields 
crude triphosphates of sufficient purity for being accepted by polymerases.[51, 64]  
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Scheme 3-4. Suggested mechanism of the salicylic ribonucleotide 1 synthesis using a salicylic phosphite reagent 10 
adapted according to J. Caton-Williams et al.[51] 
When this novel protocol was applied to the salicylaldehyde ribonucleoside 65 an isolated yield of 13% 
was obtained for the ribonucleotide 1, which significantly improved the yield compared to the 
corresponding deoxyribonucleotide. To avoid inhibitory contaminations for the RNA polymerase in the 
transcription assay, the crude ribonucleotide 1 was purified twice by RP-HPLC. The resulting 
salicylaldehyde triphosphate (STP) 1 was analyzed by analytical RP-HPLC, high-resolution ESI mass 
spectrometry and NMR. It is noteworthy that the crude STP 1 which was obtained after NaCl-ethanol 
precipitation of the reaction was already reasonably pure, as the main peak corresponds to the isolated 
triphosphate 1 (Figure 3-1, A and B). Even after two-fold purification, minor peaks were observed in the 
chromatogram in addition to the strong signal at 27.6 min (Figure 3-1, B). ESI MS revealed that all peaks 
possessed the STP molecular mass. In order to exclude contamination by triphosphate (regio)-isomers, the 
NMR spectra were carefully analyzed. The 1H-decoupled 31P NMR spectrum showed three signals, from 
the triphosphate phosphorus atoms. Due to the 2JP-P coupling two doublets and one triplet were observed 
from –23 to –11 ppm (data not shown). The triplet was readily assigned to the -phosphate phosphorus. In 
order to assign the remaining signals, a proton-coupled 31P NMR was measured. The 3JP-H coupling 
between the -phosphate phosphorus and a nucleoside proton changed the doublet at –11.5 ppm to a 
doublet of triplets (Figure 3-1, C). This indicates a coupling to a methylene proton. Since the 
salicylaldehyde nucleoside only possesses a single methylene group at the 5´-position, this finding 
confirms that the main product is the desired 5´-STP. The remaining doublet had to originate from the -
phosphate. All signals of the 1H NMR were readily assigned aided by COSY and HSQC spectra. No 
signals except those of the salicylaldehyde 5´-triphosphate were found in 1H NMR and 31P NMR spectra. 
This means that the purified STP was at least 95% pure despite the minor peaks detected by analytical RP-
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HPLC. Probably, depending on the number of counterions of the 5´-triphosphate during HPLC, minor 
shifts of the retention time can occur. 
  
 
Figure 3-1. Analytical HPLC profiles of crude (A) and purified (B) STP 1 at 260 nm, 0-30% B in 45 min. (C) 
31P NMR spectrum of the purified STP. The three signals were assigned to the -, - and -phosphate, respectively. 
The doublet of triplets at –11.4 ppm for the -phosphate proves the formation of the 5´-triphosphate. 
3.2 Synthesis of a Benzaldehyde Ribonucleotide 
In order to study the role of the ortho-hydroxy group in the salicylaldehyde base, a benzaldehyde 
nucleoside was synthesized, transformed to the triphosphate and then also applied in the transcription 
assay. The synthesis of the benzaldehyde nucleoside was achieved based on the established route for the 
salicylaldehyde nucleoside. This time, the benzaldehyde base building block 71 was readily available in 
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one step from commercial 4-bromobenzaldehyde (72) in 97% yield, without the need for flash column 
chromatography.[168] The subsequent C-glycosylation using the protocol from the salicylaldehyde 
nucleoside synthesis without acetylation, yielded 73 in an excellent 91% after isolation, even on a 
multigram scale (Scheme 3-5). However, when the in situ acetylation was applied, the resulting acetylated 
hemiketal was not stable enough to withstand flash column chromatography. Instead, the crude product 
containing about 60% (judged by 1H NMR) of the acetylated product was used directly in the subsequent 
reduction to the protected nucleoside 74. Under the conditions that were successful for the synthesis of the 
salicylaldehyde nucleoside, no desired protected nucleoside 74 was obtained. In contrast, however the non-
acetylated hemiketal could be reduced to the protected nucleoside 74 in an excellent 93% isolated yield, 
using a slightly modified protocol. Moreover, in addition to the fully protected nucleoside 74, 4% of TBS-
protected nucleoside without the acetal group was detected, which formed from Lewis acid-promoted 
deprotection during the reduction. As the subsequent reactions to the benzaldehyde nucleoside were 
deprotection steps, this side product was valuable. Interestingly, the minor change of the base building 
block for the benzaldehyde nucleoside compared to the salicylaldehyde had a pronounced effect on the 
reactivity. 
 
Scheme 3-5. Synthesis of the protected benzaldehyde nucleoside 74 starting from commercially available 4-
bromobenzaldehyde (72). 
For the global deprotection of the benzaldehyde nucleoside 74, two strategies were tested. At the 
beginning, a combined silyl ether and acetal deprotection approach according to the known procedure for 
the similar salicylaldehyde nucleoside synthesis was examined. However, this resulted exclusively in silyl 
ether cleavage, giving 52% of the acetal nucleoside 75 (Scheme 3-6). Subsequent acetal cleavage using 
HCl in a MeOH/H2O mixture provided the benzaldehyde nucleoside 76 in good 87% yield, but 
unfortunately the 1,3-propanediol was only separable by RP-HPLC. 
In order to avoid the time-consuming HPLC purification, in the second deprotection strategy the reaction 
steps were simply reversed. The acidic acetal deprotection using an aqueous HCl/THF mixture gave the 
TBS-protected benzaldehyde nucleoside 77 in 86% isolated yield (Scheme 3-6). As expected, standard 
flash column chromatography was sufficient to separate the polar 1,3-propanediol from the much less polar 
TBS-protected benzaldehyde nucleoside 77. Silyl ether cleavage using HF∙pyridine provided only 33% of 
the benzaldehyde nucleoside 76 and in total 52% of partly deprotected side products. The one- and 
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twofold-deprotected products were subjected to another round of silyl deprotection. Efforts replacing HF 
as a fluoride source by TBAF suffered from purification difficulties. As the obtained amounts of 
benzaldehyde nucleoside 76 were sufficient for the triphosphate reaction, further optimization of the silyl 
deprotection reaction was not performed. 
 
Scheme 3-6. Synthesis of the benzaldehyde nucleoside triphosphate 78 from protected nucleoside 74 by acetal 
hydrolysis, silyl ether deprotection and triphosphate formation. 
The reaction to the desired benzaldehyde nucleoside triphosphate 78 was performed according to the 
protocol from J. Caton-Williams et al.[51, 64] Fortunately, the first attempt already resulted in successful 5´-
triphosphate formation and after a two-fold RP-HPLC purification the benzaldehyde ribonucleotide 78 was 
isolated in 10% yield. Based on analytical RP-HPLC the purity was estimated to be about 95% (Figure 3-2, 
A). Due to a low signal to noise ratio of the proton-coupled 31P NMR spectrum (Figure 3-2, B), an 
additional 31P-1H HMBC measurement was necessary to unambiguously prove the identity of the 5´-
triphosphate (data not shown). 
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Figure 3-2. (A) Analytical RP-HPLC trace and (B) 31P NMR spectrum of the purified AldTP 78. HPLC conditions: 
0–20% B in 45 min, detection at 260 nm. 
In conclusion, the benzaldehyde nucleoside triphosphate 78 synthesis was achieved in a six-step sequence 
from commercial starting materials. Although the benzaldehyde nucleoside just lacks the ortho-hydroxyl 
group of the salicylaldehyde, considerable differences were observed regarding the reactivity of the 
molecule in the synthesis. Most notably, the yield of the addition-reduction C-glycosylation procedure 
increased from 56% for the salicylaldehyde to 84% for the benzaldehyde derivative. Also, an enhanced 
stability of the acetal protecting group was noticed. A neighboring group effect could account for the more 
facile acetal hydrolysis during silyl deprotection of the salicylaldehyde compared to the benzaldehyde 
derivative.  
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3.3 Synthesis of a Salicylaldehyde Ribophosphoramidite 
In case of a successful salicylaldehyde transcription, it was considered advantangeous to have access to 
RNA strands containing the artificial base for analytical purposes. Therefore, the synthesis of the 
salicylaldehyde ribophosphoramidite 79 was attempted. This compound in principle allows also the 
synthesis of salicylaldehyde-containing RNA strands for metal chelation studies in RNA-RNA and RNA-
DNA templates. 
 
Scheme 3-7. Retrosynthetic plan for the synthesis of the salicylaldehyde ribophosphoramidite 79. 
The route towards the ribophosphoramidite 79 was designed based on the synthesis of its triphosphate STP 
1 (Scheme 3-2), as the key-step C-glycosylation provided the -configured nucleoside in good yield. The 
final phosphoramidite was prepared according to standard protocols from the 2´-OTOM-protected 
nucleoside 80 (Scheme 3-7). According to a published procedure, which was claiming selective 2´-OH 
protection for a base-protected ribonucleoside, the TOM group was selected.[169] Moreover, in comparison 
to the TBS group, this group enormously decreases the coupling time during solid-phase synthesis. The 
main difference to the synthesis of the ribonucleotide was the need for an orthogonal hydroxyl protecting 
group of the sugar moiety and the base building block, to obtain the base-protected ribonucleoside 81. 
Triethylsilyl (TES) groups were chosen for the sugar hydroxyl group, as mild acidic cleavage protocols are 
known, allowing selective deprotection of the TES-protected salicyl ribonucleoside 82.[170] Following the 
established C-glycosylation procedure, the carbonyl addition of the lithiated base building block 2 to a 
TES-ribolactone 83 and subsequent reduction gave the protected ribonucleoside 82. The TES ribolactone 
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83 was to be accessed via a similar procedure as the TBS variant which had been applied in the synthesis 
of the STP. 
The TES ribolactone 83 was synthesized in a one-pot procedure from D-ribose (84) using a combination of 
published protocols.[166, 170] After bromine-mediated oxidation of ribose 84 to lactone 85, the extensively 
dried crude product was triethylsilyl-protected on all hydroxyl groups (Scheme 3-8). On a 20 mmol scale 
this afforded the TES ribolactone 83 in 72% isolated yield. However, when the scale was increased to 
40 mmol, the yield dropped to 38%. Therefore, parallel reactions were performed on 10-20 mmol scale to 
obtain a combined amount of over 20 g TES ribolactone 83 for the subsequent reactions. 
 
Scheme 3-8. Synthesis of the TES ribolactone 83 from D-ribose (84). 
The C-glycosylation reaction was performed according to the conditions established for the STP synthesis 
(Scheme 3-2). The salicylaldehyde building block 2 was lithiated and added to the TES ribolactone 83 
followed by acetylation in situ. This yielded the acetylated TES hemiketal 86 after flash column 
chromatography in 72% (Scheme 3-9), quite comparably to the 77% yield obtained for the TBS analog. In 
the subsequent reduction to the protected TES nucleoside 82, only 36% of the desired product was isolated, 
which was only half of the amount that was obtained for the TBS variant. This was attributed to the 
decreased acid stability of the TES- compared to the TBS-groups. 
 
Scheme 3-9. Synthesis of the TES-protected salicyl ribonucleoside 82 from salicylaldehyde base building block 2 and 
TES ribolactone 83. 
With the TES-protected nucleoside 82 in hand, several conditions were tested for the selective deprotecion 
of the TES groups. At the beginning, acid-mediated cleavage using NaHSO4∙SiO2 as a heterogenous 
catalyst was studied in DCM.[171] Initial test reactions involving the salicylaldehyde base building block 2 
and the TES ribolactone 83 were very promising. Whilst the TIPS group remained untouched during 16 
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hours at 30 °C, the TES ribolactone 83 was completely deprotected under the same conditions. Only minor 
acetal hydrolysis (<10%) was detected for the base building block 2. However, when the conditions were 
applied to the TES-protected nucleoside 82, mostly decomposition of the compound was observed within a 
few hours. Next, various THF/AcOH(aq) mixtures were studied for the selective deprotection of the TES-
groups. A mixture of THF/AcOH/H2O (3:1:1) for 13 h at rt for example yielded about 22% of the desired 
acetal nucleoside 81 and about 87% of the TIPS nucleoside 87 as judged by 1H NMR. Unfortunately, the 
yield of the acetal nucleoside 81 could not be improved further. Also, reprotection of the aldehyde in the 
TIPS nucleoside 87 using a literature-known procedure failed.[172] Therefore, it was decided to prepare the 
aldehyde ribophosphoramidite 88, since several phosphoramidites are published containing free aldehydes 
as a functional group.[173-174] The deprotection procedure was adjusted accordingly and the TIPS nucleoside 
87 was obtained in a very good yield of 91% after isolation (Scheme 3-10). 
 
Scheme 3-10. Synthesis of the DMTr-protected TIPS nucleoside 89 from TES-protected nucleoside 82. 
In order to judge the compatibility of the aldehyde group for solid-phase synthesis, the TIPS nucleoside 87 
was incubated for three days in the oxidation solution. Satisfyingly, no detectable amount of oxidation or 
decomposition products were found. 
Since partly deprotected products were observed during reduction of the acetylated TES hemiketal 86, 
subsequent acidic cleavage was performed using the crude product directly. This afforded the TIPS 
nucleoside in 61% isolated yield over the two steps, which is almost twice as much as for the single steps 
combined (32%). It also saved time for flash column chromatography. The DMTr protection was 
performed using standard conditions on an almost 1 g scale and yielded the 5´-O-DMTr TIPS nucleoside 
89 in 68% after isolation. 
Next, 2´-OH protection with (triisopropylsiloxy)methyl chloride (TOMCl) was attempted following 
published procedures, which claim partly selective protection in 40-75% isolated yield for various DMTr-
ribonucleosides.[169,175-177] Initially, a tin acetal is formed from the hydroxyl groups of the nucleoside in the 
presence of di-tertbutyl tin dichloride and DIPEA, followed by addition of TOMCl. The selectivity 
between 2´- and 3´-protection is described to reach up to 5:1 for this protocol.[176] When this method was 
applied to the 5´-O-DMTr TIPS nucleoside 89, a 1:1 mixture of 2´- and 3´-TOM-protected nucleosides was 
obtained with 68% yield. After painstaking repetitive flash column purification the desired 2´-TOM 
protected nucleoside 90a was separated from the 3´-isomer in 31% yield (Scheme 3-11). The material had 
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a final purity of ≥ 90%. Careful analysis of the NMR spectra allowed unambiguous identification of the 
regioisomers and the complete assignment of all signals. An alternative approach using TBSCl and an 
excess of imidazole in pyridine just resulted in the formation of the corresponding iminium adduct between 
the imidazole and the aldehyde of the DMTr nucleoside 89.[178] No TBS protected product was observed. 
Even when the imidazole was replaced by DIPEA only minor amounts (about 10%) of TBS-protected 
nucleoside were isolated as a regioisomeric 1:1 mixture. In a final effort to improve the 2´-OH protection 
issue, a special protocol involving a chiral organocatalyst was applied, which stated a 2´:3´ selectivity of 
98:2 in up to 91% yield.[179] This time, selective 2´-O-TBS protection was observed with an acceptable 
yield of about 50%. However, concomitant loss of the TIPS-group on the nucleobase rendered the resulting 
compound worthless. All further efforts to improve the reaction were abandoned. 
 
Scheme 3-11. Synthesis of the salicylaldehyde ribophosphoramidite 88 from the 5´-O-DMTr TIPS nucleoside 89. 
Then, the obtained 2´-O-TOM-protected DMTr TIPS nucleoside 90a was converted into the corresponding 
phosphoramidite. Using standard conditions, the desired salicylaldehyde ribophosphoramidite 88 was 
obtained in a good yield (89%, Scheme 3-11) and purity as judged by 31P NMR. The main two signals at 
151.3 and 151.0 ppm in the 31P NMR spectrum are the P-diastereoisomers of the desired phosphoramidite 
88. About 10% impurity was caused by the phosphoramidite product (150.3 and 149.3 ppm) from the 3´-
O-TOM nucleoside 90b, which was already present in the 2´-O-TOM nucleoside 90a starting material, 
another 5% was lost as an H-phosphonate (9.3 and 8.4 ppm, Figure 3-3). Without additional purification, 
the phosphoramidite 88 was directly applied in the solid-phase RNA synthesis. 
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Figure 3-3. 31P NMR spectrum of the salicylaldehyde ribophosphoramidite 88. 
According to the trityl values, this phosphoramidite 88 had a comparable coupling efficiency as any 
standard RNA phosphoramidite (data not shown), when it was applied in the solid-phase synthesis of RNA 
strands. For the deprotection procedure different protocols were studied with a 15mer strand containing a 
single salicylaldehyde ribonucleoside (5´-CACATTASTGTTGTdA-3´). The initial cleavage was 
performed in three ways: a) saturated aqueous ammonia in ethanol (1:3) at rt for 18 h, b) 0.4 M NaOH in 
methanol at rt for 18 h and c) a mixture of saturated aqueous ammonia and methylamine at 65 °C for 10 
min. Analytical RP-HPLC was then used to evaluate the deprotection results (Figure 3-4). In all 
chromatograms a prominent peak at 26.2 min was visible, indicating the formation of one major product 
during solid-phase RNA synthesis and basic deprotection (Figure 3-4, 1a-1c). This signal is the base peak 
in the samples treated under protocols a) and b). In the sample from protocol c) a peak at 36.5 min 
represents the main product. Despite similar sample preparation and sample volume used for the HPLC 
analysis, the intensity of this peak is much higher. An explaination could be more efficient support-
cleavage under protocol c) compared to the other protocols, yet incomplete cleavage of the oligo protecting 
group(s) (signal at 36.5 min). Concerning the homogeneity and purity of the oligo product, the 
deprotection protocol a) provided the best results. 
d in ppm
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Figure 3-4. Analytical HPLC profiles of the salicylaldehyde-containing RNA 15mer after the basic deprotection step 
(1a-1c) and after the additional TBS cleavage step (2a). HPLC conditions: 0–80% B in 45 min for 1, 0–40% B in 
45 min for 2, detection at 260 nm. 
For the subsequent removal of the TBS groups, the crude strands from a)-c) were treated with 
trimethylamine trihydrofluoride at 65 °C for 2.5 h. After quenching of the reagent and precipitation, the 
strands were analyzed by analytical RP-HPLC and MALDI-TOF. In the chromatograms of all three 
samples, the base peak was identical with a retention time of 22.6 min (Figure 3-4, 2a). Furthermore, the 
HPLC-profiles for the samples a), b) and c) became practically identical after silyl ether removal, 
indicating the formation of one main product. However, when the crude oligos were analyzed by MALDI-
TOF mass spectrometry, a m/z = 4725 was observed for all three samples (data not shown), which is not in 
accordance with the calculated mass of 4773.7 (M–H–). The lower mass of about 50 Da difference could 
neither be explained by depurination nor interruption of the solid-phase synthesis or common deprotection 
side reactions. Since the MALDI-TOF result for a synthesized control RNA strand without the 
salicylaldehyde was in agreement with the expected mass, the observed deviation was attributed to the 
artificial ribophosphoramidite. Also, the same problem was observed when other RNA strands containing a 
single salicylaldehyde base were synthesized by solid-phase synthesis. 
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Therefore, it was concluded that the free aldehyde of the ribophosphoramidite 88 was the reason for the 
observed difficulties during solid-phase synthesis and deprotection. In addition, this could also account for 
the encountered problems during 2´-OH protection. So, reprotection of the aldehyde before DMTr and 2´-
OH protection was considered to be necessary, if the synthesis was repeated. At that time, further efforts 
towards the synthesis of an salicylaldehyde ribophosphoramidite 79 were postponed.  
3.4 Transcription Experiments with STP and AldTP 
Although RNA polymerases are closely related to DNA polymerases in function and structure, they differ 
significantly in their mode of action and regulation. In order to allow transcription, a double stranded 
promotor region is needed, which defines the starting point. The double strand is unwound and the RNA 
oligomerization starts by addition of a single nucleoside triphosphate. The so-called initiation of 
transcription is marked by low processivity and a special RNA polymerase conformation, the “open form”. 
This conformation is essential for the promotor recognition, the double strand unwinding and transcription 
start. After addition of about 8-12 nucleotides the conformation changes to the “closed form”, which is 
accompanied by an increase in processivity and an unability to bind the promotor again. Due to this 
conformation change and the affinity of the RNA polymerase to the promotor, “abortive initiation” occurs. 
This means transcription is started and is aborted after addition of a few nucleotides, because the 
polymerase rebinds the promotor. Only after a certain RNA length (usually 8-12 bases) is reached and the 
RNA polymerase changes to the “closed form”, stable elongation can occur.[180] 
With the benzaldehyde 78 and salicylaldehyde ribonucleotide 1 in hand, DNA template strands for 
transcription experiments were designed. As the RNA polymerase from bacteriophage T7 was to be used 
in the transcription experiments, the DNA template contained a T7 early-stage promotor, which had been 
used for in vitro transcriptions with other artificial base pairs before.[181] In order to improve the 
transcription of the salicylaldehyde base, the position for the artificial base was positioned at +13, which is 
at the end of the abortive initiation region. Moreover, only a partial double stranded template was designed, 
in which the double stranded region is limited to the promotor region. This is advantageous, as only the 
antisense strand containing a single aldehyde base had to be synthesized and unwinding of the template 
during elongation is unnecessary. Thereby, any transcription stop caused by the mechanical resistance from 
the covalently linked salicylaldehydes was avoided.  
Aldehyde and salicylaldehyde phosphoramidites were employed for the solid-phase synthesis of the 
template strand on a 1 µmol scale. According to the trityl values, the performance of the aldehyde 
phosphoramidites was comparable to commercial phosphoramidites of the canonical bases (data not 
shown). Before cleavage from the solid-phase, an additional acidic deprotection step was needed to obtain 
the free aldehydes. The strands were carefully purified by RP-HPLC and their identity was verified by 
MALDI-TOF mass spectrometry. Acetal hydrolysis for the benzaldehyde base proved to be more difficult 
than for the salicylaldehyde. Using the exact same conditions for both modified strands, complete 
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deprotection was observed only for the salicylaldehyde-containing strand. For the benzaldehyde base, 
prolonged incubation with dichloroacetic acid was necessary to achieve similar deprotection results. The 
protocol was accordingly adapted. 
Hybridization of each of these antisense strands with the short sense strand was achieved by heating of 
equivalent molar amounts to 95 °C followed by cooling at a rate of 2 °C/min to rt. For the transcription 
assays, 2 µM template, 400 µM nucleotides and varying amounts of amine additives and metal ions were 
mixed in the adequate buffer. The T7 RNA polymerase was added to start the reaction (Figure 3-5, A). 
After several hours incubation at 37 °C, the reactions were cooled on ice, dialyzed and analyzed by 
MALDI-TOF mass spectrometry. 
For the transcriptional incorporation of the STP and AldTP opposite the salicylaldehyde in the antisense 
strand various conditions were screened. The canonical triphosphates were always used at 400 µM, the 
concentration of the aldehyde nucleotides was varied from 0.4-1.2 mM (0.4, 0.8, 1.2 mM). The amine 
concentration was varied from 0-140 mM (0, 10, 20, 30, 40, 80, 140 mM). In addition to the 
ethylenediamine, which was successfully used as the crosslinking amine in DNA replication,[182] 
methylamine and 1,2-diaminobenzene were studied as well. Upon imine formation between the template 
salicylaldehyde and the incoming (salicyl)aldehyde nucleotide, diaminobenzene would yield an extended 
conjugated system. This was considered favorable, because it would improve the important -stacking 
interaction between the adjacent bases in the nascent RNA-DNA duplex. In contrast to DNA duplexes, 
which majorly adopt the B-conformation, RNA-DNA hybrids usually adopt an A-form like conformation. 
[183] As the A-conformation duplex has a wider major groove, sterical problems were expected upon 
crosslinking of the strands during imine formation. Methylamine would form two separate imines, thus 
creating the ligand scaffold without covalent linkage between the strands. Moreover, different metal ions 
were analyzed in combination with the three amines to allow transcription via metal base pair formation. 
Besides the Cu2+ ion, Ag+, Mn2+, Fe2+ and Fe3+ were applied in transcription experiments involving STP or 
AldTP from 0.0-4.0 mM (0.0, 0.5, 1.0, 2.0, 3.0, 4.0 mM). Control transcriptions from a native template 
were conducted using these non-optimal conditions to allow differentiation between effects due to the 
conditions and the template. 
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Figure 3-5. (A) Principle of the in vitro transcription experiments. (B) MALDI-TOF spectrum of a control 
transcription using T7 RNA polymerase and 400 µM NTPs. The main peaks at m/z = 2174-2785 correspond to 
abortive initiation products (6-8 mer), the full-length product is the 21-mer at m/z = 7029. 
For analysis of the MALDI-TOF spectra from the transcription experiments, masses of the theoretically 
possible transcripts were calculated and then compared to the resulting peaks (Table 3-1). The MALDI-
TOF spectrum of a transcription experiment from a native template under optimal conditions is shown in 
Figure 3-5, B. Despite the standard conditions, the most intense peaks originate from RNA strands that are 
6-8 bases long and originate from abortive initiation. In comparison to these peaks, the signal at m/z 7029, 
which corresponds to the full-length transcription product, appears negligible. However, the signal 
intensity is not directly proportional to the real RNA amounts in the sample. The MALDI-TOF mass 
spectrometry is more sensitive for shorter oligonucleotides, as these are more readily ionized.[184] Apart 
from this drawback, the possibility to directly assign peaks to a certain oligonucleotide and to recognize 
mutation of the artificial nucleoside in the transcript was invaluable. 
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Table 3-1. Calculated masses of possible transcripts. 
length Sequence M [M–H]– 
21mer-A pppGGGAAUCCCGAGAAGUGACUA 7034.93 7033.92 
21mer-S pppGGGAAUCCCGAGSAGUGACUA 7021.90 7020.89 
20mer-S pppGGGAAUCCCGAGSAGUGACU 6692.85 6691.84 
19mer-S pppGGGAAUCCCGAGSAGUGAC 6386.83 6385.82 
18mer-S pppGGGAAUCCCGAGSAGUGA 6081.74 6080.73 
17mer-S pppGGGAAUCCCGAGSAGUG 5752.69 5751.69 
16mer-S pppGGGAAUCCCGAGSAGU 5407.65 5406.64 
15mer-S pppGGGAAUCCCGAGSAG 5101.62 5100.61 
14mer-S pppGGGAAUCCCGAGSA 4756.57 4755.57 
13mer-A pppGGGAAUCCCGAGA 4440.55 4440.55 
13mer-S pppGGGAAUCCCGAGS 4427.52 4426.51 
12mer pppGGGAAUCCCGAG 4111.49 4110.48 
11mer pppGGGAAUCCCGA 3766.44 3765.43 
10mer pppGGGAAUCCCG 3437.39 3436.43 
9mer pppGGGAAUCCC 3092.34 3091.33 
8mer pppGGGAAUCC 2787.30 2786.29 
7mer pppGGGAAUC 2482.26 2481.25 
6mer pppGGGAAU 2177.22 2176.21 
5mer pppGGGAA 1871.19 1870.18 
In order to decrease the number of experiments for the salicylaldehyde transcription condition screening, 
“optimal” concentration ranges for the additives were initially determined for a single additive 
individually. At the beginning, the triphosphate concentration was varied for STP only. The slight increase 
of abortive initiation products for 1.2 mM STP in the control transcription compared to 0.4 mM (data not 
shown) led to the decision to use the latter concentration for all subsequent experiments. Maybe a 
crosslinking reaction between the STP and an amine residue of the polymerase interferes with efficient 
transcription propagation. A similar strategy was applied for the amine additive. At first, only 
ethylenediamine was studied at different concentrations. Interestingly, the addition of up to 20 mM of 
ethylenediamine seemed to improve the full-length transcription product amount (data not shown). This is 
in accordance with observations made for other amines, which increase T7 RNA polymerase activity up to 
12-fold.[185] Even 140 mM ethylenediamine did not deteriorate the transcription considerably. Therefore, 
amine additive concentrations of 0, 20 and 140 mM were chosen for all three amine additives in subsequent 
experiments. Likewise, Cu2+ was selected as a starting point to narrow down the experiment number. As 
expected, an elevated Cu2+ concentration of 4.0 mM almost stopped the production of the full-length 
transcript completely in the control experiments (data not shown). Even with 2 mM of Cu2+ the common 
transcript pattern including full-length product was observed for the control reaction. Due to the T7 RNA 
polymerase preparation protocol, the final enzyme was provided in a 1 mM EDTA containing buffer, which 
complexed some of the added metal cation. The resulting concentration of available metal cation in the 
experiment was therefore lowered by 100-300 µM based on the assumption of one Cu2+ per EDTA. For the 
subsequent screen of alternative metal ions, the 2 mM concentration was hence selected as a starting point. 
Instead of performing almost 4000 transcription experiments to screen all conditions, these initial 
experiments decreased the amount to a feasible 100. Condition refinement, including reaction temperature, 
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incubation duration and concentration of the additives was to be performed for “interesting” results from 
these transcriptions. 
No difference between Cu2+ and Mn2+ addition was observed in the experiments. Compared to these metal 
cations, equal amounts of silver and iron salts had a detrimental effect on transcription. More abortive 
initiation fragments were observed, and at 3 mM Ag+ no transcription products were observed at all (data 
not shown). Similar negative effects were found for diaminobenzene. This is in contrast to methylamine 
and ethylenediamine, which did not alter the transcription considerably. 
The influence of the incubation time and temperature were studied as well. Short incubation durations (0.5 
and 1.0 h) only provided MALDI spectra with low intensity, indicating low amounts of transcripts. Long 
incubations of 15 h or longer also led to a decreased signal intensity, which suggested residual RNAse 
activity within the samples or metal-ion-mediated strand scission. An incubation time of 4-5 h was selected 
for almost all of the subsequent experiments, as it provided the best signal/noise ratio in MALDI and the 
best signals for full-length transcripts. For the reaction temperature, 37 °C incubation was compared to 
20 °C and 40 °C. Almost no difference was observed between 20 °C incubation for 5 h compared to 37 °C. 
The same observation was made for the elevated temperature (40 °C, data not shown). Since 37 °C 
represents the optimal temperature for the T7 RNA polymerase activity, all subsequent experiments were 
performed at 37 °C, for 4-5 h.Initial experiments involving the salicylaldehyde-containing template, STP 
and Cu2+ and ethylenediamine showed the appearance of small amounts of 13 mer in addition to a strong 
12 mer signal in the MALDI spectrum (data not shown). No full-length transcripts were found. Due to a 
poor signal/noise ratio, unambiguous determination whether STP incorporation had occurred or not was 
impossible. However, since similar MALDI spectra were obtained in experiments with AldTP and with 
only dNTPs, mutation of the salicylaldehyde position was considered. The addition of ethylenediamine and 
Cu2+ was necessary to force any transcription beyond the artificial nucleoside. 
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Figure 3-6. MALDI-TOF spectrum of a salicylaldehyde-containing transcription using T7 RNA polymerase, 400 µM 
STP and NTPs, 1.4 mM Cu2+ and 20 mM ethylenediamine. 
Finally a condition was found which allowed full-length transcription from a salicylaldehyde-containing 
template. By adding 1.4 mM Cu2+ and 20 mM ethylenediamine and incubation at 37 °C for 5 h, a tiny signal 
at 7031.9 was observed (Figure 3-6). When compared to the expected mass of 7021 (Table 3-1), it was 
obvious that the salicylaldehyde had been mutated. Calculations for alternative transcripts replacing the 
position by natural nucleosides revealed that adenosine was probably incorporated opposite the 
salicylaldehyde of the template (calc. 7033.9). A similar mutation had been observed before for the DNA 
salen pair, when no ethylenediamine and Cu2+ were present.[13] Again, the main signals in the spectrum 
were derived from abortive initiation fragments 1868-3089 (corresponding to 5-9 mers) and the 12 mer at 
4107.9, which is directly before the artificial nucleoside in the template. This indicated the difficulties of 
the polymerase to transcribe past this position, despite the “misincorporation” of the undesired adenosine 
in position 13. 
3.5 Transcription Experiments using T7 RNA Polymerase Mutants 
In a last attempt to achieve transcription of the benzaldehyde or salicylaldehyde base, a biological 
approach involving mutation of the T7 RNA polymerase was envisioned. Unfortunately the use of other 
RNA polymerases was not feasible, as very few RNAPs are commercially available and each polymerase 
needs a different promotor and therefore a different template.  
The T7 RNAP is well characterized and the crystal structure and data of several mutants are available in 
the literature.[186-187] The plasmid pBH161_T7RNAP carrying the wild-type T7 RNA polymerase gene 
including a (His)6-tag was generously provided by Dr. Sabine Schneider. For mutagenesis, active site 
residues involved in the selection of nucleotides during transcription, were selected as a target. The 
mutation of the phenylalanine in position 644 and the histidine 784 were described to considerably increase 
0
500
1000
1500
2000
2500
3000
1000 2000 3000 4000 5000 6000 7000 8000 9000 10000
in
te
n
si
ty
m/z
7031.9
12 mer
4107.9
3089.3
2478.6
1868.8
6101.7
2173.9
44  Results and Discussion 
 
the rate of misincorporation of nucleotides and subsequent mispair extension.[187] In a PCR, mutated 
primers were used for site-directed mutagenesis of the T7 RNAP gene at the corresponding positions to 
alanine. The non-mutated methylated template was digested by DpnI and the reaction mixture including 
the mutated plasmid was subsequently transformed into E. coli DH5. Plasmids of colonies growing in the 
presence of a selection marker were sequenced to prove mutation at the desired position. T7 RNAP_F644A 
and H784A were generated successfully. In contrast, all efforts to generate a double mutant combining 
both mutations, failed despite various primer designs and mutation strategies. Maybe without external 
induction by IPTG, the T7 RNAP is expressed at a background level and changes the transcriptome of the 
host cell. The increased amount of incorrect transcripts by the double mutant RNAP could lead to 
misfolded and nonfunctional proteins and therefore kill the host organism. 
 
Figure 3-7. Coomassie stained SDS-PAGE of T7 RNA polymerase expression and purification. M = marker, Z1-3 = 
cell lysate of E. coli BL21 carrying plasmid pBH161_T7RNAP before expression induction, E1-3 = cell lysate like in 
Z after induction using IPTG, P1-3 = purified T7 RNA polymerases. (1: wt, 2: F644A, 3: H784A). 
The expression of the wild-type (1), the mutant F644A (2) and H784A (3) T7 RNAP were carried out in 
E. coli BL21 (Figure 3-7, E1-3). The T7 RNAP was purified from the soluble protein of the cell lysate by 
affinity purification with Ni-NTA beads. On average, 20-50 mg of T7 RNA polymerase were purified from 
1 L culture in good purity as judged by SDS PAGE (Figure 3-7, P1-3).  
In order to prove the activity of the purified enzymes, a test transcription was performed using the natural 
NTP set. Afterwards, transcription assays involving STP and AldTP and varied amounts of amines and 
metal ions were applied and the products were analyzed by MALDI-TOF mass spectrometry. 
Differences in transcription experiments between the wild-type and the mutants were obvious. 
Surprisingly, the mutant F644A did not provide any full-length transcript, even when the “optimized” 
conditions were applied, which had given full-length product for the wild-type T7 RNA polymerase. 
Instead, transcription stopped before the incorporation opposite the artificial nucleoside (Figure 3-8, A). 
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For the mutant H784A also a peak from the 12 mer fragment was observed. This time the intensity was 
higher than for the abortive initiation fragments. In addition, a prominent peak of the 13 mer (4453) and a 
tiny peak of full-length transcript were found (7032). Both mass-to-charge ratios strongly suggested that 
under the applied conditions the salicylaldehyde in the template was transcribed into an A (cf. Table 3-1). 
In summary, no condition, (salicyl)aldehyde triphosphate or RNA polymerase mutant was found which 
allowed faithful transcription of the salicylaldehyde. 
 
Figure 3-8. MALDI-TOF mass spectra from transcription experiments using T7 RNAP_F644A (A) and T7 
RNAP_H784A (B) in the presence of 400 µM STP and NTPs, 1.4 mM Cu2+, 20 mM ethylenediamine and 2 µM 
salicylaldehyde-containing template. 
After all efforts to transcribe the salicylaldehyde nucleoside had failed, we decided to change the design of 
the base pair considerably. As metal ions reduce the compatibility with enzymes enormously, the new 
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concept was exclusively based on reversible imine chemistry. An amine base and an aldehyde base were to 
provide interstrand crosslinks, without the need for additives, like amines or metal ions. At the beginning, 
these new nucleosides had to be synthesized as phosphoramidites for their incorporation into DNA strands.  
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Part II – A Covalent Base Pair 
Although the salen base pair was selectively replicated in DNA, the need for the external additives 
ethylenediamine and Cu(II) ions is a major disadvantage for a broad application. The metal ions can 
denature enzymes and are toxic for living organisms at elevated concentrations. Therefore, we envisioned 
the concept of a base pair which solely interacts via a reversible covalent bond. To avoid the need for an 
external amine, a heterobase system comprising an amine- and an aldehyde-containing base was designed. 
As a starting point for the detailed design, the salicyladehyde base was used as the aldehyde side in the 
beginning. The amine base design was based on conjugated systems which were isosteric to a 
salicylaldehyde with an ethylenediamine attached via an imine. 
The design and synthesis of the amine base derivatives was performed by Dr. M. Tomás-Gamasa. During 
the project, a modular synthesis for amine base nucleosides and their corresponding phosphoramidites was 
established. This allowed the synthesis of a small library of amine base-containing strands that were 
analyzed against aldehyde base-containing strands in melting temperature experiments. Amine-aldehyde 
pairs which lead to an increase of the melting temperature were studied in more detail. 
3.6 Overview of the Synthesized Amine and Aldehyde Phosphoramidites 
For the synthesis of the amine base nucleosides a modular procedure was developed which involved the 
organometallic addition of a bishalide aromatic compound to a TBS-protected deoxyribolactone 91 
(Scheme 3-12) and subsequent reduction of the intermediate hemiketal. This was basically identical to the 
method that had been used in the synthesis of the salicylaldehyde ribonucleotide, yet the protocol was 
adapted according to a procedure described in literature.[188] Various vinyl-containing amines were then 
cross-coupled to the halogen aromatic nucleoside 92 to access a small library of protected amine base 
nucleosides 93. After deprotection of the sugar silyl ethers, the resulting nucleosides 94 were subsequently 
transformed into the corresponding phosphoramidites 95 using standard procedures. At the beginning, only 
1,4-dibromobenzene was chosen as the aromatic halide and the vinyl-containing amines for the cross-
coupling were varied. Three amine nucleoside phosphoramidites were prepared using this synthesis route: 
An aromatic amine 96, an aliphatic amine 97 and a pyridine amine 98 phosphoramidite (Figure 3-9). Upon 
imine formation with the (salicyl)aldehyde nucleoside, the aromatic amine and the aliphatic amine were 
supposed to adapt a structure with a similar sterical demand compared to the salen complex. Since the 
amino group in the pyridine amine is shifted by one position compared to the other two amine nucleosides, 
the geometrical necessities for imine formation could be studied.  
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Scheme 3-12. Modular synthesis of the amine phosphoramidites for solid-phase synthesis. 
The synthesis of the salicylaldehyde base nucleoside and its phosphoramidite was established in the 
group.[12] Thus, freshly prepared dS phosphoramidite 99 was directly used for the synthesis of strands for 
melting temperature experiments. In addition, the synthesis of a benzaldehyde base nucleoside 
phosphoramidite was designed based on the established routes. Compared to the salicylaldehyde it lacks 
the ortho-hydroxylgroup and thereby was used to determine its importance for the stability of the imine. 
The synthesis was described and performed by Meng Su.[41] Briefly, 4-bromobenzaldehyde was acetal 
protected, lithiated and added to TBS-protected deoxyribose lactone 91. The resulting hemiketal was 
reduced to the protected nucleoside using Lewis acid conditions. Finally the TBS groups were removed 
and the nucleoside was transformed to the DMTr-protected phosphoramidite 100. Altogether, three amine 
and two aldehyde phosphoramidites were prepared for solid-phase synthesis of strands for melting 
temperature analyses.  
 
Figure 3-9. Overview of the synthesized amine and aldehyde phosphoramidites. DMTr = 4,4´-dimethoxytrityl, TIPS 
= triisopropylsilyl. 
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3.7 Melting Temperature Analysis of Strands Containing Amine and Aldehyde Bases 
With the three amine base phosphoramidites and the two aldehyde base phosphoramidites in hand, DNA 
strands for melting temperature analysis were synthesized. The synthesis of the salicylaldehyde containing 
strand was performed as described by C. Kaul and G. Clever.[12-13] Based on this protocol, which only 
needed an additional acidic cleavage step during deprotection, the strand containing the aldehyde 
nucleoside was prepared. According to the trityl values, no difference in performance was observed 
compared to the commercial phosphoramidites. After the deprotection procedure, the mass of the desired 
benzaldehyde-containing strand and of the acetal-protected form was found in MALDI-TOF samples. 
Obviously, the acetal of the benzaldehyde nucleoside is more stable than the acetal of the salicylaldehyde 
nucleoside. Therefore, the acidic cleavage step after the solid-phase synthesis was prolonged. The aldehyde 
strands were purified by RP-HPLC, their identity was verified by MALDI-TOF mass spectrometry and the 
total concentration was determined by UV-Vis. 
The synthesis of the amine base-containing strands needed more adaption of the protocols. Initial efforts to 
apply the standard solid-phase DNA synthesis procedure suffered from a deprotection problem. Although 
all amine base phosphoramidites were synthesized with trifluoroacetyl protecting groups on the amine 
residue, the strands which were isolated after the deprotection were found to possess a single acetyl group. 
As the standard phosphoramidites are completely deprotected under the applied conditions, we concluded 
that the trifluoracetyl group had been replaced by the acetyl group during a capping step. Deprotection of 
the TFA group during solid-phase synthesis could be promoted by the acidic “deblock solution” and 
thereafter the amine was acetyl-protected in the capping step. Unfortunately, no suitable deprotection 
condition was found which allowed removal of the acetyl group without strand decomposition, except for 
the pyridine amine. Therefore, the capping step after incorporation of the amine base was omitted in the 
solid-phase DNA synthesis. This enabled the successful synthesis of the amine-containing strands for the 
melting temperature experiments. Although the capping steps after about half of the solid-phase synthesis 
were omitted, no considerable decrease in yield and coupling efficiency was observed. Strands containing 
the aromatic amine, the aliphatic amine and the pyridine amine nucleoside were synthesized. After 
deprotection, purification by RP-HPLC and identity confirmation by MALDI-TOF mass spectrometry, the 
concentration was determined by UV-Vis. For a comprehensive overview of the strands that were 
synthesized and utilized in various combinations for the melting temperature studies see Table 5-5, p. 149. 
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Table 3-2. Overview of the synthesized amine and aldehyde base-containing strands for melting temperature 
experiments and the purchased control strands. n.d. = not determined 
Entry Name Oligonucleotide Sequence 5´-3´ Mass (calc.) Mass (found) 
1 Benzaldehyde 1 TAC AAC AAldT AAT GTG 4555.0 4552.7 
2 Benzaldehyde 2 CAC ATT AAldT GTT GTA 4537.0 4535.2 
3 Salicylaldehyde 1 TAC AAC AST AAT GTG 4571.0 4569.6 
4 Salicylaldehyde 2 CAC ATT AST GTT GTA 4553.0 4551.8 
5 Aromatic Amine CAC ATT AAroT GTT GTA 4625.9 4624.0 
6 Aliphatic Amine CAC ATT AAliT GTT GTA 4578.1 4576.0 
7 Pyridine Amine CAC ATT APyrT GTT GTA 4627.1 4625.5 
8 Control 1 CAC ATT AAT GTT GTA 4565.0 n.d. 
9 Control 2 TAC AAC ATT AAT GTG 4574.1 n.d. 
10 Control 3 TAC AAC AGT AAT GTG 4599.1 n.d. 
 
Equal amounts of complementary strands were hybridized and the melting temperatures were determined 
by following the 260 nm UV-signal upon several cycles of heating and cooling. At the beginning, the 
benzaldehyde strands (Table 3-2, Entry 1+2) were studied in the presence and absence of external amines 
and metals. For comparison, control strands possessing only natural bases were measured containing a 
central match or mismatch pair. The combination of the benzaldehyde strands had a melting temperature 
(TM) of 37 °C, which is only slightly higher than the 35 °C of a duplex having a central C-A or A-G 
mismatch. This TM was neither changed by the addition of methylamine, 1,2-diaminobenzene, 
ethylenediamine nor by additional metal ions like Cu2+, Mn2+ and Ag+. It was therefore concluded that a 
stable imine formation for the benzaldehyde nucleoside is not possible under the applied conditions. Next, 
combinations of a benzaldehyde strand and a salicylaldehyde strand (Table 3-2, Entry 1+4 and 2+3) were 
analyzed with and without amines and metal ions. Under all conditions the TM was determined as 40°C. 
This is in between the melting temperature of a mismatch (35 °C) and a match (48 °C). Once again, the 
results indicated that the benzaldehyde nucleoside cannot form a stable imine bond with the provided 
amines in contrast to the salicylaldehyde self-pair. 
Then, amine base-containing strands were combined with (salicyl)aldehyde-containing strands. The 
combination of the aliphatic amine-containing strand with the benzaldehyde strand had a melting 
temperature of only 37 °C (Table 3-3, entry 5). A slight increase to 39 °C was observed for the pyridine 
amine and even 42 °C for the aromatic amine opposite the benzaldehyde (Figure 3-10, B, black and red). 
Moreover, in the case of the aromatic amine and the benzaldehyde, the curves for the annealing and 
melting were not superimposable. Instead, a TM of 38 °C was determined for the annealing (Figure 3-10, B, 
blue). All combinations of the amine strands with the benzaldehyde strand did result in a melting 
temperature decrease compared to the TM of 48 °C for the control duplex with the central T-A pair (Figure 
3-10, A, red). Instead, the melting temperatures are slightly above the 35 °C, which were determined for 
Results and Discussion  51 
 
the G-A or C-A mismatch. This indicates that the combination of the aliphatic amine or the pyridine amine 
with the benzaldehyde generates a situation similar to a mismatch, with the imine bond not established. For 
the aromatic amine with a melting temperature in between a match and a mismatch, it was assumed that the 
imine is partly formed. Upon close observation of the corresponding melting curve (Figure 3-10, B, red), 
actually two melting events can be detected, one at 42 °C and the other at 68 °C. We therefore suggest that 
only for the DNA fraction which has the higher melting temperature the imine is formed. The other 
fraction behaves like a mismatch. 
 
Figure 3-10. Melting profiles of control duplexes (A) and combinations of the benzaldehyde with an aromatic amine 
and pyridine amine containing strand (B). Note that the blue (annealing) and the red (melting) curve in B were 
obtained from the same double strand. 
Next, the three amine base containing strands were combined each with the salicylaldehyde strand. The 
combination of the strand containing the pyridine amine with the salicylaldehyde had a melting 
temperature of 38 °C (Figure 3-11, A, black). For the aliphatic amine opposite the salicylaldehyde two 
melting temperatures, at 37 °C and 44 °C for the annealing (blue) and the melting (red) were determined. 
As the curves from cooling and heating were not superimposable, different pathways for annealing and 
heating were implied. The delayed reaction of the system and the dependence of the reaction outcome from 
the past state (here temperature) is called hysteresis.[189] In comparison to the control, both combinations 
had a decreased melting temperature. However, for the aliphatic amine the interaction to the 
salicylaldehyde, resulted in only a minor decrease by 4 K, which is 9 K higher than the TM of 35 °C for the 
mismatch. This indicated successful imine formation for the combination. In accordance to the 
observations made for the benzaldehyde base, the melting temperature increase for the aromatic amine 
opposite the salicylaldehyde was the highest. A TM of 79 °C was determined for the heating and 38 °C 
during annealing. Thus, the hysteresis effect was more distinct compared to the two other amine bases. The 
strong increase of the melting temperature indicated that a stable interstrand imine bond was formed. 
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Figure 3-11. Melting profiles of double strands with a central (A) salicylaldehyde pyridine amine (black), 
salicylaldehyde aliphatic amine (red, blue) and (B) salicylaldehyde aromatic amine combination (red, blue). The blue 
curves are from annealing, the red curves are from melting if hysteresis was observed.  
In order to study the observed hysteresis behaviour in the case of the salicylaldehyde and the aromatic 
amine, melting curves were measured at various pH values and at faster and slower cooling/heating rates. 
Initially, the cooling/heating rate was decreased from 1.0 K/min to 0.1 K/min. The TM for the heating 
decreased from 79 to 62 °C, whilst the TM determined for the cooling increased from 38 to 46 °C. Thus, the 
hysteresis decreased from 41 to 16 K, which indicates that a slow process is the reason for the observed 
effects. A further increased rate of 5 K/min had only a minor consequence for the TM (79 and 39 °C) 
compared to the starting condition. 
Table 3-3. Determined melting temperatures of the DNA duplexes described in this chapter. The names are chosen 
according to the central base pair, the sequence of the strand combinations can be found in Table 3-2. All values 
below were determined at pH 9 and a rate of 1 K/min cooling/heating. 
Entry Name Strand Combination TM [°C] 
1 T-A match Control 1 and Control 2 48 
2 G-A mismatch Control 1 and Control 3 35 
3 Ald-Ald Benzaldehyde 1 and Benzaldehyde 2 37 
4 Sal-Ald Salicyladehyde 1 and Aldehyde 2 40 
5 Ald-Ali Benzaldehyde 1 and Aliphatic Amine 37 
6 Ald-Pyr Benzaldehyde 1 and Pyridine Amine 39 
7 Ald-Aro Benzaldehyde 1 and Aromatic Amine 38,[a] 42[b] 
8 Sal-Ali Salicylaldehyde 1 and Aliphatic Amine 37,[a] 44[b] 
9 Sal-Pyr Salicylaldehyde 1 and Pyridine Amine 38 
10 Sal-Aro Salicylaldehyde 1 and Aromatic Amine 38,[a] 79[b] 
[a] TM for the annealing, [b] TM for the melting 
Then, the pH was varied at a constant cooling/heating rate of 1.0 K/min in order to study the influence of 
protonation states on the hysteresis. Based on the conditions that had been applied for the salicylaldehyde 
metal base pair, the starting pH of 9 was selected in a CHES buffered solution for all described 
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experiments. At this pH the melting temperature increase of the salicylaldehyde metal base pair had been 
found highest. Also for the S:To (salicylaldehyde:aromatic amine) pair, the highest melting temperature of 
79 °C was determined under these conditions. When the pH was decreased to 7, the TM for the melting 
decreased to 68 °C. At the same time the TM determined for the hybridization during cooling increased 
from 38 to 46 °C. Thus, the observed hysteresis decreased from 41 to 22 K, which indicates that 
protonated/deprotonated residues are involved in the melting/reannealing process of the S:To pair. 
The smallest hysteresis of only 6 K was observed at pH 7 and a rate of 0.1 K/min. At this condition melting 
temperatures of 49 and 55 °C were measured for the hybridization and the melting, respectively. Therefore, 
both TM are above 48 °C, which was observed for the control duplex containing a central A-T pair. This 
means that selective binding between the salicylaldehyde and the aromatic amine is possible, when the 
system has enough time to adjust a suitable conformation. 
 
Figure 3-12. Proposed (A) H-bond stabilized imine form and (B) hysteresis model of the To:S pair. 
Based on the findings for the S:To pair, a model was proposed which might explain the hysteresis effect 
(Figure 3-12, B). The central hypothesis is a slow rate of imine formation and hydrolysis. When the duplex 
is heated, the canonical base pairs melt, but the central S:To crosslink stabilizes the duplex (c) until the 
imine bond is hydrolyzed (d). During cooling, the natural bases might already adapt Watson-Crick base 
pairing, yet the central unformed crosslink represents a typical mismatch (a), which slowly reacts to the 
imine (b). 
From all aldehyde-amine combinations in the melting temperature experiments, only the interaction 
between the aromatic amine To and the salicylaldehyde S had a stabilizing effect on the duplex compared 
to the natural base pairs. The ortho-hydroxyl group adjacent to the aldehyde in the salicylaldehyde was 
determined as an important factor for the imine stability, as the combination of the aromatic amine and the 
benzaldehyde base destabilizes the duplex. An intramolecular H-bond from the hydroxyl group to the 
imine, which increases the stability of the reversible covalent bond (Figure 3-12, A), was therefore 
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suggested. Moreover, the importance of -stacking and conformational space for base pair formation was 
highlighted by comparing the interaction of the aliphatic amine and the aromatic amine with the 
salicylaldehyde. Although both amine bases possess the amine in almost the same distance from the 1’-
carbon, the increase of the melting temperature and thus a stable imine formation was only observed for 
the aromatic amine. We assume that the -stacking to the directly adjacent bases in the duplex aligns the 
aromatic amine in a position which can react preferably with the aldehyde. Also the loss of entropy upon 
binding is smaller, as the fully conjugated aromatic amine is more rigid compared to the aliphatic amine. 
The observed hysteresis, especially for the aromatic amine with the salicylaldehyde, was an indication for 
the slow imine formation and hydrolysis. Maybe this characteristic can be exploited in future work to 
construct a nanodevice with a time-dependent memory or DNA origami with a time-dependent shape-
memory. 
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3.8 Synthesis of a Salicylaldehyde and an Aromatic Amine Deoxyribonucleotide 
After observation of the stabilizing interaction between salicylaldehyde S and the aromatic amine To in the 
melting temperature experiments, enzymatic incorporation of the artificial nucleotides by DNA 
polymerases was studied. This could allow to generate long covalently linked DNA strands for especially 
stable nanostructures that are not accessible by conventional solid-phase DNA synthesis. In order to 
analyze the enzymatic acceptance, primer extension experiments were planned. The corresponding DNA 
templates were synthesized with the existing phosphoramidites, which had been used for the melting strand 
synthesis before. Only the deoxyribonucleotides of the artificial bases were missing at that time. 
 
Scheme 3-13. Synthesis of the salicylaldehyde deoxynucleoside 5’-triphosphate 102 (dSTP). 
The synthesis of the salicylaldehyde deoxynucleoside 101 and its phosphoramidite 99 was designed and 
established by G. Clever. Also dSTP had been synthesized by C. Kaul and M. Wagner before, following 
the famous Ludwig-Ruth triphosphate reaction protocol (1.3 Chemical (Tri)phosphorylation Methods, 
p. 4).[48-49] However, the RP-HPLC purification was tedious and the dSTP was obtained in only 2% 
yield.[13] Protected salicylaldehyde nucleoside was still present from the performed phosphoramidite 
synthesis and provided a one-step access to the salicylaldehyde deoxynucleoside. Having made good 
experiences with the more recent triphosphorylation method in several syntheses, we decided to apply the 
reaction to the salicyl deoxynucleoside 101 as well.[64] Satisfyingly, after twofold RP-HPLC purification, 
the dSTP 102 was obtained in 15% yield (Scheme 3-13). The NaCl-ethanol precipitation step during the 
reaction workup of the triphosphate immensely improved the purity of the crude triphosphate product and 
therefore simplified the purification. HRESI mass spectrometry in combination with 31P and 1H NMR 
proved the formation of the 5´-dSTP in accordance with published data.[13] In analytical RP-HPLC a very 
broad peak was observed for the dSTP (data not shown), which hampered a meaningful estimation of the 
purity. This behavior is based on the special property of the salicylaldehyde deoxynucleoside and has been 
observed before.[182] As no additional signals to the signals of 5´-dSTP were observed in the 1H and 
31P NMR spectra, the purity was estimated to be at least 95%. 
The synthesis of the aromatic amine nucleoside 103 (To) and its phosphoramidite was designed and 
established by Dr. M. Tomás-Gamasa. Generously, some TFA-protected aromatic amine nucleoside 104 
and the completely deprotected nucleoside 103 were provided for the synthesis of the aromatic amine 5´-
triphosphate. To ensure a successful synthesis two triphosphate reactions were setup in parallel. In the first 
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case, the TFA-protected aromatic amine 104 was used to avoid chemoselectivity problems during the 
triphosphorylation reaction and was to be saponified to give the aromatic amine deoxynucleoside 
triphosphate 105 (dToTP) in a subsequent reaction. In the second case, the aromatic amine 103 was directly 
applied to the triphosphorylation reaction without any protecting group (Scheme 3-14). 
 
Scheme 3-14. Synthesis of the aromatic amine deoxynucleoside 5’-triphosphate dToTP 105 by two different routes. 
Surprisingly, initial experiments using the established triphosphate protocol did not provide the desired 
product. The freshly purchased 2-chloro-1,3,2-benzodioxa-phosphorin-4-one (10) was completely oxidized 
as judged by 31P NMR. Therefore, the phosphite reagent 10 was synthesized from salicylic acid and 
phosphorus trichloride according to a described procedure, using only small amounts of toluene as a 
solvent.[190] As PCl3 is very toxic, corrosive and also prone to oxidation, distillation of the purchased 
chemical was avoided. Also utmost care was taken to prevent any leakage of PCl3 and also developing HCl 
gas during reflux, by passing the cooled gases through an aqueous saturated solution of NaHCO3. All steps 
of the reaction and the workup were performed under an atmosphere of argon to prevent the oxidation of 
the P(III) species. In the 31P NMR spectra a prominent peak at 148.2 ppm proved the presence of the 
desired P(III) salicyl phosphite reagent in the product. Another peak was observed at       –3.5 ppm at about 
20% of the total 31P species, which originates from the unwanted P(V) form of the reagent. This 
demonstrates the sensitivity of the reagent for oxidation but could also be due to POCl3 present in the 
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employed PCl3 due to longterm storage. As the crude phosphite reagent was acceptably pure, distillation of 
the almost colorless solid was omitted in subsequent reactions. 
Gratifyingly, the so-synthesized salicyl phosphite 10 yielded the desired triphosphates in both setups when 
employed in the reaction protocol (Scheme 3-14). After two-fold RP-HPLC purification the amine 
protected aromatic triphosphate 106 was obtained in 24% yield. The alternative route from the aromatic 
amine nucleoside gave dToTP 105 in 8% isolated yield and also 4% 3´-triphosphate side product. Despite 
the lower yield in the case of the unprotected amine, no phosphoramidate product, which could originate 
from the reaction of the aromatic amine with the preformed triphosphate reagent, was isolated. Instead, 
much nucleoside was reisolated according to analytical RP-HPLC. It was assumed that although the 
phosphoramidate side product is formed in the reaction, it is mostly hydrolyzed upon workup and 
purification. For the deprotection of the amine protected triphosphate 106 to the dToTP 105, conditions 
similar to protocols from DNA solid-phase synthesis strand cleavage were used. This yielded 39% of the 
desired dToTP 105 after RP-HPLC purification. The low yield is probably due to hydrolysis of the 
triphosphate at the elevated pH during the deprotection procedure. NMR spectra unambiguously proved 
the identity of the 5´-dToTP 105, and analytical RP-HPLC verified the high purity of the product (Figure 
3-13). 
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Figure 3-13. (A) Analytical RP-HPLC trace of the purified dToTP 105 at 260 nm detection using a gradient from 0–
70% B in 45 min. (B) 31P NMR spectrum of the purified dToTP 105. 
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3.9 Primer Extension Experiments with dSTP and dToTP 
Several compounds were necessary for the primer extension experiments involving the artificial 
salicylaldehyde base dS and aromatic amine dTo. Apart from the triphosphates, dSTP 102 and dToTP 105, 
template strands containing each artificial base in the n+1 position were prepared from the corresponding 
phosphoramidites. The strands were synthesized and deprotected according to the protocols established for 
the strands of the melting temperature studies (3.7). After RP-HPLC purification and confirmation of the 
identity by MALDI-TOF, the purity was assessed by analytical RP-HPLC. Oligonucleotides with a purity 
greater than 95% were used for the primer extension experiments. In addition, control templates and 5’-
fluorescein labeled primers were purchased from METABION. Control templates were unmodified in the 
n+1 position, and thus allowed evaluation whether the applied experimental conditions were suited for the 
polymerases. The 5’-fluorescein labeled primer enabled analysis of the primer extension reaction via its 
fluorescence after denaturing polyacrylamide gel electrophoresis (PAGE). Sequences of synthesized and 
purchased strands for primer extensions presented within this work can be found in Table 5-6, p. 149. 
Utmost care was taken to avoid any source of external primary or secondary amine, like e.g. from the 
buffer used for the primer extension, that could interfere with the imine formation between dS and dTo. 
Therefore, tris(hydroxymethyl)amino-methane (Tris) and spermidine containing buffers were replaced by 
custom buffer mixtures. The buffering agent was replaced by N-cyclohexyl-2-aminoethanesulfonic acid 
(CHES for pH 8-9) and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES for pH 7-8). The 
DNA stabilizing compound spermidine was omitted, as it is not crucial for DNA polymerase function. For 
further details on buffer composition and primer extension conditions see Table 5-1, p. 147 and 5.4.15, p. 
157. 
3.9.1 Primer Extensions with dSTP 
In the beginning, various polymerases were analyzed for their ability to incorporate the salicylaldehyde 
nucleotide (dSTP) opposite the templating aromatic amine (To) base in single nucleotide incorporations 
(SNI). Therefore, a template hybridized from the primer P1a and the To-containing strand P1b was 
incubated with different DNA polymerases in the presence of 400 µM dSTP (Figure 3-14, A). Several 
polymerases were found capable of forming the base pair under the applied conditions of the experiment to 
a different extent. However, only Klenow fragment (KF) managed quantitative conversion of the primer as 
judged after denaturing PAGE (Figure 3-14, B). The exonuclease deficient forms of KF and Deep vent® 
showed some remaining non-elongated primer. For Bst Pol I and KOD XL only traces of the +1 elongated 
primer were observed (Figure 3-14, B). Instead of elongation products, degradation of the primer was 
observed in the case of One Taq®. Notably, the exonuclease activity of KF did not consider the artificial 
base as a mismatch, as exclusive n+dS product formation was observed. 
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Figure 3-14. (A) Template and principle of the primer extension experiment. (B) Denaturing PAGE from SNI 
experiments in the presence of 400 µM dSTP using different polymerases. M is the marker and N is the negative 
control. Polymerases: KFexo– = Klenow fragment exonuclease deficient, KF = Klenow fragment, Deep = Deep vent, 
Taq = One Taq, KOD = KOD XL, Bst = Bst Pol I.  
Encouraged by the good incorporation by KF, full elongation of the primer was attempted. When all five 
dXTPs were applied in primer extensions to the To containing template, only for KFexo– a very faint band of 
fully elongated primer was found (Figure 3-15, dXTP). Most of the other polymerases including KF 
yielded the +1 elongation product or just the primer (data not shown). Extension beyond an incorporated 
artificial base pair is known to be a major roadblock in artificial base pair design.[191-192] Next, a two-step 
procedure was applied in which first the dSTP was incorporated by KF followed by addition of the natural 
dNTPs and a second polymerase. So, each polymerase was studied for its ability to elongate the dS 
containing primer, independently of its capability to selectively form the S:To pair. In this way, KF and 
KFexo– only provided traces of the completely elongated primer and mostly the dS containing primer (data 
not shown). However, Bst Pol I was able to further elongate after dSTP incorporation by KF. It is 
noteworthy that Bst Pol I was found unable to form S:To efficiently (cf. Figure 3-14) and thus did not 
provide any full-length product, when 5 dXTPs were applied. By combining the polymerases KF and 
Bst Pol I, complete elongation was achieved in the presence of 5 dXTPs (Figure 3-15). Only faint 
additional bands were observed. These were assigned to the n+dS product, but also n+dA misincorporation 
opposite dTo, and even further elongation was detected. It is assumed that KF incorporates the dSTP at 
37 °C within 10 min, then the temperature increase to 60 °C denatures this polymerase and Bst Pol I 
continuous elongation.  
The special property of the salicylaldehyde base to change the migration speed in the PAGE could be used 
to distinguish between correct elongation and mutasynthesis by dA. When only dNTPs were added to a 
primer extension by KF, a faint band of the +1 product was observed (Figure 3-15, dNTP), which migrates 
faster than the primer elongated by dS, (Figure 3-15, dSTP). 
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Figure 3-15. Denaturing PAGE from primer extension experiments using 1 pmol template, 2U polymerase and 
varying nucleotide compositions. M is the marker, N is the negative control and +1 is the control elongated by a 
single nucleotide. Single nucleotide insertion by KF (10 min, 37 °C) for dSTP or dNTP. (Attempted) full elongation 
by KFexo– (6 h, 37 °C) and a mixture of KF and Bst Pol I (i. 10 min, 37 °C, ii. 6 h, 60 °C) in the presence of 5 dXTPs. 
Polymerases: KFexo– = Klenow fragment exonuclease deficient, KF = Klenow fragment, Bst = Bst Pol I.  
In order to exclude mutation of the artificial base position by a natural nucleotide, the selectivity of the 
dSTP incorporation by KF was studied in single nucleotide insertions. Therefore, each of the five 
nucleotides was provided in separate reactions with the To template. While dSTP completely yielded the 
+1 elongation, only for dATP some +1 elongation was observed after denaturing PAGE. This indicated 
that mutation of dS to dA could be possible. For dCTP, dGTP and dTTP even some degradation of the 
primer was detected (Figure 3-16). Moreover, an additional slowly migrating band was observed for the 
dSTP incorporation, which indicated crosslink formation between the elongated primer and the template. 
Despite the denaturing conditions of the PAGE some double strand was observed. This demonstrated the 
stabilizing effect of the imine connection between the aldehyde and the amine base. 
 
Figure 3-16. Denaturing PAGE from SNI experiments for the To template in the presence of 200 µM dTTP, dATP, 
dGTP, dCTP and 400 µM dSTP using KF polymerase (10 min, 37 °C).  
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3.9.2 Primer Extensions with dToTP 
The experiments for the incorporation of dToTP opposite a templating dS (oligo P1a and P1c, Table 5-6, p. 
149) were performed analogously to the primer extensions in the converse case. The results from 
polymerase screening in SNI providing only 400 µM of dToTP were different from the previous 
experiments for the dSTP. None of the studied polymerases managed quantitative +1 elongation within 
10 min, although some extension was observed for KF, KFexo-, Deep vent exo– and Bst Pol I (Figure 3-17). 
Again, KF proved to be most suited for the incorporation of the artificial nucleotide. 
 
Figure 3-17. (A) Template and principle of the primer extension experiment. (B) Denaturing PAGE from SNI 
experiments in the presence of 400 µM dToTP using different polymerases. M is the marker, N is the negative control 
and +1 is the positive control. Polymerases: KF = Klenow fragment, KFexo– = KF exonuclease deficient, Deep = Deep 
vent, KOD = KOD XL, Bst = Bst Pol I.  
Quantitative single nucleotide elongation for the dToTP was achieved by increasing the incubation time to 
20 min using KF. This condition was also applied to the first step in the two-step procedure aiming at full 
primer elongation. In the second step various polymerases were analyzed for their ability to incorporate 
dNTPs to the dTo-elongated primer. However, only for KFexo– a very faint band of full-length primer was 
observed (Figure 3-18). All other studied polymerases were found completely unable to elongate after 
dToTP incorporation. Even the polymerase mixture that was able to provide full-length product in the case 
of dSTP opposite the templating dTo, did not provide more than traces of the desired product. The reasons 
for the observed differences in primer extensions between incorporation of dToTP opposite dS and dSTP 
opposite dTo were enigmatic at that point. Also the encountered difficulties to provide full-length product 
at all, were proof for the shortcomings of the dTo:dS pair in enzymatic replication. 
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Figure 3-18. Denaturing PAGE from primer extension experiments using 1 pmol template, 2U polymerase and 
varying nucleotide compositions. M is the marker, N is the negative control and +1 is the control elongated by a 
single nucleotide. Single nucleotide insertion by KF (20 min, 37 °C) for dSTP or dNTP. Attempted full elongation by 
KFexo– (6 h, 37 °C) and a mixture of KF and Bst Pol I (i. 10 min, 37 °C, ii. 6 h, 60 °C) in the presence of 5 dXTPs. 
Polymerases: KFexo– = Klenow fragment exonuclease deficient, KF = Klenow fragment, Bst = Bst Pol I.   
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3.10 Co-crystallization of Bst Pol I with S:To Containing DNA 
In order to gain insight into the structural properties of the covalent base pair, DNA strands containing the 
S:To were crystallized together with a DNA polymerase. For this reason the DNA polymerase from 
Geobacillus stearothermophilus (Bst Pol I) was chosen, because it allowed full elongation for dSTP 
opposite dTo and had been crystallized successfully in the group before. Expression and purification were 
performed according to the established protocols and the purified enzyme was generously provided by 
Barbara Steigenberger. Concomitantly, DNA strands were synthesized containing the artificial 
nucleobases in various positions to allow crystallization of preinsertion- (+2), insertion- (+1) and 
postinsertion (-5) complexes (Table 3-4) and were carefully purified by RP-HPLC. For the design of the 
template DNA 5´-overhangs of 3-4 bases were chosen, as this is the normal substrate for the polymerase in 
contrast to the alternative blunt end DNA. The obtained strands were hybridized to a final concentration of 
500 µM and one volume was mixed with an equal volume of the purified Bst Pol I 10 mg/mL. This equates 
a molar DNA:protein ratio of about 3:1, which after 1 h incubation on ice was used for the crystallization 
setups. In the case of the preinsertion complex dSTP was added to a final 660 µM before the incubation 
step to allow formation of a ternary complex between polymerase, DNA and incoming nucleotide. Crystals 
were grown using the hanging drop vapor diffusion technique in 0.1 M MES (pH = 5.8), 46-49% of 4 M 
(NH4)2SO4 and 2-3% 2-methyl-2,4-pentanediol (MPD). Gratifyingly, within 3-14 days the polymerase-
DNA crystals (Figure 3-19) grew at 18 °C for all three DNA templates. They were harvested after three 
weeks, transferred into a cryo-solution and frozen until the X-ray experiment. Beam-line measurements 
were kindly performed by Dr. Sabine Schneider. The crystal structure was solved by Dr. Markus Müller 
using molecular replacement and the existing structure with the pdb code: 2XY5. Details regarding data 
collection and structure refinement can be found in 5.4.14 p. 154.[41] 
Table 3-4. Overview of the DNA strands and templates that were used for co-crystallization with Bst Pol I.  
Entry Name DNA strands Template 
1 Preinsertion 
5´-CACToCGAGTCAGGCT-3´ 
5´-AGCCTGACTCG-3´ 
5´-CACToCGAGTCAGGCT-3´ 
    3´- GCTCAGTCCGA-5´ 
2 Insertion 
5´-CACToCGAGTCAGGCT-3´ 
5´-AGCCTGACTCGS-3´ 
5´-CACToCGAGTCAGGCT-3´ 
   3´-S GCTCAGTCCGA-5´ 
3 Postinsertion 
5´-ATGCGACCToTCCCT-3´  
5´-AGGGASGGTC-3´  
5´-ATGCGACCToTCCCT-3´ 
    3´-CTGGS AGGGA-5´ 
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Figure 3-19. Crystals of DNA-containing Bst Pol I depicted as grown in mother liquor after 12 days in polarized 
light. (Left) drop containing a DNA with the S:To base pair in the postinsertion template (-5) at 0.1 M MES (pH = 
5.8), 3% MPD and 47% of 4 M (NH4)2SO4, (right) close-up view of a single crystal. 
Well-diffracting crystals were obtained for all three setups which scattered with adequate resolution (about 
2.0 Å) to perform molecular replacement. However, in the initial structure before the structure refinement 
it was noticed that the DNA template was orientated with the blunt end towards the active site instead of 
the expected 5´-overhang as intended. Unfortunately, this meant that for the preinsertion and insertion 
template setups the interesting DNA part was pointing away from the enzyme. In the region so distant from 
the polymerase active site, the DNA strand is more flexible and therefore cannot result in a well-ressolved 
structure. Thereby, the data collected for the crystals from the insertion and preinsertion template were 
rendered useless. Reasons for the observed preference of the blunt end over the 5´-overhang in all crystal 
structures could result from the incubation step of the polymerase together with the DNA strand at 0 °C. 
Maybe an incubation step at rt or even elevated temperatures, like 60 °C, which are close to the enzyme 
activity optimum can resolve the issue. A definite solution to this problem is the design of the DNA 
template as a palindrome. 
Luckily, the position of the S:To base pair in the postinsertion complex was basically in the centre of the 
DNA duplex, even when the blunt end was in the active site of Bst Pol I. Therefore, the refined structure 
including the S:To base pair inside the DNA duplex could be solved for this setup. The base pair is so far 
away from the active site that the polymerase simply serves as a crystallization scaffold for the DNA.  
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Figure 3-20.[41] (A) Crystal structure of Bst Pol I in complex with a To:S crosslink containing DNA. (B) The To:S 
crosslink overlaid with a canonical dG:dC base pair. The C1′–C1′ distance of 10.8 Å for the unnatural crosslink is 
identical with the distance observed for the canonical base pair. (C) Rear view of the To:S crosslink, showing a twist 
out of plane. To is depicted in yellow, S in orange.  
The structure shows that the To:S bases face each other and that they are covalently linked via the expected 
imine interaction. An overlay with a structure of a canonical dG:dC base pair at this position proves that 
the To:S crosslink provokes only small structural perturbations in the duplex (Figure 3-20, B). The distance 
of 10.8 Å between the C1´ in the deoxyriboses of the artificial crosslink is identical to the natural G:C pair 
(10.8 Å). In contrast, the previously reported metal- and ethylenediamine mediated S homobase pair, has a 
distance of 11.4 Å. [13] The improved fit of the To:S crosslink is achieved because To adopts a conformation 
which was unexpected, with the stilbene double bond rotated away from the counterbase. It could be that 
the need to populate this rotameric conformation is the reason for the sluggish full elongation after dToTP 
incorporation opposite a S template. The To:S crosslink is not perfectly planar, with the S slightly twisted 
from the To plane (Figure 3-20, C). The oxygen atom from the S base and the imine bond are placed in the 
same plane, like a bicyclic system trying to avoid the steric clash with the alkene. 
Based on the X-ray results a model for the enzymatic incorporation of To opposite the templating dS was 
proposed, which might explain the observations made in primer extension experiments (Scheme 3-15). 
When the dToTP is incorporated opposite the templating dS the imine bond forms in a conformation which 
is expected for the S:To nucleoside dimer in solution. This “open” conformation of the base pair disturbs 
proper DNA duplex formation, as it is too wide. The isomerization to the “closed” form, which we 
observed in the crystal structure, could occur via hydrolysis of the imine, rotation next to the alkene and 
reformation of the imine. As the imine hydrolysis is slow and the isomerization requires the dTo 
nucleobase to adapt an unfavorable conformation, primer extensions stop after dToTP incorporation. 
Interestingly, the incorporation of dSTP opposite a templating dTo is much easier and the primer can be 
fully elongated. Therefore, it is assumed that the canonical bases in the template strand directly adjacent to 
A B
C
10.8 Å
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the dTo support the “closed” conformation through -stacking. By stabilizing this conformation, e.g. by 
chemical modifications and redesign of the To nucleoside, the acceptance by the polymerase and the 
incorporation efficiency should be improved. 
 
Scheme 3-15. Proposed model for a possible conformational isomerization in a growing DNA strand. On the left is 
the conformation we expect in solution and upon single nucleotide insertion in unproductive primer extensions, on the 
right is the conformation observed in the crystal structure which is isosteric to a canonical base pair.  
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3.11 Chemical Efforts to Improve the Enzymatic Incorporation Efficiency 
In the crystal structure we observed that the improved fit of the To:S base pair was due to an unfavorable 
conformation of the aromatic amine base with the trans-stilbene rotated away from the center. As this is 
the less favorable conformation in solution, we hypothesized that this could also account for the poor 
processivity of the DNA polymerase in primer extension experiments. By “locking” the aromatic amine 
nucleoside through a cyclic system that is analogous to the less favorable conformation, an improved 
acceptance by polymerases and an increase in melting temperature was expected for this “improved” 
nucleoside compared to the initial To:S pair. Possible molecular analogs of the unfavorable trans-stilbene 
conformation are an indene and a naphthalene derivative (Figure 3-21). As the indene derivative is difficult 
to synthesize, the naphthalene was selected as a replacement. 
 
Figure 3-21. Assumed preferred conformation of the To base in solution (A), observed conformation in a DNA strand 
from a X-ray structure (B). Suggested indene- (C) and naphthalene (D) analogs that represent “locked” isosteres of 
the To base. R = deoxyribose. 
3.11.1 Synthesis of a Naphthalene Amine Base Triphosphate 
The synthesis of the naphthalene amine nucleoside 107 was based on the developed modular synthesis that 
had been used for the amine nucleoside library with one major exception. After C-deoxribonucleoside 
formation via the hemiketal and subsequent reduction with Et3SiH, a Suzuki-Miyaura reaction was 
employed instead of the Heck coupling. Only minor or no adjustments were necessary for the subsequent 
reaction steps.  
The reaction sequence starts by addition of the monolithiated form of 2,6-dibromo-naphthalene to the TBS-
protected deoxyribolactone 91 (Scheme 3-16) analogously to the procedure that was applied in the 
synthesis of the other amine bases. However, when the crude reaction product from this carbonyl addition 
was directly used in the BF3 catalyzed reduction, it was impossible to completely purify the resulting TBS-
protected bromo-naphthalene nucleoside 108 by chromatography after the reaction. Therefore, the 
hemiketal 109 had to be isolated by flash column chromatography before the subsequent reduction to 
obtain the pure TBS-protected bromo-naphthalene nucleoside 108. As the naphthalene hemiketal 109 was 
more stable compared to the benzene hemiketal, this only resulted in minor loss of the product. Again, the 
formation of an -configured bromo-naphthalene nucleoside was not observed. 
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Scheme 3-16. Overview of the TFA-protected naphthalene amide nucleoside 112 synthesis. 
In the Suzuki-Miyaura cross-coupling the TFA-protected boronate 110 was coupled to the bromo-
naphthalene nucleoside 108 using standard conditions and the ferrocene Pd(II) catalyst, Pd(dppf)Cl2 
(Scheme 3-16). Although the starting materials were not completely dissolved, the desired cross-coupling 
product 111 was formed in 45% isolated yield. Side products were either TFA or onefold TBS-deprotected 
forms of the coupling product, which were recycled in subsequent reactions to the unprotected nucleoside. 
For the TBS-deprotection standard conditions involving HF∙pyridine were used, which gave the TFA-
protected naphthalene amine nucleoside 112 in 69% isolated yield. As the enzymatic acceptance was in the 
main focus of research at that time, no phosphoramidite was synthesized from the nucleoside 112. 
 
Scheme 3-17. Synthesis of the naphthalene amine triphosphate 113 (dNaaTP) from TFA-protected nucleoside 112. 
Saponification of the TFA-amine nucleoside 112 using mild conditions with LiOH gave the completely 
unprotected naphthalene amine nucleoside 107 in 79% yield after flash column chromatography (Scheme 
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3-17). The reaction to the 5´-triphosphate of the naphthalene amine deoxynucleoside (dNaaTP) 113 was 
again performed using the self-synthesized salicyl phosphite reagent 10 according to the procedure from 
Caton-Williams et al. which had been successfully applied to several other nucleosides before in this work. 
After precipitation, the crude product was purified twice by semipreparative RP-HPLC and the resulting 
fractions were analyzed by MALDI-TOF and analytical RP-HPLC. Satisfyingly, NMR spectroscopy and 
mass spectrometry of the major combined fraction revealed that 5´-dNaaTP was successfully obtained in 
17% isolated yield. The base peak in the analytical RP-HPLC profile from the crude product (Figure 3-22, 
A) was found to be the desired triphosphate when compared to the purified dNaaTP (Figure 3-22, B). 
Depending on the number of triethylammonium counterions of the triphosphate small shifts (up to 1 min) 
in retention time were observed, which lead to an underestimation of the purity. According to analytical 
RP-HPLC, two-fold purified dNaaTP only had a purity of about 90%. However, judged by the 31P and 1H 
NMR results at least 95% pure 5´-triphosphate was obtained.  
   
Figure 3-22. Analytical RP-HPLC profiles from (A) crude dNaaTP precipitated after the triphosphate reaction and 
(B) purified dNaaTP at 260 nm detection using a gradient from 0–50% in 45 min. 
To ensure the correct formation of the 5´-triphosphate, 1H-coupled 31P NMR experiments were performed. 
Three signals were observed for the dNaaTP in the 31P NMR spectrum, of which two only showed 2JP-P 
couplings of about 20 Hz and one also 3JP-H couplings of about 6 Hz (Figure 3-23). The latter signal was 
assigned to the -phosphate and due to the multiplet, a doublet of triplets, it was clearly identified as being 
attached to a 5´-position. The signal at –23.5 ppm couples with two phosphorus and therefore the resulting 
triplet was assigned to the -phosphate. For the remaining phosphorus from the -phosphate the expected 
doublet was observed at –11.0 ppm. 
Only minor amounts of the 3´-triphosphate were observed (data not shown) in other fractions from the 
semipreparative RP-HPLC, which demonstrated the decent chemo- (amine versus hydroxyl nucleophile, 
primary versus secondary alcohol) and regioselectivity (5´- versus 3´-OH) of the reaction method. 
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Figure 3-23. 31P NMR spectrum of the purified dNaaTP. The three signals were assigned to the -, - and -
phosphate. The doublet of triplets for the -phosphate proves the formation of the 5´-triphosphate. 
3.11.2 Primer Extension Experiments with dNaaTP 
With the dNaaTP in hand and the DNA template still available from the experiments with dToTP, the 
acceptance of the new amine base by the polymerases was studied. At first, single nucleotide insertions of 
dNaaTP opposite the S using different polymerases and 200 µM of the nucleotide were performed. Within 
10 min of incubation at the adequate temperature for each polymerase quantitative incorporation was 
observed for KF, vent exo– and Bst Pol I. For KFexo– almost complete insertion, and for KOD XL only very 
little insertion was found (Figure 3-24). Compared to the results obtained in similar experiments for dToTP 
this already indicated an improvement. 
d  in ppm
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
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Figure 3-24. Denaturing PAGE from SNI experiments in the presence of 200 µM dNaaTP using different 
polymerases. M is the marker, P is the positive control and N is the negative control. Polymerases: KF = Klenow 
fragment, KFexo– = Klenow fragment exonuclease deficient, ventexo– = Deep vent exonuclease deficient, KOD = KOD 
XL, Bst = Bst Pol I 
Encouraged by this result, a full-length extension was attempted by applying a two-step protocol. In the 
first step the dNaaTP is incorporated in a SNI using KF for 1 min followed by addition of all canonical 
dNTPs and assaying different polymerases for 30 min incubation after heat inactivation of KF. At the 
beginning several polymerases (KF, KFexo–, vent exo–, KOD XL, Bst Pol I, Taq, Q5 and Therminator) were 
tested in this way. However, with the exception of the Therminator polymerase and to a minor extent KF 
no elongation beyond the +1 was observed (data not shown). So, for a consecutive study these two 
polymerases and in addition Bst Pol I and KFexo– were selected for a two-step elongation protocol with an 
increased incubation time (3 h) for the second step. This time, fully elongated primer was observed for all 
four polymerases (Figure 3-25). However, KF, KFexo– and Bst Pol I majorly produced the +1 elongated 
primer and only traces of the full-length product. Besides for the Klenow fragment polymerases, 
considerable amounts of +2 were found, indicating that the subsequent elongation after natural nucleotide 
incorporation adjacent to the dNaa is difficult. For the Therminator polymerase no primer was visible. 
Instead elongated primer products of 30 or almost 30 mer size were found, indicating reasonable 
acceptance of the dNaaTP nucleotide. 
 
Figure 3-25. Denaturing PAGE from a two-step primer extension experiment. First SNI using KF and 200 µM 
dNaaTP, then 200 µM dNTPs and different polymerases. P is the positive control, N is the negative control and +1 is 
the first step from the two-step protocol (3 h incubation) 
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In parallel, the same polymerases were tested for their ability to fully elongate the primer in the presence of 
all five dXTPs from the beginning in a one-step protocol. To our delight, the Therminator polymerase was 
able to produce the fully elongated primer, whereas KF and KFexo– only produced tiny amounts and 
majorly +1 and further stalled products. Bst Pol I however exclusively produced the +1 product (Figure 
3-26). 
 
Figure 3-26. Denaturing PAGE from a one-step primer extension experiment using different polymerases and 
200 µM of the 5 dXTPs. Polymerases: KF = Klenow fragment, KFexo– = Klenow fragment exonuclease deficient, Bst 
= Bst Pol I, Therm. = Therminator. 
Having found a polymerase which was able to fully elongate the primer after incorporation of the dNaaTP, 
it was necessary to prove the correct replication and to exclude a simple mutation at the artificial base 
position. Therefore, primer extension experiments were conducted to determine the selectivity for the 
incorporation of the dNaaTP opposite the templating S by the KF and Therminator polymerases. As the KF 
had been used for the experiments with S:To and in the two-step protocol for the +1 step for dNaaTP, a SNI 
was performed using each dXTP. No misincorporation was observed for any of the canonical dNTPs. 
While the dNaaTP exclusively yielded the +1 elongated primer, no incorporation was observed for any of 
the canonical dNTPs. Instead, the primer was degraded until the last correct position of the nucleotide 
which was applied to the primer extension reaction (Figure 3-27).[193-194] When the same experiment was 
performed with the Therminator polymerase, which was the best in the one-step elongations, a completely 
different result was obtained. This time +1 elongation was observed for dA, dC, dG, and dNaaTP. In the 
case of dTTP even +3 elongation was found. Under the conditions used the Therminator polymerase 
simply incorporates any dXTP opposite the templating S, yet it only continues elongation beyond the 
mismatch, if there are matching base pairs like for dT (Figure 3-28). This result illustrated the ability of the 
polymerase to tolerate mismatches and incorporate modified nucleotides. Whether meaningful elongation 
of the primer without mutation was possible in the presence of the 5 dXTPs therefore remained 
questionable. 
P           N          Kf Kfexo– Bst Therm.
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Figure 3-27. Denaturing PAGE from a SNI using KF polymerase and 200 µM of each dXTP. M is the marker, N is 
the negative control and +1 is the singly elongated control. 
 
Figure 3-28. Denaturing PAGE from a SNI using the Therminator polymerase and 200 µM of each dXTP. M is the 
marker, N is the negative control and +1 is the singly elongated control. 
In order to clarify this issue and to study the time-dependence of the full elongation, primer extension 
reactions involving the Therminator polymerase and all 5 dXTPs were stopped after 30, 60, 120 and 
180 min. A sample of a 180 min extension was used for MALDI-TOF mass spectrometry after phenol-
chloroform extraction. Within 30 min the Therminator polymerase only manages to incorporate a single 
base opposite the templating S, after 60 min some further elongated primer is visible which is remarkably 
shorter than the full-length product from the marker (Figure 3-29). Only after 120 min some fully 
elongated primer occurs, yet the presumed +1 product is clearly visible. Complete consumption is observed 
for the 3 h sample, but the resulting band is accompanied by a smear, which has also been observed for 
primer exentsions involving dToTP.  
N        +1      dA dC dG dT dNaa M
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Figure 3-29. Denaturing PAGE from primer extensions using the Therminator polymerase and 200 µM of each dXTP 
for different incubation times. 
Finally, the MALDI measurement of the 180 min sample clarified the specificity issue (Figure 3-30). It 
was known that dA has the highest probability of misincorporation opposite a templating S,[13] so the mass 
spectrum was searched for the corresponding strands (Table 3-5). The main peak was assigned to a +6 
elongated primer possessing a single dNaa with the found m/z of 9556.6 in agreement with the calculated 
mass (9558) and is probably the main product from the primer extension (Figure 3-30). This means that the 
final dA incorporation at the very end of the template did not occur for this signal (Table 3-5, entry 5). For 
the full-length product including the dNaa a m/z of 9879.2 (+7) was found, which deviates from the 
expected 9873 considerably. However the low signal to noise ratio for this peak might attribute for the 
mass difference and also indicates a low abundancy of the full-length product. Yet, it remains unclear why 
the incorporation of the canonical dNTPs towards the end of the template is so difficult in the case of the 
dNaa incorporation to the primer. Peaks which indicate dA misincorporation opposite the templating S 
could be the m/z of 8249.3 and 9471.3, which are relatively close to the 8240 and 9474 that are expected 
for the primer elongated by AT instead of NaaT and ATTGCT instead of NaaTTGCT (Table 3-5, entry 2 
and 6). 
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Figure 3-30. MALDI-TOF spectrum of primer extension products from one-pot reactions with 200 µM dNaaTP, 
dNTPs and 20 pmol of the salicylaldehyde containing template using one unit of Therminator polymerase for 3 h at 
70 °C. 
Table 3-5. Masses of possibly elongated primers from the primer extension experiment. 
Entry Primer +  Expected mass  
X = A, g/mol 
Expected mass 
X = Naa, g/mol 
1 X 7934 8018 
2 XT 8240 8324 
3 XTT 8546 8630 
4 XTTG 8877 8961 
5 XTTGC 9168 9252 
6 XTTGCT 9474 9558 
7 XTTGCTA 9789 9873 
 
More surprisingly, the MALDI measurement from the one-pot primer extension hints towards a 
remarkable selective incorporation of the dNaaTP opposite the dS, when all dXTPs are present. This is in 
contrast to the result from the primer extension experiment aiming at determining the selectivity of the 
Therminator polymerase in SNIs, which showed possible incorporation of all dNTPs opposite of dS, when 
no dNaaTP was present (Figure 3-28). Altogether this is evidence for the kinetically favored acceptance of 
the dNaaTP by the Therminator polymerase opposite dS compared to the natural dNTPs, as it does not 
possess a 3’-5’ exonuclease activity.  
In conclusion, it was shown that the enzymatic acceptance of the amine base could be improved by a minor 
chemical redesign of the initial To base. The synthesis of the naphthalene amine base triphosphate, 
dNaaTP, was accomplished in only six steps from commercially available starting materials. Primer 
extension experiments proved that full elongation and selective incorporation of dNaaTP opposite the dS is 
possible in the presence of all dXTPs, when using the Therminator polymerase. This is a tremendous 
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improvement compared to the To base, which did not allow efficient full elongation even when polymerase 
mixtures or a sequential order of component addition was used. Reasons for the improved acceptance of 
the dNaa in comparison to the dTo base might be the increased -stacking ability and the stronger rigidity. 
By introducing the additional cyclic system, the degree of conformational freedom is reduced, and thus the 
loss of entropy upon binding and adaption of a defined conformation is decreased. Ironically, the 
acceptance by Bst Pol I which was in the X-ray structure together with the initial S:To base pair and 
allowed the deduction of the new amine base design, still halts after the dNaaTP incorporation, indicating a 
major problem with the “improved amine base”. 
3.11.3 Design and Proposed Synthesis of Further Improved Covalent Base Pairs 
 
Figure 3-31. Proposed design of the further improved covalent base pair and the corresponding nucleosides. The H-
bond accepting functional group is marked in red. 
The existence of a minor groove H-bond acceptor is one striking common property of published artificial 
base pairs which feature enzymatic acceptance by polymerases similar to the canonical bases regarding 
efficiency of the incorporation rate and selectivity.[135, 163, 195-196] The X-ray crystal structure from the Klen 
taq polymerase in a ternary complex with a DNA containing the dNaM base in the template and an 
incoming d5SICS triphosphate showed close contacts of a tyrosine residue and the minor groove H-bond 
acceptor.[197] This finding is in accordance with existing structures also for natural DNA[198] and seems to 
be a determining factor for DNA synthesis processivity by the polymerase. The mechanism adds up to the 
other control factors, like -stacking ability and correct geometry of the newly formed base pair. Therefore, 
the logical consequence for the further improvement of the developed covalent base pair from our group 
was the introduction of a suitable functional group capable of accepting H-bonds. At the same time the 
synthetic effort was to be kept at a minimum. 
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Scheme 3-18. Retrosynthetic analysis of the isoquinoline amine nucleoside. The molecule can be traced back to three 
major building blocks, of which two are already known. 
In order to prove the hypothesis that the H-bond accepting moiety will improve the acceptance by the DNA 
polymerase, synthesis of the 5´-triphosphate isoquinoline nucleoside and evaluation in primer extension 
studies against the initial dS base, was planned. The isoquinoline amine base nucleoside 114 could be 
accessed in a straightforward 5-step reaction sequence (Scheme 3-18). A final saponification of fully 
protected isoquinoline amine nucleoside 115 might give the desired nucleoside 114. Before the 
deprotection, protected molecule 115 could be provided via a silyl-Hilbert-Johnson type nucleosidation 
from Hoffer´s chlorosugar 3 and TFA-protected isoquinoline amine 116. Analogously to the synthesis of 
the naphthalene amine nucleoside, a Suzuki-Miyaura cross-coupling between TFA-boronate 110 and 
bromo-isoquinoline derivative 117 is intended for the synthesis of base building block 116. The synthesis 
of boronate 110 was already established during the synthesis of naphthalene amine nucleoside 107 (chapter 
3.11.1, p. 68). For the bromo-isoquinoline 117 an amidation condensation reaction from 4-bromo-
benzamine and methyl dimethoxyacetate was proposed similar to existing procedures.[199-200]  
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Part III – Click Chemistry Labeling of Phosphate-modified 
Nucleotides 
Phosphates are important functional units in signal transduction pathways,[46, 201] which regulate protein-
protein interactions[202] and enzyme activity.[203] Due to their charge they considerably change the 
hydrophobicity of the modified protein, which can lead to a local conformation change and ultimately to an 
altered protein structure.[204] Most of the organic phosphate in our body is captured in the form of the 
energy providing molecule ATP. At any given day, every one of us turns over an ATP amount equivalent 
to their body weight.[45] Also, DNA and RNA is synthesized from nucleotides within our body and the 
phosphate backbone of the DNA provides the necessary connectivity and charge. 
Therefore, new methods to create modified phosphate groups is a promising field for future applications. 
Many of the existing phosphate modifications were introduced by solid-phase synthesis and were 
chemically addressed with the Cu(I)-catalyzed alkyne-azide cycloaddition reaction. By this means, a DNA 
with a clickable backbone was generated that allowed to chemically ligate a linear DNA to a circular 
form.[98] Also the biocompatibility of the generated triazole backbone was demonstrated by in vivo 
transcription of a red fluorescent protein in human cells.[101] Some enzymatic approaches rely on the natural 
promiscuity of the enzymes to incorporate substrate analogs to a certain extent and thereby introduce 
alkynes or azides for subsequent modification in vitro.[205-206] This method has the potential to generate 
long site-specifically modified RNA strands, which hardly can be obtained by solid-phase synthesis. 
Another obstacle of this approach is the chemical synthesis of the modified substrate itself, which often is 
long and tedious. This part summarizes efforts about the synthesis, incorporation and application of 
alkyne-phosphate modified nucleotides. 
3.12 Synthesis of -Labeled Nucleotides 
Despite of immense technical challenges, studies involving single enzyme molecules are in vogue.[102] 
These developments are fueled by the advancement of the technical instrumentation for analysis and the 
ability to create smaller devices with defined properties. At the same time the design and synthesis of 
reporter molecules that generate a signal upon enzymatic conversion, is an ongoing challenge. In order to 
improve the crucial signal to noise ratio, these reporters are usually fluorescent probes mimicking 
substrates or cofactors of the applied enzyme of interest.[207] Unwanted alterations of the enzyme activity 
are minimized by introducing these modifications in positions that barely interact with the enzyme. Even 
real-time information can be acquired without the need for special miniature technical equipment. For 
example, ubiquitin activation has been studied with an ATP reporter molecule, which possesses a FRET 
donor-acceptor pair.[14] Single molecule real-time (SMRT) sequencing represents a combination of these 
technologies. In principle, this sequencing technique not only provides sequence information of a single 
DNA molecule, but also information about naturally occurring modified bases like 5-methyl-, 5-
hydroxymethyl-, 5-formyl- and 5-carboxy-deoxycytidine via altered incorporation kinetics.[3, 208-210] This 
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method requires -phosphate modified deoxynucleotides with a different fluorophore on every nucleotide. 
Upon addition to the growing primer strand, the fluorophore is released concomitantly with 
pyrophosphate.[3] Known syntheses of -labeled nucleotides involve multistep procedures with low overall 
yields and require anhydrous conditions, which are unfavorable for the watersoluble triphosphates.[7, 211] 
Consequently, there is potential for improvement in the synthesis of -labeled nucleotides. Our idea was to 
introduce an alkyne linker at the -phosphate of the nucleotide for subsequent modification by click 
chemistry.[212] 
 
Scheme 3-19. Synthesis of alkyne labeled nucleotides from dNTP and NTP sodium salts. Note that the products 118-
125 were isolated as their tris- and tetrakis triethylammonium salts after RP-HPLC. 
Based on the conditions from Morr et al. 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide hydrochloride 
(EDC∙HCl) was used as a coupling reagent, in order to attach 1-aminobut-3-yne at the -phosphate of the 
triphosphates.[213] This afforded the alkyne -phosphoramidates in good isolated yields of 70% to 86% for 
all major eight natural nucleotides (Scheme 3-19). Other coupling reagents like carbonylimidazole and 
N,N´-dicyclohexylcarbodiimide afforded lower yields in accordance with the literature and required 
anhydrous conditions.[214] Screening for best reaction conditions, different coupling reagents and 
alternative synthesis strategies was performed by F. M. Kink during his master’s thesis.[215] 
Despite the high functional group density of nucleotides, no protecting groups were necessary to 
selectively obtain the -phosphate alkyne triphosphates by our method. The correct configuration was 
unambiguously proven by NMR. Indicative is the coupling between the -phosphorus and 5’-H in 31P-
1H HMBC measurements (data not shown). Moreover, analytical RP-HPLC of aliquots from different time 
points of the reaction allowed tracking of the reaction progress. As the reaction time progresses, the 
deoxycytidine triphosphate amount decreases, while the -alkyne deoxycytidine triphosphate 119 amount 
increases (Figure 3-32, A). Apart from the starting material and the product peak, no additional peak is 
observed in the chromatogram, thus demonstrating the selectivity of the coupling method. In our final 
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protocol, the solvent DMF and the 1-aminobut-3-yne were extracted with CHCl3 and the remaining 
aqueous layer was used for NaCl-ethanol precipitation of the -modified triphosphate. Thereby the purity 
of the “crude” product was improved considerably and possible side reactions during concentration of the 
aqueous layer were avoided.  
 
Figure 3-32. HPLC profile of (A) aliquots from the -alkyne modification of dCTP and (B) crude product of -
fluorescein dTTP after 1 h reaction time (black). (B) The starting materials, -alkyne dTTP 121 (blue dotted) and the 
fluorescein azide a (red dotted) are depicted for comparison. 
Subsequently, Cu(I)-catalyzed alkyne-azide cycloaddition (CuAAC) was used to provide a set of 
fluorophore modified nucleotides.[71-72] In order to find the suitable conditions for the CuAAC between the 
alkyne triphosphates and the fluorophore azides, we took advantage of a coumarin azide b (Scheme 3-20). 
This azide is non-fluorescent, yet becomes a fluorophore upon reaction to the triazole. Moreover, it can be 
easily accessed in a few steps from commercially available starting materials.[216] The initial “click-
conditions” screening between the -dTTP alkyne 121 and the coumarin azide b was performed by F. M. 
Kink.[215] Reaction success was evaluated via the fluorescence intensity upon irradiation with a UV-lamp 
for thin-layer-chromatography analysis at 366 nm and analytical RP-HPLC. The final protocol involves in 
situ formation of Cu(I) from CuSO4 and fresh sodium ascorbate in a THF/H2O mixture. Only a slight 
excess of the fluorophore azide over the alkyne triphosphate was used at 0-25 °C. In this way the -
coumarin dTTP 121b and -coumarin ATP 122b were synthesized in 70% and 77% isolated yield, 
respectively. Characterization by HRESIMS and NMR spectroscopy allowed to verify product formation.  
Encouraged by the result, fluorophore azides with different absorbance and emission maxima were used 
for the click reaction with the -alkyne nucleotides. Since the fluorophores, which are routinely applied in 
SMRT sequencing are expensive,[7] additional fluorophore azides, namely BODIPY c, carboxyfluorescein 
a, and an analog of an alexa fluorophore d were synthesized (Scheme 3-20). Two of the used fluorophores, 
the carboxyfluorescein and the alexa analaog IR-806 are commercially available and were simply 
transformed to an azide by attaching a PEG-azide-amine by amide coupling or conjugate substitution, 
respectively. The BODIPY fluorophore was generously provided as a phenolic alcohol by Dr. B. Hackner. 
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Briefly, the phenolic alcohol was reacted to a succinimidyl carbonate which was in situ converted to 
BODIPY c by addition of the PEG-azide-amine linker. Due to chemical and physical properties of the 
PEG-azide, the introduction of the linker-azide was facile and the hydrophilicity of the resulting 
fluorophore azides was increased. 
The small set of fluorophore azides was used in click reactions of -dTTP 121 under the condition 
established for the coumarin azide b. This condition was ideal for the carboxyfluorescein azide a and 
provided the triazole product within 1 h in at least 90% conversion yield as shown by analytical HPLC 
(Figure 3-32, B). However, for the BODIPY azide c almost no product was formed using these conditions. 
Instead, precipitation of the fluorophore azide c was observed, which indicated a major solubility problem 
for the fluorophore in the 1:1 mixture of THF/H2O. By increasing the THF content, the solubility of the 
BODIPY azide c was improved. Still the reaction progress was unsatisfactory, as most of the starting 
material remained after 4 h. Using additional amounts of CuSO4 and ascorbate however, almost 
quantitative conversion (≥ 90%) was finally achieved for the reaction between -dTTP 121 and BODIPY 
azide c within 3 h. Despite special precautions, which avoided light exposure of fluorophore azide d, the 
resulting click product and the azide d itself decomposed within a few hours in solution. The 
decomposition was accompanied by a change in color from blue to violet. 
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Scheme 3-20. Click chemistry based synthesis of -fluorophore labeled nucleotides from -alkyne labeled nucleotides 
118-125 and fluorophore azides a-e (red star). 
In order to complete the set of four different fluorophore cycloadducts, additional fluorophore azides were 
purchased. The limit of the click protocol was illustrated by the poor yields, which were obtained with the 
Eterneon 480/635 azide® as a click partner (data not shown). Due to the poor solubility of the azide in 
solvent mixtures that contain enough water to establish sufficient CuSO4 and ascorbate concentrations, 
only trace amounts of the “clicked” nucleotide were isolated. In contrast to this, the water soluble TAMRA 
azide e allowed quantitative conversion of the -alkyne nucleotide within 2 h. Probably, a click protocol 
applying mostly hydrophilic fluorophore azides is convenient for nucleotides. It is important to note that no 
Cu(I)-stabilizing ligands like TBTA or THPTA were necessary to achieve full conversion in 1–4 h in the 
presence of only 1.5 equivalents of fluorophore azide per alkyne nucleotide. Inspired by the high purity of 
the crude -alkyne products and the subsequent click reaction, a one-pot protocol for the -coumarin dTTP 
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121b was developed. After formation of the -alkyne dTTP 121, the crude product was directly applied to 
the click reaction with coumarin azide b. In this way, the -coumarin dTTP 121b was obtained in 60% 
yield from dTTP after HPLC purification. Thereby, one time-consuming preparative HPLC step was 
avoided and the yield was identical compared to the calculated total yield of the step-wise procedure. 
Altogether, four different -fluorophore labeled dTTPs 121a-c, 121e were synthesized by CuAAC in 70-
90% yield (Table 3-6, Entry 4 – 7). The fluorophores possessed different absorbance and emission 
maxima, as evident from their physical data and visual inspection at daylight and upon excitation at 
366 nm (Figure 3-33). Chemically different dyes (rhodamine, fluorescein, coumarin and BODIPY) 
illustrate that the protocol is mild and tolerates a variety of functional groups. In addition, -fluorescein 
nucleotides were prepared from the eight -alkyne nucleotides (Table 3-6, Entry 1 – 4, 9 – 12). No 
considerable difference in yield and reaction progress was observed between the nucleotides by analytical 
RP-HPLC.  
Table 3-6. Overview of the successful CuAAC reactions. 
entry -NTP azide product conditions yield (%)1) 
chemical formula 
[M – H]– 
MS 
calc. m/z 
MS 
found m/z 
1 dATP a 118a A ≥90 C43H48N10O20P3- 1117.2265 1117.2221 
2 dCTP a 119a A ≥90 C42H48N8O21P3- 1093.2152 1093.2110 
3 dGTP a 120a A ≥90 C43H48N10O21P3- 1133.2214 1133.2168 
4 dTTP a 121a A ≥90 C43H49N7O22P3- 1108.2149 1108.2113 
5 dTTP b 121b A ≥90, 702) C23H26N6O16P3- 0735.0624 0735.0620 
6 dTTP c 121c C ≥90 C44H60BF2N9O18P3- 1144.3336 1144.3344 
7 dTTP e 121e B ≥90 C42H49N9O17P3- 1044.2465 1044.2438 
8 ATP b 122b A ≥90, 772) C23H25N9O15P3- 0760.0688 0760.0687 
9 ATP a 122a A ≥90 C43H48N10O21P3- 1133.2214 1133.2224 
10 CTP a 123a A ≥90 C42H48N8O22P3- 1109.2101 1109.2122 
11 GTP a 124a A ≥90 C43H48N10O22P3- 1149.2122 1149.2163 
12 UTP a 125a A ≥90 C42H47N7O23P3- 1110.1942 1110.1913 
1) yield determined by analytical RP-HPLC; 2) isolated yield after RP-HPLC purification; reaction conditions:  
A) 1.5 eq fluorophore azide, 0.1 eq CuSO4, 2.0 eq sodium ascorbate, 0 °C to 25 °C, 1 h, THF/H2O = 1:1;  
B) 1.5 eq fluorophore azide, 0.1 eq CuSO4, 2.0 eq sodium ascorbate, 0 °C to 25 °C, 2 h, THF/H2O = 1:3.  
C) 1.5 eq fluorophore azide, 0.3 eq CuSO4, 6.0 eq sodium ascorbate, 25 °C, 3 h, THF/H2O = 3:1. 
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Figure 3-33. (A) Optical appearance of the fluorophore-labeled dTTP 121a-121e and the Eterneon 480/635 azide® 
(red orange) at daylight. (B) Fluorophore-labeled dTTP 121a-c, 121e upon excitation with light at 366 nm. 
As phosphoramidates are prone to hydrolysis, especially under acidic conditions,[217] we studied the 
stability of the -alkyne 121 and -fluorescein dTTP 121a at pH 4, 7 and 10 over 3 h at 37 °C or 72 °C. For 
comparison, natural dTTP was incubated under the same conditions as well. All samples were analyzed by 
RP-HPLC after incubation. At pH 4, the -alkyne dTTP 121 was completely hydrolyzed to dTTP, while 
about 75% of the -fluorescein dTTP 121a was still intact. No hydrolysis was observed for any of the 
modified nucleotides at pH 7. Interestingly, at pH 10 the dTTP was less stable than its modified congeners. 
While for the natural triphosphate up to three peaks were observed, after incubation at 72 °C, about 98% of 
the -fluorescein dTTP 121a was still unaltered. Since most of the enzymes, which are routinely used in 
molecular biology require a neutral pH, we concluded that the chemical stability of our modified 
nucleotides is sufficient. 
3.13 Enzymatic Incorporation of -Labeled Nucleotides into DNA 
Next, the use of -labeled nucleotides as substrates for nucleotide consuming enzymes, especially DNA 
polymerases, was investigated. Therefore, primer extensions were performed involving the Klenow 
fragment (KF) from E. coli. The template was designed in a way that for the full extension of the primer 
each dNTP had to be incorporated exactly once. During incorporation of the fluorophore nucleotides, the 
label is cleaved off together with pyrophosphate resulting in a natural DNA strand (without any additional 
modification). To ensure an unambiguous result of the primer extension experiments, all applied labeled 
nucleotides were carefully purified by RP-HPLC. 
In one set of experiments the natural dTTP was completely replaced by one of the four different -
fluorophore labeled dTTPs 121a-c, 121e. The samples were analyzed by denaturing PAGE. A fluorescein 
on the 5´-position of the primer (Figure 3-34, A) allowed observation of the assay products via their 
fluorescence without staining. For all four -fluorophore dTTPs, complete primer extension was observed 
(Figure 3-34, B). However, the incorporation of fluorescein-labeled dTTP 121a seemed problematic, as an 
additional band was observed (Figure 3-34, B, dT4). In the second set of experiments, the influence of the 
same label (fluorescein) on the incorporation of different deoxynucleotides was studied. Therefore, one of 
the four dNTPs was replaced by the -fluorescein congener in consecutive experiments. Full extension was 
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observed for almost all samples in the denaturing PAGE. Again, for the fluorescein-labeled dTTP 121a an 
additional band was observed (Figure 3-34, C, dN3), which indicates compatibility issues for this substrate. 
 
Figure 3-34. (A) Template strand for the primer extension experiments. (B) Denaturing PAGE from primer extension 
experiments replacing dTTP by -fluorophore dTTPs (1: BODIPY, 2: coumarin, 3: TAMRA, 4: fluorescein) and (C) 
replacing a single dNTP each by a -fluorescein dNTP (1: dA*, 2:dG*, 3:dT*, 4:dC*). 
3.14 Enzymatic Incorporation of -Labeled Nucleotides into RNA 
We next studied the enzymatic compatibility of the -modified ribonucleotides. To this end, the -alkyne 
and -fluorophore ribonucleotides were used for in vitro transcription experiments. In procaryotic 
transcription, the first added ribonucleotide remains as a triphosphate, thus generating 5´-triphosphate 
RNA oligonucleotide transcripts. By replacing this nucleotide with a -labeled nucleotide, the modification 
could be introduced into the RNA strand during transcription. Moreover, the labeling is site-specific, as the 
modification of any subsequently introduced -labeled nucleotide is cleaved off together with 
pyrophosphate. Similar efforts, applying an -dienophile or -azide modified monophosphate, have 
produced RNA transcripts that can undergo inverse electron demand Diels-Alder reactions with tetrazines 
or Cu(I) catalyzed alkyne/azide cycloadditions, respectively.[205, 218]  
The DNA template for the transcription was designed as an early-stage T7 RNA polymerase promotor and 
a single stranded region coding for a 21-mer transcript. Since most of the T7 promotors have a 
transcription start site that begins with the incorporation of GTP, the canonical GTP was replaced by -
labeled GTP in the transcription experiments. The in vitro transcription outcome was analyzed by MALDI-
TOF mass spectrometry. Different T7 RNA polymerase mutants were studied for their ability to accept the 
labeled nucleotides, as they were available from former transcription experiments (see 3.5 Transcription 
Experiments using T7 RNA Polymerase Mutants, p. 43). 
  
N      dT dT1    dT2   dT3   dT4 N      dN dN1   dN2   dN3   dN4
A
B C
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Table 3-7. Templates used for in vitro transcription experiments and resulting full-length transcripts including 
calculated mass.*5’-alkyne label, 1non-templated A addition, 2 5’-fluorescein label. 
Entry Template and Resulting Transcript 
Transcript 
Mass [M–H]– 
Transcript*  
Mass [M–H]– 
1 5´-ATAATACGACTCACTATAGGG 
3´-TATTATGCTGAGTGATATCCCTTAGGGCTCTTCACTGAT 
 
pppGGGAAUCCCGAGAAGUGACUA 
 
 
 
 
7033.9 
 
 
 
7085.0 
2 5´-ATAATACGACTCACTATAGGCCTTTCACTACTCCTACCT 
3´-TATTATGCTGAGTGATATCCGGAAAGTGATGAGGATGGA 
 
pppGGCCUUUCACUACUCCUACCU 
pppGGCCUUUCACUACUCCUACCUA1 
 
 
 
6741.8 
7070.9 
 
 
 
6792.9 (7369.3)2 
7122.0 
 
First experiments with -alkyne GTP 124 and wild-type enzyme resulted in formation of alkyne labeled 5-
9 mer polyguanosine RNA fragments. When equal concentrations of the four NTPs were added together 
with the -alkyne GTP 124 in the transcription, almost no peaks from alkyne modified fragments were 
observed. Transcription experiments in which the natural GTP was completely replaced by its alkyne 
congener, provided a peak at m/z 7083 indicating the successful production of the alkyne-labeled RNA 21-
mer transcript (Figure 3-35). As the transcript contains 7 guanosines (Table 3-7, Entry 1), this result shows 
that the -alkyne GTP incorporation in internal positions of the transcript is possible. During this process, 
the label was released together with pyrophosphate. The intensity of the full-length peak increased when 
the wild-type RNA polymerase was replaced by the mutant forms F644A and H784A, which are known to 
possess a less strict substrate selection.[187] Also, a delayed addition of the natural GTP after 1 h 
transcription time considerably improved the yield of the alkyne full-length product. Probably, before the 
addition, the transcription complexes were progressing slowly during incorporation of -labeled GTP at 
internal positions. Due to the preference of the RNA polymerase for its natural substrate, the GTP replaced 
the labeled form upon addition and improved the transcription progress. When the time point for the 
natural GTP addition was delayed to 10 or 30 min after transcription start with -alkyne GTP, ATP, CTP 
and UTP, the yield of unlabeled transcripts increased. 
Despite all efforts to optimize the amount of labeled RNA transcripts, the MALDI-TOF mass spectrum 
was dominated by 5´-alkyne labeled abortive initiation fragments 5-9 mers (m/z 1918.9 to 3140.8, Figure 
3-35). Besides this, the mass of the sense strand of the template was observed at m/z 6431.4. Although 
peaks in the MALDI-TOF mass spectrum are not quantitative, the result indicates the presence of only low 
amounts of the labeled full-length transcript. 
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Figure 3-35. MALDI-TOF mass spectrum from in vitro transcription labeling experiments using wild-type T7 RNA 
polymerase, 2 µM of template (Table 3-7, p. 87, entry 1), 400 µM -alkyne GTP 124, ATP, CTP, UTP and after 
55 min GTP. 
Small interfering RNAs (siRNA) can regulate the posttranscriptional gene expression.[219] Several efforts 
are under way to develop siRNA-based therapeutics, but cell-specific and intracellular delivery of the 
polyanionic molecules is a major problem.[220] Recently, an anandamide receptor-mediated uptake of 
dendrimeric siRNA was developed within the Carell group, which allows targeted delivery of siRNAs to 
neuronal cells.[94] The anandamide siRNA dendrimers were prepared through CuAAC from alkyne-
modified RNA and an anandamide-azide branching molecule. All alkyne-modified RNAs were prepared 
by solid-phase synthesis.[94]  
Enzymatic synthesis could provide an alternative access to an alkyne containing siRNA. A template which 
encodes for a part of the luciferase gene from Renilla reniformis was employed for in vitro transcriptions 
with -alkyne GTP 124. The resulting transcript could act as a small interfering RNA (siRNA) in a dual-
luciferase reporter assay. The reporter assay was used to quantify the cellular uptake of oligonucleotides 
attached to a dendritic anandamide ligand.[94]  
As the transcript only contains two guanosines at the start (Table 3-7, Entry 2), more facile labeling of the 
transcript was expected. Again several conditions were screened to optimize the labeling efficiency and the 
samples were analyzed by MALDI-TOF mass spectrometry. This time, only abortive initiation fragments 
of 5-7 mers were observed, indicating an improved processivity for the template under the applied 
conditions (Figure 3-36). The signals at m/z 2137 and 2443 were assigned to the alkyne-labeled 6 mer and 
7 mer, respectively. Unexpectedly, the signal at m/z 1855, was not just the alkyne labeled 5 mer, but 
probably contained an additional C to A mutation, as its calculated mass (1859) fits best to the observed 
result. Nevertheless, the peak for the labeled full-length transcript (additional A, m/z 7121) was small and 
also the unlabeled form was found (m/z 7069). 
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Figure 3-36. MALDI-TOF mass spectrum from in vitro transcription labeling experiments using wild-type T7 RNA 
polymerase, 2 µM of template (Table 3-7, p. 87, entry 2), 400 µM -alkyne GTP, ATP, CTP, UTP and after 75 min 
GTP. 
Then, efforts were undertaken to introduce a fluorophore azide to the alkyne-labeled transcript by click 
chemistry. After extensive dialysis of the alkyne-labeled transcripts, the azidocoumarin b (Scheme 3-20, p. 
83), CuSO4 and ascorbate were added in a THF/H2O mixture. After 3-4 h the sample started to fluoresce 
upon excitation at 366 nm, which indicated successful reaction progress. However, only small peaks of the 
expected product were observed by MALDI-TOF (data not shown). Alternative reaction conditions, which 
were applied for effective click-labeling of DNA in the Carell group,[91, 93] could not improve the yield. 
Isolation of the labeled RNA by RP-HPLC was not possible.  
Therefore, direct labeling during in vitro transcription using -fluorescein GTP 124a was studied for the 
Ren luci template (Table 3-7,p. 87, Entry 2). At the beginning, the natural GTP was replaced by the 
fluorescent analog 124a and after different transcription incubation times (0, 5, 30, 60, 120 min) additional 
GTP was added. Notably, an early time point of the addition (0 and 5 min) improved the yield of 
fluorescein labeled transcripts (data not shown). Consequently, all five nucleotides were added to the 
transcription from the beginning and various concentration ratios of GTP:-fluorescein GTP were 
analyzed. A ten- to twentyfold excess of the labeled GTP was found to give the best yields of fluorescein 
modified transcripts as judged by MALDI-TOF. When the samples were applied to denaturing PAGE, 
direct visualization of the labeled transcription products was possible via their intrinsic fluorescence 
(Figure 3-37, A). Subsequently, the same gel was treated with SYBR green II staining to visualize non-
labeled transcripts as well. Clearly, fluorescein-labeled full-length product was obtained especially when 
the natural GTP amount was low. This was also confirmed by MALDI-TOF mass spectrometry (Figure 
3-37, B), as a peak at m/z 7368.0 was found which is close to the calculated molecular mass of 7369.3. 
However, the amount of abortive initiation fragments (m/z 2063.3 to 3000) increased enormously as 
0
500
1000
1500
2000
2500
3000
3500
4000
4500
1000 2000 3000 4000 5000 6000 7000 8000 9000 10000
in
te
n
si
ty
 a
.u
.
m/z
7068.9
7121.0
0
10
20
30
40
50
60
70
80
90
6500 6700 6900 7100 7300 7500 7700
in
te
n
si
ty
 a
.u
.
m/z
1855.4
2137.4
90  Results and Discussion 
 
compared to the control transcription. In addition, peaks corresponding to labeled transcripts lacking 
several bases were observed from 6000-7000 Da. Despite the successful 5’-fluorescein labeling of the 
transcript, these findings indicate a significant decrease in transcription efficiency upon incorporation of 
the -fluorescein GTP. 
 
 
Figure 3-37. (A) PAGE and (B) MALDI-TOF mass spectrum from in vitro transcription labeling experiments. 
Conditions: T7 RNA polymerase, 2 µM of template (Table 3-7, p. 87, entry 2), 400 µM -fluorescein GTP 124a, ATP, 
CTP, UTP and 20-80 µM GTP. *G:G is the ratio of labeled to unlabeled GTP. 
3.15 Enzymatic Labeling Efforts Involving -Labeled Nucleotides 
The labeling efforts involving the RNA polymerase had shown that 5´-labeling during transcription is 
possible, yet rather inefficient. Therefore, a different enzyme was studied for its ability to incorporate -
phosphate labeled nucleotides. 
The T4 polynucleotide kinase was examined as it catalyzes the transfer of a -phosphate from ATP to the 
5´-hydroxyl group of single- and double stranded DNA and RNA.[221] With the help of -labeled ATPs in 
the in vitro assays, site selective labeling of oligonucleotides was targeted. Using -alkyne 122, -
fluorescein ATP 122a and a single stranded DNA oligonucleotide (5´-
AGCCAGTACATCACAAGAACTCA-3´), the m/z equal to the mass of the phosphorylated DNA strand 
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was observed in the MALDI-TOF mass spectrum. The same result was found in the sample containing 
ATP, whereas a negative control without ATP did not give any 5´-phosphorylated oligonucleotide. As the 
employed phosphoramidates are prone to hydrolysis, an adenosine-5´-[-(propargyl)]triphosphate was 
purchased. Phosphate ester hydrolyze much slower compared to the phosphoramidates.[43] Again, the usage 
of this more stable nucleotide resulted in the formation of the 5´-phosphorylated DNA. Obviously, the 
reaction catalyzed by the T4 polynucleotide kinase not only facilitates the hydrolysis of the triphosphate, 
but also of other residues attached to the -phosphate. Maybe, by providing a -alkyne phosphonate ATP, 
this issue could be solved. However, as other groups have already synthesized -azide phosphonate 
ATP[217] and did not report on its application in enzymatic labeling, we assume that it is incompatible with 
this enzyme. 
3.16 Synthesis and Application of an -Alkyne Deoxyguanosine 5´-Triphosphate 
Inspired by the simple synthesis of the -labeled nucleotides, -labeled nucleotides were next synthesized. 
If these were consumed during enzymatic DNA synthesis, the introduction of a modified phosphate into 
the DNA backbone would become possible. The synthesis strategy started by linking the 1-aminobut-3-yne 
to the nucleoside monophosphate using already established protocols (see 3.12).[212] In a subsequent 
reaction, the labeled monophosphate was converted to the triphosphate following a published procedure.[53]  
EDC-mediated reactions of 1-aminobut-3-yne with the monophosphate of dAMP, dCMP, dGMP and 
dTMP were analyzed by analytical HPLC. Considerable differences in conversion were observed, which 
demonstrated the influence of the nucleobase on the reactivity of the 5’-phosphate. As the yield for the 
reaction to the alkyne-dGMP 126 was most promising, the initial synthesis strategy was established with 
dGMP first. Slight adaption of the initial protocol furnished the -alkyne dGMP 126 in 43% yield after 
RP-HPLC isolation (Scheme 3-21).  
 
Scheme 3-21. Synthesis of the -alkyne dGMP 126 from deoxyguanosine monophosphate. 
The reaction from the monophosphate to the triphosphate was based on a published procedure, whose basic 
principle is from the 1970s, and was chosen as it provides the natural triphosphates in at least 80% yield 
without the need for protecting groups.[53] At the beginning the monophosphate is activated under basic 
conditions and attacks the sulfonylimidazolium salt 127 (Scheme 3-22). The resulting sulfonyl 
phosphorylanhydride 128 reacts with the imidazole and gives an activated phosphorus species 129. This 
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phosphorimidazolidate 129 is in situ converted to the triphosphate by attack of pyrophosphate. In order to 
circumvent that the phosphorimidazolidate 129 is quenched by water and acetate, the starting materials 
needed to be free of water and triethylammonium acetate buffer (from HPLC purification). Formation of 
the phosphorimidazolidate 129 can be examined with the help of its yellow color. After addition of excess 
amounts of pyrophosphate to the activated compound, the yellow color remained even for prolonged 
incubation (>24 h). This indicated almost no reaction progress, as upon triphosphate formation the color 
should disappear as the intermediate is consumed. Analytical RP-HPLC confirmed the observation, as 
most of the starting material was still visible and only a small product peak of the desired -alkyne GTP 
130 was found (Figure 3-38). The best yield was achieved using 4 equivalents of pyrophosphate and 
incubation at 25 °C for 8 h. Then, the -alkyne GTP was isolated in 2% yield after careful purification by 
RP-HPLC. This only allowed characterization of the compound by high-resolution ESIMS and UV-Vis. 
Probably, the additional residue on the phosphate group decreases the electron density, thus rendering the 
phosphorimidazolidate more stable. Therefore, the attack by the pyrophosphate is less favorable. Also 
sterical hindrance from the butyne moiety could account for the very low yield of the -labeled GTP 130 
compared to the reported triphosphate yields from the natural monophosphate.[53] 
 
Scheme 3-22. Proposed mechanism of the reaction from -alkyne dGMP 126 to -alkyne dGTP 130 adapted from 
Mohamady et al.[53] 
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Figure 3-38. Analytical HPLC profile from the reaction of -alkyne dGMP 126 (22.9 min) to -alkyne dGTP 130 
(28.4 min) after 8 h reaction time and detection at 260 nm. 
Despite of the poor yield of -alkyne dGTP 130, the amounts were sufficient to perform primer extension 
experiments in which the modified triphosphate 130 replaced natural dGTP. The results provided insight 
whether the labeled nucleotide is a substrate for the enzymatic introduction of DNA backbone 
modifications. Therefore, a template strand with each of the 4 major natural bases missing (19 mer hybrid 
template) and a template ending directly before dGTP incorporation (20 mer hybrid template) was 
employed. These were then incubated together with an exonuclease-deficient and an exonuclease active 
DNA polymerase and varying nucleotide compositions. The reaction outcome was analyzed by denaturing 
PAGE. 
For almost all samples, in which the natural dGTP was replaced by the -alkyne dGTP 130 (Figure 3-39, 
Lane 4-7,11-14), the same bands were observed as for the positive controls (Figure 3-39, Lane 2-3,9-10). 
Only for two samples, using the exonuclease-deficient Klenow polymerase and the 20 mer hybrid 
template, incomplete elongation was found (Figure 3-39, Lane 6-7). However, this finding cannot be 
explained by inefficient incorporation of the labeled dGTP, as the almost identical experiment with the 19 
mer hybrid template yielded the +2 and +4 elongated primer (Figure 3-39, Lane 4-5).  
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Figure 3-39. Primer extension experiments involving -alkyne dGTP 130. The template shown here is the 19 mer 
hybrid template; the corresponding 20 mer hybrid template is elongated by dA. The table summarizes the nucleotide 
composition of the experiments. Note that in lane 6, 7, 13 and 14 the 20 mer hybrid template was used. 
The result that the -alkyne dGTP 130 gives efficiently elongated primer like the natural dGTP is 
unexpected. Particularly for the exonuclease active polymerase elongation stop after incorporation of the 
labeled nucleotide was anticipated. In addition, no gel-shift for the supposed labeled DNA was observed in 
comparison to the non-labeled strand. This aroused the suspicion that the label might have disappeared 
during/before incorporation. Several efforts were undertaken to unambiguously clarify whether enzymatic 
incorporation of the -alkyne dGTP 130 provided indeed a labeled DNA strand. Finally, analytical RP-
HPLC of the -modified dGTP 130, which had been used in the primer extension experiment, proved 
hydrolysis to dGTP (about 5%). Since an excess of the -alkyne nucleotide was used in the primer 
extensions, even the small amount of the natural dGTP generated by hydrolysis was sufficient to provide 
efficient primer elongation. 
From the results, it was obvious that the phosphoramidate based -modified nucleotides were by no means 
suitable substrates to analyze whether enzymatic DNA backbone labeling is possible. Future efforts should 
rely on labels introduced via phosphate esters or even phosphonates, to avoid unwanted hydrolysis. This 
however, will impede the synthetic effort. 
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4 Conclusions and Outlook 
Several artificial base pairs are reported in the literature, which can be replicated by DNA polymerases.[5, 9-
10, 13, 122, 133, 163] Only a fraction of these base pairs can also be successfully transcribed[58, 116, 123, 181, 196] into 
RNA and subsequently translated into proteins.[119, 126] Strategies relying on alternative hydrogen 
bonding[58, 118, 120, 126] or hydrophobic interactions[5, 8-10, 42, 123, 130, 139, 181] are commonly used to create 
unnatural base pairs. Work from within the Carell group shows that the enzymatic replication of an 
artificial metal-base pair is possible with good fidelity.[13] Transcription and translation of this base pair 
was the aim at the beginning of this PhD thesis. All necessary compounds were prepared successfully and 
combined for in vitro transcriptions. Different aldehyde nucleotides and T7 RNA polymerase mutants were 
studied under a plethora of conditions. Despite all efforts, transcription of the salicylaldehyde base was not 
possible without mutation of the artificial base to a canonical nucleoside in the resulting transcript. 
As a consequence, the base pair strategy was adopted and metal ion complexation was avoided completely. 
Instead, reversible covalent imine chemistry was exploited as the sole source of interstrand interaction. 
Therefore, the existing salicylaldehyde interacted with a suitbable amine-containing base, which was 
designed to fit into a DNA duplex. In cooperation with Dr. M. Tomás-Gamasa, a small set of amine base 
phosphoramidites was designed and synthesized. The salicylaldehyde phosphoramidite was utilized in the 
solid-phase synthesis of an aldehyde containing strand. Likewise, different amine-containing strands were 
prepared and the interaction between aldehyde- and amine-containing DNA strands was studied in melting 
temperature experiments. The combination between an aromatic amine and the salicylaldehyde proved to 
be highly stabilizing for the DNA duplex and the melting temperature increased by up to 31 K, compared 
to the control duplex. Notably, the melting curves obtained for heating and cooling of this strand were not 
superimposable and thus displayed hysteresis. By applying different cooling and heating rates or by 
increasing or decreasing the pH, this hysteresis effect was changed. Based on the data, we concluded that 
the imine formation and hydrolysis within the duplex is slower than the H-bond mediated melting and 
annealing of the adjacent bases. The comparison to a benzaldehyde base, which lacked the ortho-
hydroxylgroup of the salicylaldehyde, clearly proved its importance for stabilizing the imine by hydrogen 
bonding.  
Encouraged by the observed interaction between the aromatic amine and the salicylaldehyde in melting 
temperature experiments, incorporation of the artificial bases by DNA polymerases was analyzed. 
Therefore, the corresponding aromatic amine (dToTP) and salicylaldehyde triphosphates (dSTP) were 
synthesized and applied in primer extension experiments. A combination of Klenow fragment and the 
polymerase Bst Pol I was found capable of faithfully elongating a primer from an aromatic amine 
containing template, when dSTP and all dNTPs were present from the start. Base pair formation of the 
dToTP opposite the templating salicylaldehyde was possible but subsequent elongation could not be 
achieved.  
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In order to gain insight into the isosteric nature of the base pair, a DNA containing the pair was co-
crystallized with Bst Pol I. The structure revealed that within the duplex the amine-aldehyde pair adopts a 
conformation which is unfavorable in solution, yet is completely isosteric to canonical base pairs and does 
not distort the DNA duplex. We therefore concluded that the need for this uncommon conformation might 
be the reason for the poor performance with the DNA polymerase. To verify our hypothesis, a naphthalene 
amine nucleoside was synthesized, which is almost a complete isostere of the observed conformation of the 
aromatic amine in the crystal structure, and was transformed to the triphosphate (dNaaTP). Indeed, this 
considerably improved the performance in primer extension experiments. Using the Therminator 
polymerase, faithful base pair formation and subsequent elongation was possible in the presence of 
dNaaTP and all canonical dNTPs. Based on this result, a further improved amine-aldehyde base pair was 
designed, which is intended to enhance enzyme acceptance by providing minor groove H-bond acceptors 
for the polymerase.  
The S:To or S:Naa pair represent the first candidates of a novel class of unnatural base pairs, which interact 
through reversible covalent bonding and are potential substrates for DNA polymerases. Further chemical 
optimization could result in an aldehyde-amine base pair, which is replicated in polymerase chain reactions 
with comparable fidelity and efficiency like the natural bases, in the near future. At the same time, this is 
the first example of a site-specific and reversible DNA crosslink. Complex DNA nanostructures for in vivo 
applications could be stabilized by incorporating the amine-aldehyde pairs. 
Terminally phosphate modified nucleotides are important substrates in next-generation sequencing 
methods.[3, 103, 208] The Cu(I)-catalyzed alkyne-azide cycloaddition (CuAAC) has been used extensively to 
functionalize DNA postsynthetically.[87-88, 91, 93, 97] Despite its success, CuAACs had not been applied in the 
synthesis of phosphate modified nucleotides.  
In the course of the project, a short and efficient synthesis of -labeled nucleotides was established, which 
provided access to a variety of phosphate modified nucleotides through Cu(I)-catalyzed click chemistry. 
When the labeled nucleotides were employed in primer extension experiments, we found that they are 
accepted by the Klenow fragment DNA polymerase. Also, a -alkyne and -fluorescein modified 
guanosine triphosphate was incorporated by the T7 RNA polymerase in in vitro transcriptions. This 
allowed site-specific labeling of the RNA transcript at the 5´-position. Inspired by the chemical strategy to 
introduce the modification, an -alkyne dGTP was prepared. Unfortunately, it was found to be chemically 
unstable and was therefore inappropriate for chemo-enzymatic labeling. Also efforts to provide 
postsynthetic 5´-oligonucleotide labeling with -alkyne ATP substrates by the T4 oligonucleotide kinase 
were unsuccessful. Instead of label-transfer, only phosphate group transfer was observed, like for the 
natural ATP, even when a hydrolytically more stable -alkyne ATP was employed. While the stability of 
the -modified phosphoramidates was sufficiently stable for RNA-labeling by transcription, the -alkyne 
dGTP hydrolyzed even under mild conditions. Especially for the application with hydrolytically active 
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enzymes, like e.g. kinases, it is advisable to have at least a phosphate ester or even phosphonate bond for 
connecting the label. Although the synthesis of these labeled compounds is much more complicated and 
time-consuming, the results presented in this thesis clearly indicate that such an approach is necessary to 
overcome the hydrolytic instability.  
In conclusion, the CuAAC mediated synthesis of -labeled nucleotides is short, modular and the resulting 
compounds are potential candidates for next-generation sequencing approaches. Moreover, -labeled GTP 
allows site-specific labeling of RNA transcripts (5’-end) in vitro. Efforts to expand the labeling strategy to 
other systems, demonstrate the need for chemical redesign of the substrates and could also profit from 
engineered or evolved enzymes. 
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5 Experimental Part 
5.1 General Methods and Materials for Synthesis 
Chemicals were purchased from SIGMA ALDRICH, FLUKA, ABCR, ALFA AESAR or ACROS ORGANICS and 
used without further purification. Sensitive compounds like triphosphate derivatives were freeze-dried on a 
lyophilizer (CHRIST ALPHA 2-4 LD). All other solutions were concentrated in vacuo on a HEIDOLPH rotary 
evaporator with a Vario PC2001 diaphragm pump by VACUUBRAND. The solvents for organic synthesis 
were of reagent grade and purified by distillation. Dry solvents were bought from SIGMA-ALDRICH. 
Acetonitrile for HPLC purification was purchased from VWR. Water was purified by a Milli-Q Plus 
system from MERCK MILLIPORE. 
All reactions were carried out with magnetic stirring, and if moisture and air sensitive, in oven-dried 
glassware (>12 h, 110 °C) under nitrogen. The temperature of reactions (except rt) was adjusted with a 
solvent/dry ice-, solvent/ice-mixture or an oil bath and the temperature monitored with a thermometer 
outside the flask. 
Chromatographic purification of products was accomplished using flash column chromatography on 
MERCK Geduran Si 60 (40 – 63 μm) silica gel (normal phase) or by reversed-phase high-performance 
liquid chromatography (RP-HPLC). Thin layer chromatography (TLC) was performed on MERCK 60 
(silica gel F254) plates and visualized under UV light (λ = 254 and 366 nm) and staining with potassium 
permanganate (1.5 g KMnO4, 10.0 g K2CO3, 125 mg NaOH in 200 mL water) or ceric ammonium 
molybdate (10.0 g ammonium molybdate tetrahydrate, 2 g Ce(SO4)2∙4H2O, 180 mL ddH2O, 20 mL conc. 
H2SO4). 
1H, 13C, 19F and 31P NMR spectra were recorded in deuterated solvents on VARIAN OXFORD 200, BRUKER 
ARX 300, VARIAN VXR400S, VARIAN INOVA 400, BRUKER Avance III (cryoprobe) 400, BRUKER AMX 
600 and BRUKER Avance III HD (cryoprobe) 800 spectrometers and calibrated to the residual solvent peak 
using reported values.[222] As an external reference triphenyl phosphate (–18 ppm) was used for 31P NMR 
spectra. The chemical shifts (d) are given in ppm, the coupling constants (J) in Hz. Multiplicities are 
abbreviated as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad and 
combinations of these. For assignment of the structures, additional 2D NMR spectra (COSY, HSQC, 
HMBC) were measured. The numbering of atoms in a molecule in the experimental diagrams is depicted 
for clarity and does not correspond to IUPAC numbering. 
Matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectra were recorded on a 
BRUKER AUTOFLEX II. For MALDI-TOF measurements the samples were dialyzed on a 0.025 µm VSWP 
filter (MILLIPORE) against ddH2O for 2 h and then co-crystallized in a 3-hydroxypicolinic acid matrix 
(HPA: 25 mg 3-hydroxypicolinic acid, 5 mg ammonium citrate, 5 μL 15-crown-5 in 0.5 mL H2O/MeCN = 
1:1). High resolution electrospray ionization mass spectra (HRMS-ESI) were recorded on a THERMO 
FINNIGAN LTQ-FT (ESI-FTICR), and high resolution electron impact ionization mass spectra (HRMS-EI) 
were recorded on a THERMO FINNIGAN MAT 95. IR spectra were recorded on a PERKIN ELMER spectrum 
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BX instrument and are reported as follows: wavenumber ῦ in cm–1. The pH values of buffers were adjusted 
using a MP 220 pH meter (METTLER TOLEDO). UV spectra and melting profiles were measured on a 
JASCO V-650 spectrometer using quartz glass cuvettes with 1 cm path length. For fluorescence 
measurements a VARIAN Cary Eclipse spectrofluorometer was used. The extinction coefficient of the 
artificial nucleotides (dToTP, dSTP, STP, dNaaTP) was determined by Beer-Lambert law from 4-5 
adequate concentrations (absorbance 0.10-1.00) measured in triplicate on the UV-Vis spectrometer or on a 
NanoDrop ND-1000 Spectrophotometer (THERMO SCIENTIFIC). 
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) 
The following devices were used for the analysis and purification of the synthetic DNA/RNA strands, 
some nucleosides and the nucleoside (tri)phosphates. In order to remove insoluble particles, samples for 
preparative HPLC were filtered through a 0.2 µm GHP filter membrane (Acrodisc®), and samples for 
analytical HPLC were centrifuged at maximum speed, prior to loading. 
Analytical RP-HPLC was performed on an analytical HPLC WATERS Alliance (2695 Separation Module, 
2996 Photodiode Array Detector) equipped with the column Nucleosil 120-3 C18 from MACHEREY 
NAGEL. Using a flow of 0.5 mL/min, gradients of 0–30% B in 45 min or 0–40% B in 45 min were applied 
for the oligonucleotides. Preparative RP-HPLC was performed on a HPLC WATERS Breeze (2487 Dual λ 
Array Detector, 1525 Binary HPLC Pump) equipped with the columns Nucleosil 100-7 C18, VP 250/10 
C18 or VP 250/32 C18 from MACHEREY NAGEL. Using a flow of 5 mL/min, a gradient of 0–30% B was 
applied for 15 mer oligonucleotides and 0–40% B was applied for 30 mer oligonucleotides. For conditions 
of (tri)phosphate purification, see the individual chemical synthesis of the compounds. 
Buffer systems: Buffer A: 0.1 M triethylammonium acetate in water 
 Buffer B: 0.1 M triethylammonium acetate in 80% (v/v) acetonitrile  
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5.2 Chemical Synthesis 
5.2.1 Preparation of the Triphosphate Reagent Solution 
2-Chloro-4H-benzo[d][1,3,2]dioxaphosphinin-4-one (10) 
 
 
C7H4ClO3P 
MW: 202.53 g/mol 
The synthesis is based on a modified procedure from M. Donahue et al.[190] 
Salicylic acid was predried overnight by applying high vacuum (10–2 mbar), and then a part (3.45 g, 
25.0 mmol, 1.0 eq) was transferred to a heat-dried round-bottom flask (50 mL) under an atmosphere of 
argon. Dry toluene (3.8 mL) and phosphorus trichloride (2.4 mL, 3.78 g, 27.5 mmol, 1.1 eq) were added 
and the mixture was refluxed at 110 °C for 2 h. The developing HCl gas was passed into a saturated 
aqueous solution of NaHCO3 for quenching. After cooling the pale green reaction solution to rt all volatiles 
were removed (and quenched) in vacuo. The resulting colorless solid (about 85% P(III) product 10 as 
determined by 31P NMR) was used without further purifications for the triphosphate reagent formation. 
1H NMR (400 MHz, CDCl3): δ (ppm) = 8.03 (dd, J = 7.9, 1.7 Hz, 1H, Har), 7.63 (ddd, J = 8.4, 7.5, 1.8 Hz, 
1H, Har), 7.27 (t, J = 7.7 Hz, 1H, Har), 7.08 (d, J = 8.3 Hz, 1H, Har). 
31P NMR (162 MHz, 1H-decoupled, CDCl3): δ (ppm) = 148.2. 
General Procedure 1: Triphosphate Reagent Solution 
This procedure describes an exemplary setup for the generation of a triphosphate reagent solution, which 
can be applied to different nucleosides with a total amount of about 480 µmol in parallel based on 
published protocols.[51-52, 64] 
The phosphite 2-chloro-4H-benzo[d][1,3,2]dioxaphosphinin-4-one (10) and the tributylamine 
pyrophosphate ((TBA)2PPi)[50] were dried under high vacuum for at least 3 h, the tributylamine was dried 
over molecular sieves 3 Å for at least 3 h prior to usage. All reagents were kept under an atmosphere of 
argon and the flasks (50 mL) were heat-dried. To a stirring solution of (TBA)2PPi (550 mg, 1.0 mmol, 
2.0 eq) in dry DMF (1.7 mL) was added tributylamine (1.86 mL, 1.45 g, 7.9 mmol, 15.8 eq) at rt. After 
5 min, the resulting emulsion was poured into a solution of 2-chloro-4H-benzo[d][1,3,2]dioxaphosphinin-
4-one (10, 203 mg, 1.0 mmol, 2.0 eq) in dry DMF (1.7 mL) and stirred for 30 min at rt. The resulting 
solution contains about 190 mM of a preformed triphosphate reagent, which is usually applied to the dry 
nucleoside at 0 °C using 2 equivalents of the reagent per equivalent of the nucleoside. 
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5.2.2 Synthesis of the Salicylaldehyde Ribonucleotide 
(3R,4R,5R)-3,4-Bis(tert-butyldimethylsilyloxy)-5-((tert-butyldimethylsilyloxy)methyl)dihydrofuran-
2(3H)-one (67)[167, 223] 
 
C23H50O5Si3 
MW: 490.90 g/mol 
β-D-Ribose (6.0 g, 40 mmol, 1.0 eq) and NaHCO3 (6.7 g, 80 mmol, 2.0 eq) were dissolved in dH2O (70 
mL) and cooled to 0 °C. Bromine (2.2 mL, 43 mmol, 1.1 eq) was added dropwise to the stirring solution at 
0 °C and the mixture was allowed to warm to rt slowly and stirred for 2 h. The excess bromine was 
quenched by titration with a solution of Na2S2O3 until complete color discharge, the solution was 
concentrated in vacuo (60 °C) and the residue was excessively dried for at least 20 h under high vacuum. 
The off-white solid containing ribolactone 85 was dissolved together with imidazol (23.4 g, 344 mmol, 
8.6 eq) in dry DMF (120 mL) and cooled to 0 °C. Then, tert-butyldimethylsilyl chloride (21.2 g, 
141 mmol, 3.5 eq) was added in one portion under stirring, the solution was allowed to warm to rt and 
finally heated to 50 °C for 3 h. The mixture was poured into dH2O (250 mL) and was extracted with 
diethyl ether (3 x 150 mL). The combined organic layers were washed with a saturated aqueous solution of 
NaHCO3, then NaCl and finally dH2O (100 mL each), dried over Na2SO4, filtered and concentrated in 
vacuo. Flash column chromatography (silica, 18 x 10 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 
→ 50:1) yielded the TBS-protected ribolactone 67 (11.7 g, 23.8 mmol, 60%) as a colorless solid. 
Rf (iHex/EtOAc, 10:1) = 0.7. 
1H NMR (300 MHz, CDCl3): δ (ppm) = 4.57 (d, J = 5.2 Hz, 1H), 4.26–4.23 (m, 2H), 3.84 (dd, J = 11.7, 
3.0 Hz, 1H), 3.80 (dd, J = 11.7, 2.2 Hz, 1H), 0.94 (s, 9H), 0.89 (s, 9H), 0.88 (s, 9H), 0.18 (s, 3H), 0.13 (s, 
3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H). 
13C NMR (75 MHz, 1H-decoupled, CDCl3): δ (ppm) = 175.3, 85.8, 72.2, 70.8, 62.6, 26.1, 26.0, 25.9, 18.6, 
18.5, 18.4, −4.4, −4.4, −4.6, −4.8, −5.3, −5.5. 
IR (ATR): ν ̃(cm–1) = 2953, 2929, 2885, 2857, 2362, 2340, 1787, 1472, 1463, 1252, 1166, 1104, 984, 953, 
832, 776. 
HRMS (ESI): calc. for C23H54O5NSi3+ [M+NH4]+: 508.3304; found: 508.3302.  
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(5-Bromo-2-(1,3-dioxan-2-yl)phenoxy)triisopropylsilane (2) 
 
C19H31BrO3Si 
MW: 415.44 g/mol 
Multigram synthesis (> 30 g of the salen base building block 2) was performed according to the known and 
published procedures from Clever et al. with only minor adjustments.[12] NMR and mass data confirmed 
the identity of the compounds and were in agreement with the published data. 
 
(2R,3R,4R,5R)-2-(4-(1,3-Dioxan-2-yl)-3-(triisopropylsilyloxy)phenyl)-3,4-bis(tert-butyldimethylsilyloxy)-
5-((tert-butyldimethylsilyloxy)methyl)tetrahydrofuran-2-yl acetate (69) 
 
C44H84O9Si4 
MW: 869.47 g/mol 
Under an atmosphere of argon the protected salicyl base building block 2 (2.88 g, 6.93 mmol, 1.7 eq) was 
dissolved in dry diethyl ether (20 mL), degassed and cooled to –78 °C. Then, tBuLi (1.6 M in pentane, 
8.7 mL, 13.86 mmol, 3.4 eq) was slowly added dropwise within 25 min and the solution was stirred for 2 h 
at –78 °C. TBS-protected ribolactone 67 (2.00 g, 4.08 mmol, 1.0 eq) dissolved in dry THF (16 mL) was 
added dropwise to the lithiated base. After 30 min, acetic anhydride (2.30 mL, 2.50 g, 24.48 mmol, 6.0 eq) 
was added and stirred for 15 min at –78 °C before it was allowed to warm to rt. The mixture was poured 
into ice water (120 mL) and was extracted with diethyl ether (3 x 100 mL). The combined organic layers 
were dried over Na2SO4, filtered and concentrated in vacuo (at max. 30 °C). Flash column chromatography 
(silica, 17 x 5.5 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 → 50:1 → 20:1) afforded the 
acetylated hemiketal 69 (2.45 g, 2.82 mmol, 69%) as a colorless solid. 
Rf (iHex/EtOAc, 10:1) = 0.3. 
1H NMR (599 MHz, CDCl3): δ (ppm) = 7.50 (d, J = 8.1 Hz, 1H, 5-H), 7.12 (dd, J = 8.1 Hz, J = 1.7 Hz, 
1H, 6-H), 6.82 (d, J = 1.7 Hz, 1H, 2-H), 5.83 (s, 1H, 7-H), 4.25 (ddd, J = 5.3, 3.2, 2.2 Hz, 1H, 4´-H), 4.24-
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4.19 (m, 2H, 8-H), 4.15 (dd, J = 5.1, 2.1 Hz, 1H, 3´-H), 3.97-3.89 (m, 2H, 8-H), 3.85 (dd, J = 10.8, 3.3 Hz, 
1H, 5´-H), 3.77-3.72 (m, 2H, 2´-H and 5´-H), 2.28-2.19 (m, 1H, 9-H), 2.02 (s, 3H, OCOCH3), 1.42-1.37 
(m, 1H, 9-H), 1.32-1.25 (m, 3H, Si(CH(CH3)2)3), 1.14-1.09 (m, 18H, Si(CH(CH3)2)3), 0.93 (s, 9H, 
SiC(CH3)3), 0.92 (s, 9H, SiC(CH3)3), 0.90 (s, 9H, SiC(CH3)3), 0.10 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), 
0.07-0.05 (m, 6H, 2 x SiCH3), −0.10 (s, 3H, SiCH3), −0.36 (s, 3H, SiCH3).  
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 168.4 (OCOCH3), 152.7 (1/3/4-C)*, 141.9 (1/3/4-
C)*, 128.6 (1/3/4-C)*, 127.1 (5-C), 118.6 (6-C), 115.6 (2-C), 106.2 (1´-C), 97.5 (7-C), 86.7 (4´-C), 80.3 
(2´-C), 71.9 (3´-C), 67.54 (8-C), 67.51 (8-C), 63.2 (5´-C), 26.0 (SiC(CH3)3), 25.9 (SiC(CH3)3 and 9-C), 
25.8 (SiC(CH3)3), 22.1 (OCOCH3), 18.1 (Si(CH(CH3)2)3), 13.0 (Si(CH(CH3)2)3), −4.2 (SiCH3), –4.5 
(SiCH3), –4.6 (SiCH3), –5.3 (SiCH3), –5.4 (SiCH3), –5.5 (SiCH3). 
IR (ATR): ν̃ (cm–1) = 2950, 2929, 2858, 2894, 1758, 1472, 1463, 1416, 1390, 1363, 1251, 1236, 1101, 
1000, 950, 940, 880, 834, 774.  
HRMS (ESI): calc. for C42H81O7Si4+ [oxocarbenium from M] +: 809.5054; found: 809.5058. 
 
((2S,3S,4R,5R)-2-(4-(1,3-Dioxan-2-yl)-3-(triisopropylsilyloxy)phenyl)-5-((tert-
butyldimethylsilyloxy)methyl)tetrahydrofuran-3,4-diyl)bis(oxy)bis(tert-butyldimethylsilane) (66) 
 
C42H82O7Si4 
MW: 811.44 g/mol 
To a stirring solution of the acetylated hemiketal 69 (2.20 g, 2.53 mmol, 1.0 eq) in dry toluene (16.5 mL) 
was added triethylsilane (1.21 mL, 0.88 g, 7.60 mmol, 3.0 eq) at –30 °C. After 5 min stirring the solution 
was warmed to –20 °C, BF3∙OEt2 (0.16 mL, 1.26 mmol, 0.5 eq) was added dropwise and stirring continued 
for 5 min. The deep dark green solution was quenched with an aqueous saturated solution of NaHCO3 
(12.5 mL) and diluted with dH2O (12.5 mL) and warmed to rt. The mixture was immediately extracted 
with diethyl ether (3 x 100 mL) and the combined organic layers were dried over Na2SO4, filtered and 
dried in vacuo. Flash column chromatography (silica, 20 x 5.5 cm, wet load, gradient; iHex/EtOAc = 1:0 
→ 100:1 → 50:1 → 25:1) afforded the fully protected salicyl nucleoside 66 (0.63 g, 0.78 mmol, 30%) as a 
colorless wax. 
Rf (iHex/EtOAc, 10:1) = 0.7. 
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1H NMR (599 MHz, CDCl3): δ (ppm) = 7.51 (d, J = 7.9 Hz, 1H, 5-H), 7.04 (dd, J = 8.0 Hz, J = 1.4 Hz, 
1H, 6-H), 6.77 (d, J = 1.2 Hz, 1H, 2-H), 5.85 (s, 1H, 7-H), 4.74 (d, J = 5.9 Hz, 1H, 1´-H), 4.28-4.18 (m, 
2H, 8-H), 4.07 (t, J=3.9, 1H, 3´-H), 4.05-4.01 (m, 1H, 4´-H), 3.97-3.91 (m, 2H, 8-H), 3.80-3.76 (m, 2H, 2´-
H and 5´-H), 3.72 (dd, J = 10.7, 5.5 Hz, 1H, 5´-H),  2.30-2.18 (m, 1H, 9-H), 1.45-1.37 (m, 1H, 9-H), 1.31 
(hept, J = 7.7 Hz, 3H, Si(CH(CH3)2)3), 1.12 (dd, J = 7.5, 2.7 Hz, 18H, Si(CH(CH3)2)3), 0.94 (s, 9H, 
SiC(CH3)3), 0.92 (s, 9H, SiC(CH3)3), 0.85 (s, 9H, SiC(CH3)3), 0.11 (s, 3H, SiCH3), 0.10 (s, 3H, SiCH3), 
0.07 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3), –0.09 (s, 3H, SiCH3), –0.24 (s, 3H, SiCH3). 
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 152.9 (1/3/4-C)*, 142.7 (1/3/4-C)*, 128.1 (1/3/4-
C)*, 126.9 (5-C), 119.6 (6-C), 115.8 (2-C), 97.5 (7-C), 84.2 (4´-C), 83.6 (1´-C), 79.3 (2´-C), 73.1 (3´-C), 
67.6 (8-C), 63.9 (5´-C), 26.1 (SiC(CH3)3), 25.9 (2 x SiC(CH3)3), 25.8 (9-C) 18.1 (Si(CH(CH3)2)3), 13.1 
(Si(CH(CH3)2)3), –4.4 (SiCH3), –4.6 (SiCH3), –4.6 (SiCH3), –4.8 (SiCH3), –5.4 (2 x SiCH3). 
IR (ATR): ν̃ (cm–1) = 2950, 2929, 2894, 2858, 1472, 1464, 1427, 1390, 1361, 1252, 1150, 1123, 1100, 
1081, 1003, 988, 939, 881, 832, 814, 774, 680, 671. 
HRMS (ESI): calc. for C42H83O7Si4+ [M+H]+: 811.5210; found: 811.5219. 
 
4-((2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-hydroxybenzaldehyde (65) 
 
C12H14O6 
MW: 254.24 g/mol 
Route A: To a stirring solution of the fully protected salicyl nucleoside 66 (600 mg, 0.74 mmol, 1.0 eq) in 
THF (9.1 mL) in a 50 mL polypropylene tube, was added HF∙pyridine (0.77 mL, 29.6 mmol, 40.0 eq) at 
0 °C. The solution was allowed to warm to rt and stirred for 1.5 h before  
dH2O (78 µL, 4.3 mmol, 5.8 eq) was added and stirring was continued for 24 h. Me3SiOMe (8.4 mL, 
61.1 mmol, 82.5 eq) was added and stirring was continued for 30 min. The solvent was removed in 
vacuo and flash column chromatography (silica, 16 x 4 cm, wet load, gradient; DCM/MeOH = 1:0 → 50:1 
→ 9:1) afforded the salicylaldehyde nucleoside 65 (83 mg, 0.33 mmol, 44%) as a yellow solid after 
excessive drying under high vacuum. 
Route B: To a stirring solution of the acetylated hemiketal 69 (2.49 g, 2.86 mmol, 1.0 eq) in dry toluene 
(18.8 mL) at –30 °C was added triethylsilane (1.37 mL, 8.58 mmol, 3.0 eq). After 5 min stirring the 
solution was warmed to –20 °C, BF3∙OEt2 (0.18 mL, 1.43 mmol, 0.5 eq) was added dropwise and stirring 
was continued for 5 min. The deep dark green solution was quenched with an aqueous saturated solution of 
NaHCO3 (13.5 mL) and diluted with ddH2O (13.5 mL) and warmed to rt. The mixture was immediately 
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extracted with diethyl ether (3 x 70 mL) and the combined organic layers were dried over Na2SO4, filtered 
and dried in vacuo. The crude product mixture, which contained the fully protected nucleoside 66 (about 
50% determined by 1H NMR) was dissolved in THF (17.6 mL) transferred to a 50 mL polypropylene tube 
and cooled to 0 °C. HF∙pyridine (1.04 mL, 114.4 mmol, 40.0 eq) was added at 0 °C and the solution was 
warmed to rt. After 3 h at rt, dH2O (0.15 mL, 16.6 mmol, 5.8 eq) was added and stirring continued for 72 h. 
The solution was quenched with Me3SiOMe (16.3 mL, 236.6 mmol, 82.5 eq) at rt within 30 min and 
concentrated in vacuo. Flash column chromatography (silica, 16 x 4 cm, wet load, gradient; DCM/MeOH = 
1:0 → 9:1) afforded the salicylaldehyde nucleoside 65 as a mixture with 1,3-propanediol (370 mg, about 
205 mg ribonucleoside 65, 28% from hemiketal 69 based on 1H NMR) as a yellow oil. Preparative RP-
HPLC purification (0–30% acetonitrile in ddH2O in 45 min) afforded the salicylaldehyde nucleoside 65 
(145 mg, 0.57 mmol, 20% from acetylated hemiketal 69) as a dark yellow solid. 
Rf (DCM/MeOH, 9:1) = 0.2. 
1H NMR (400 MHz, CD3OD): δ (ppm) = 9.98 (s, 1H, 4´´-H), 7.64 (d, 3J = 8.0 Hz, 1H, 5-H), 7.10 (ddd, 
J = 8.0, 1.5, 0.5 Hz, 1H, 6-H), 7.07-7.05 (m, 1H, 2-H), 4.69 (d, 3J = 6.9 Hz, 1H, 1´-H), 4.04-4.00 (m, 1H, 
3´-H), 4.00-3.95 (m, 1H, 4´-H), 3.84-3.80 (m, 1H, 2´-H), 3.80-3.69 (m, 2H, 5´-H). 
13C NMR (101 MHz, 1H-decoupled, CD3OD): δ (ppm) = 196.7 (4´´-C), 163.2 (3-C), 152.2 (1-C), 133.7 (5-
C), 122.1 (4-C), 118.3 (6-C), 115.6 (2-C), 86.6 (4´-C), 84.7 (1´-C), 79.2 (2´-C), 73.0 (3´-C), 63.5 (5´-C). 
IR (ATR): ν̃ (cm–1) = 3445, 3312, 3211, 2972, 2950, 2936, 2876, 1658, 1626, 1566, 1498, 1436, 1382, 
1345, 1304, 1223, 1210, 1189, 1159, 1117, 1106, 1074, 1049, 1028, 1007, 979, 951, 902, 872, 845, 806, 
782, 747, 732, 723, 694, 677, 639. 
HRMS (ESI): calc. for C12H13O6– [M–H]–: 253.0718; found: 253.0721. 
 
((2R,3S,4R,5S)-5-(4-Formyl-3-hydroxyphenyl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl triphosphate (1) 
 
C12H17O15P3 (hypothetic free acid) 
MW: 494.18 g/mol 
Triphosphate reagent solution (0.84 mL, 160 µmol, 2.0 eq, prepared according to general procedure 1, p. 
100) was added to the excessively dried salicylaldehyde nucleoside 65 (20.3 mg, 80 µmol, 1.0 eq) in an 
argon atmosphere at rt. After 90 min an iodine solution (20 mM I2 in Py/H2O = 9:1) was added until a slight 
yellow-brown color remained for 15 min (approx. 0.7 mL), followed by the addition of ddH2O (2.0 mL), 
and stirring was continued at rt for 1.5 h. An aqueous solution of NaCl (3 M, 0.5 mL) was added, and the 
solution was transferred to a 50 mL centrifugation tube, vortexed vigorously and mixed with EtOH 
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(absolute, 15 mL). Precipitation was achieved by cooling to –80 °C for 45 min, followed by centrifugation 
(10 min, 3200 x g). The supernatant was discarded and the pellet was redissolved in buffer A (1.0 mL) and 
lyophilized. The residue was purified twice by RP-HPLC (0–20% B in 65 min). This afforded the 
salicylaldehyde triphosphate 1 tetrakis-triethylammonium salt as a yellow solid (10.9 mg, 10.4 µmol, 13%) 
after freeze-drying. 
1H NMR (400 MHz, D2O): δ (ppm) = 9.86 (s, 1H, 4´´-H), 7.65 (d, J =7.9 Hz, 1H, 5-H), 7.09-7.01 (m, 2H, 
6-H and 2-H), 4.69-4.66 (m, 1H, 1´-H), 4.27-4.21 (m, 1H, 3´-H), 4.18-4.12 (s, 1H, 4´-H), 4.12-4.07 (m, 
2H, 5´-H), 4.05-3.97 (m, 1H, 2´-H). 
31P NMR (162 MHz, D2O): δ (ppm) = –11.07 (d, 2JPP = 19.8 Hz, -P), –11.41 (dt, 2JPP = 19.7 Hz, 
3JPH = 4.3 Hz, -P), –23.54 (t, 2JPP = 20.0 Hz, -P). 
HRMS (ESI): calc. for C12H16O15P3– [M–H]–: 492.97075; found: 492.97086. 
UV-Vis (H2O): Abs (nm) = 289 (base peak), 233, 330. 
Extinction coefficient (H2O):  (289 nm) = 13500 M‒1cm‒1,  (260 nm) = 10300 M‒1cm‒1. 
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5.2.3 Synthesis of the Benzaldehyde Ribonucleotide 
2-(4-Bromophenyl)-1,3-dioxane (71) 
 
 
C10H11BrO2 
MW: 243.10 g/mol 
To a stirring solution of 4-bromobenzaldehyde (72, 7.00 g, 35.28 mmol, 1.0 eq) in toluene (44 mL) 1,3-
propanediol (3.00 mL, 41.92 mmol, 1.2 eq) and BF3∙OEt2 (0.11 mL, 0.86 mmol, 3-mol%) were added and 
the solution was heated to reflux (111 °C) for 4.5 h. After cooling to rt, half-saturated aqueous NaHCO3 
(140 mL) was added and the organic layer was separated. The aqueous layer was extracted with toluene (2 
x 75 mL) and the combined organic layers were dried over MgSO4 and concentrated in vacuo. Dioxane 71 
was yielded as a colorless solid (8.35 g, 34.3 mmol, 97%) without further purifications. 
Rf (iHex/EtOAc, 10:1) = 0.4. 
1H NMR (599 MHz, CDCl3): δ (ppm) = 7.52-7.46 (m, 2H, 2-H and 6-H), 7.38-7.33 (m, 2H, 3-H and 5-H), 
5.46 (s, 1H, 4´-H), 4.29-4.23 (m, 2H, 7a-H and 9a-H), 4.01-3.94 (m, 2H, 7b-H and 9b-H), 2.26-2.18 (m, 
1H, 8a-H), 1.45 (ddt, J = 13.5, 2.6, 1.2 Hz, 1H, 8b-H). 
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 137.9 (1-C), 131.50 (2-C and 6-C), 127.94 (3-C 
and 5-C), 122.96 (4-C), 100.96 (4´-C), 67.51 (7-C and 9-C), 25.83 (8-C). 
mp.: 59 °C. 
IR (ATR): ν ̃(cm–1) = 2969, 1592, 1382, 1100, 1010, 800. 
MS (ESI): calc. for C10H1279BrO2+ [M+H]+: 243.00; found: 242.93. 
 
(2S,3R,4R,5R)-2-(4-(1,3-Dioxan-2-yl)phenyl)-3,4-bis(tert-butyldimethylsilyloxy)-5-((tert-
butyldimethylsilyloxy)methyl)tetrahydrofuran-2-ol (73) 
 
C33H62O7Si3 
MW: 655.10 g/mol 
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To a degassed stirring solution of the bromo-dioxane 71 (2.68 g, 11.0 mmol, 1.7 eq) in dry THF (31 mL) at 
–78 °C under an atmosphere of argon was added tBuLi (1.5 M in pentane, 13.8 mL, 22.1 mmol, 3.4 eq.) 
dropwise within 30 min. After 2 h stirring at –78 °C, a solution of the TBS-protected ribolactone 67 
(3.18 g. 6.5 mmol, 1.0 eq) in dry, degassed THF (26.0 mL) was added dropwise and stirring was continued 
for 1 h. A saturated aqueous solution of NH4Cl (4 mL) was added and the mixture was allowed to warm to 
rt. The mixture was diluted with dH2O (100 mL) and extracted with diethyl ether (3 x 160 mL). The 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. Flash column 
chromatography (silica, 25 x 6.0 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 → 50:1 → 20:1→ 
10:1 → 5:1) afforded the desired hemiketal 73 (3.88 g, 6.1 mmol, 91%) as a colorless solid. 
Rf (iHex/EtOAc, 10:1) = 0.3. 
1H NMR (400 MHz, CDCl3): δ (ppm) = 7.63 (d, J = 8.3 Hz, 2H, 2-H and 6-H), 7.43-7.38 (d, J = 8.4 Hz, 
2H, 3-H and 5-H), 5.49 (s, 1H, 7-H), 5.05 (s, 1H, 1´-OH), 4.25 (ddd, J = 11.9, 5.0, 1.5 Hz, 2H, 8a-H and 
10a-H), 4.20 (t, J = 3.2 Hz, 1H, 4´-H), 4.18 (dd, J = 4.6, 1.0 Hz, 1H, 3´-H), 4.01 (d, J = 4.7 Hz, 1H, 2´-H), 
4.00-3.93 (m, 2H, 8b-H and 10b-H), 3.88-3.75 (m, 2H, 5´-H), 2.29-2.15 (m, 1H, 9a-H), 1.46-1.39 (m, 1H, 
9b-H), 0.93 (s, 9H, SiC(CH3)3), 0.92 (s, 9H, SiC(CH3)3), 0.81 (s, 9H, SiC(CH3)3), 0.12 (s, 3H, SiCH3), 0.11 
(s, 6H. 2 x SiCH3), 0.10 (s, 3H, SiCH3), –0.19 (s, 3H, SiCH3), –0.55 (s, 3H, SiCH3). 
13C NMR (101 MHz, 1H-decoupled, CDCl3): δ (ppm) = 141.6 (1-C), 138.6 (4-C), 126.9 (2-C and 6-C), 
125.3 (3-C and 5-C), 104.1 (1´-C), 101.8 (7-C), 85.0 (4´-C), 78.1 (2´-C), 74.9 (3´-C), 67.49 (8-C and 10-
C), 63.7 (5´-C), 25.92 (2 x SiC(CH3)3), 25.89 (SiC(CH3)3), 18.45 (SiC(CH3)3), 18.03 (SiC(CH3)3), 17.97 
(SiC(CH3)3), –4.44 (SiCH3), –4.49 (SiCH3), –4.68 (SiCH3), –5.29 (SiCH3), –5.5 (SiCH3), –5.6 (SiCH3). 
mp.: 69 °C. 
IR (ATR): ν ̃(cm–1) = 2929, 1472, 1252, 1108, 833. 
HRMS (ESI): calc. for C33H61O7Si3– [M–H]–: 653.3731; found: 653.3733. 
 
((2S,3S,4R,5R)-2-(4-(1,3-Dioxan-2-yl)phenyl)-5-((tert-butyldimethylsilyloxy)methyl)tetrahydrofuran-3,4-
diyl)bis(oxy)bis(tert-butyldimethylsilane) (74) 
 
C33H62O6Si3 
MW: 639.10 g/mol 
Triethylsilane (2.32 mL, 14.5 mmol, 3.3 eq.) was added to a stirring solution of hemiketal 73 (2.88 g, 
4.40 mmol, 1.0 eq.) in dry DCM (15.9 mL) at –78 °C. After 10 min, BF3∙OEt2 (0.66 mL, 5.28 mmol, 
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1.2 eq.) was added dropwise and stirring was continued for 1 h. A half-saturated aqueous solution of 
NaHCO3 (43 mL) was added, the mixture was warmed to rt and extracted with DCM (3 x 75 mL). The 
combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Flash column 
chromatography (silica, 25 x 6.0 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 → 50:1 → 20:1→ 
10:1 → 5:1) afforded the desired TBS-protected acetal nucleoside 74 (2.61 g, 4.1 mmol, 93%) as a 
colorless solid and also TBS-protected benzaldehyde nucleoside 77 (0.12 g, 0.2 mmol, 4%). 
Rf (iHex/EtOAc, 10:1) = 0.5. 
1H NMR (599 MHz, CDCl3): δ (ppm) = 7.44-7.40 (m, 4H, 2-, 3-, 5- and 6-H), 5.49 (s, 1H, 7-H), 4.79 (d, J 
= 6.8 Hz, 1H, 1´-H), 4.27 (ddd, J = 11.9, 5.0, 1.5 Hz, 2H, 8a-H and 10a-H), 4.14-4.12 (m, 1H, 3´-H), 4.03-
4.01 (m, 1H, 4´-H), 4.01-3.95 (m, 2H, 8b-H and 10b-H), 3.86-3.82 (m, 1H, 2´-H), 3.83-3.76 (m, 2H, 5´-H), 
2.29-2.18 (m, 1H, 9a-H), 1.44 (ddt, J = 13.5, 2.6, 1.2 Hz, 1H, 9b-H), 0.94 (s, 9H, SiC(CH3)3), 0.92 (s, 9H, 
SiC(CH3)3), 0.82 (s, 9H, SiC(CH3)3), 0.12 (s, 3H, SiCH3), 0.11 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3), 0.07 (s, 
3H, SiCH3), –0.13 (s, 3H, SiCH3), –0.38 (s, 3H, SiCH3). 
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 141.6 (1-C), 138.2 (4-C), 126.8 (2-C and 6-C), 
125.8 (3-C and 5-C), 101.8 (7-C), 85.4 (4´-C), 83.4 (1´-C), 79.7 (2´-C), 73.5 (3´-C), 67.5 (8-C and 10-C), 
63.6 (5´-C), 26.2 (SiC(CH3)3), 26.1 (2 x SiC(CH3)3), 25.9 (9-C), 18.6 (SiC(CH3)3), 18.2 (SiC(CH3)3), 18.1 
(SiC(CH3)3), –4.25 (SiCH3), –4.32 (SiCH3), –4.4 (SiCH3), –4.9 (SiCH3), –5.2 (SiCH3), –5.3 (SiCH3). 
IR (ATR): ν̃ (cm–1) = 2858, 1593, 1471, 1382, 1102, 1010, 834. 
HRMS (ESI): calc. for C33H63O6Si3+ [M+H]+: 639.3927; found: 639.3921. 
 
4-((2S,3S,4R,5R)-3,4-Bis(tert-butyldimethylsilyloxy)-5-((tert-
butyldimethylsilyloxy)methyl)tetrahydrofuran-2-yl)benzaldehyde (77) 
 
 
C30H56O5Si3 
MW: 581.02 g/mol 
To a stirring solution of the acetal TBS nucleoside 74 (0.66 g, 1.04 mmol, 1.0 eq) in THF (6.3 mL) was 
added aqueous HCl (2 M, 0.69 mL) at rt. After 1 h, the reaction solution was neutralized with aqueous 
NaHCO3, diluted with dH2O (50 mL) and extracted with diethyl ether (3 x 100 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated in vacuo. Flash column chromatography (silica, 
20 x 3.0 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 → 50:1 → 20:1→ 10:1 → 5:1) afforded the 
TBS-protected benzaldehyde nucleoside 77 (0.52 g, 0.90 mmol, 86%) as a colorless solid. 
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Rf (iHex/EtOAc, 10:1) = 0.6. 
1H NMR (599 MHz, CDCl3): δ (ppm) = 10.00 (s, 1H, 7-H), 7.83 (d, J = 8.0 Hz, 2H, 2-H and 6-H), 7.61 (d, 
J = 8.4 Hz, 2H, 3-H and 5-H), 4.84 (d, J = 8.0 Hz, 1H, 1´-H), 4.16-4.11 (m, 1H, 3´-H), 4.07-4.05 (m, 1H, 
4´-H), 3.87 (dd, J = 8.0, 4.4 Hz, 1H, 2´-H), 3.83 (dd, J = 11.0, 3.8 Hz, 1H, 5´-H), 3.79 (dd, J = 11.0, 2.7 
Hz, 1H, 5´-H), 0.94 (s, 18H, 2 x SiC(CH3)3), 0.81 (s, 9H, SiC(CH3)3), 0.14 (s, 3H, SiCH3), 0.12 (s, 3H, 
SiCH3), 0.10 (s, 3H, SiCH3), 0.10 (s, 3H, SiCH3), –0.12 (s, 3H, SiCH3), –0.50 (s, 3H, SiCH3). 
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 192.3 (7-C), 148.3 (4-C), 136.1 (1-C), 129.7 (2-C 
and 6-C), 127.6 (3-C and 5-C), 86.7 (4´-C), 82.5 (1´-C), 79.9 (2´-C), 74.3 (3´-C), 63.8 (5´-C), 26.1 
(SiC(CH3)3), 26.04 (SiC(CH3)3), 25.98 (SiC(CH3)3), 18.5 (SiC(CH3)3), 18.2 (SiC(CH3)3), 18.1 (SiC(CH3)3), 
–4.2 (SiCH3), –4.29 (SiCH3), –4.32 (SiCH3), –5.26 (SiCH3), –5.34 (2 x SiCH3). 
 
4-((2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)benzaldehyde (76) 
 
C12H14O5 
MW: 238.24 g/mol 
To a stirring solution of TBS-protected benzaldehyde nucleoside 77 (0.30 g, 0.52 mmol, 1.0 eq) in THF 
(6.4 mL) in a 50 mL polypropylene tube was added HF∙pyridine (284 µL, 15.60 mmol, 30.0 eq.) at 0 °C. 
The mixture was allowed to warm to rt and after 24 h, dH2O (54 µL, 3.02 mmol, 5.8 eq) was added. 
Stirring was continued for 48 h, Me3SiOMe (4.48 mL, 32.5 mmol, 62.5 eq.) was added and after 30 min 
the mixture was concentrated in vacuo. Flash column chromatography (silica, 20 x 2.0 cm, wet load, 
gradient; DCM/MeOH = 1:0 → 100:1 → 50:1 → 20:1 → 10:1 → 5:1) and subsequent RP-HPLC (0–30% 
B in 45 min) afforded the benzaldehyde nucleoside 76 (40 mg, 0.17 mmol, 33%) as a colorless solid. In 
addition, single and double TBS-protected benzaldehyde nucleosides were isolated in 52% combined yield. 
Rf (DCM/MeOH, 9:1) = 0.3. 
1H NMR (400 MHz, CD3OD): δ (ppm) = 9.97 (s, 7-H, about 70%), 7.89 (dt, J = 8.0, 0.3 Hz, 2H, 3-H and 
5-H), 7.71-7.66 (m, 2H, 2-H and 6-H), 7.45 (s, 7-H, hydrated aldehyde form, about 30%), 4.79 (d, 3J = 
7.0 Hz, 1H, 1´-H), 4.08-3.99 (m, 2H, 3´-H and 4´-H), 3.88-3.82 (m, 1H, 2´-H), 3.84-3.71 (m, 2H,      5´-H). 
13C NMR (101 MHz, 1H-decoupled, CD3OD): δ (ppm) = 193.9 (7-C), 149.5 (4-C), 137.4 (1-C), 130.7 (3-C 
and 5-C), 127.8 (2-C and 6-C), 127.0 (hydrated form 7-C), 86.8 (4´-H), 84.7 (1´-H), 79.3 (2´-H), 73.0 (3´-
H), 63.5 (5´-H). 
mp.: 138.5 °C. 
IR (ATR): ν ̃(cm–1) = 3313, 2848, 2456, 1682, 1606, 1210, 1042, 815. 
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HRMS (ESI): calc. for C12H13O5– [M–H]–: 237.0768; found: 237.0770. 
 
((2R,3S,4R,5S)-5-(4-Formylphenyl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl triphosphate (78) 
 
 
 
C12H17O14P3 (hypothetic free acid) 
MW: 478.18 g/mol 
The excessively dried benzaldehyde nucleoside (40.8 mg, 170 µmol, 1.0 eq) was dissolved in dry DMF 
(0.82 mL) and the triphosphate reagent solution (1.79 mL, 340 µmol, 2.0 eq, prepared according to general 
procedure 1, p. 100) was added at rt under stirring in an argon atmosphere. An iodine solution (20 mM I2 in 
Py/H2O = 9:1) was added to the reaction mixture until a slight yellow-brown color remained for 15 min 
(approx. 2.5 mL), followed by ddH2O (6.0 mL) and stirred for 1.5 h at rt. An aqueous solution of NaCl 
(3 M, 3.9 mL) was added, and the solution was transferred to a 50 mL centrifugation tube, vortexed 
vigorously and mixed with EtOH (absolute, 35 mL). Precipitation was achieved by cooling to –20 °C 
overnight, followed by centrifugation (10 min, 3200 x g). The supernatant was discarded and the resulting 
pellet was redissolved in buffer A (1.5 mL) and lyophilized. The residue was purified twice by RP-HPLC 
(0–20% B in 65 min). This afforded the benzaldehyde triphosphate 78 as a colorless tetrakis-
triethylammonium salt (13.8 mg, 17.6 µmol, 10%) after freeze-drying. 
1H NMR (400 MHz, D2O): δ (ppm) = 9.99 (s, 1H, 4´´-H), 8.04 (d, 3J = 8.0 Hz, 2H, 2-H and 6-H), 7.77 (d, 
3J = 8.7 Hz, 2H, 3-H and 5-H), 4.95 (d, 3J = 7.5 Hz, 1H, 1´-H), 4.42 (dd, J = 5.2, 3.2 Hz, 1H, 3´-H), 4.37-
4.31 (m, 1H, 4´-H), 4.30-4.25 (m, 2H, 5´-H), 4.22 (dd, J = 7.5, 5.2 Hz, 1H, 2´-H).  
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = ‒10.74 - –11.10 (m, 1P, -P), ‒11.30 (d, 
2JPP = 20.1 Hz, 1P, -P), –22.74 - –23,50 (m, 1P, P-β). 
HRMS (ESI): calc. for C12H15Na3O14P3+ [M‒2H+3Na]+: 544.9362; found: 544.9362. 
Extinction coefficient (H2O):  (260 nm) = 7200 M–1cm–1 
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5.2.4 Synthesis of a Salicylaldehyde Ribophosphoramidite 
(3R,4R,5R)-3,4-bis(triethylsilyloxy)-5-((triethylsilyloxy)methyl)dihydrofuran-2(3H)-one (83) 
 
C23H50O5Si3 
MW: 490.90 g/mol 
β-D-Ribose (3.0 g, 20 mmol, 1.0 eq) and NaHCO3 (3.4 g, 40 mmol, 2.0 eq) were dissolved in dH2O 
(30 mL) and cooled to 0 °C. Bromine (1.1 mL, 22 mmol, 1.1 eq) was added dropwise to the stirring 
solution at 0 °C and the mixture was allowed to warm to rt slowly and stirred for 2 h. Excess bromine was 
quenched by titration with a solution of Na2S2O3 until complete color discharge and the solution was 
concentrated in vacuo (at 60 °C). The residue was excessively dried for at least 20 h under high vacuum. 
The resulting off-white solid containing ribolactone 85 was dissolved together with imidazol (6.8 g, 
100 mmol, 5.0 eq) in dry DMF (50 mL) and cooled to 0 °C. Chlorotriethylsilane (13.5 mL, 80 mmol, 
4.0 eq) was added dropwise under stirring and the solution was warmed to rt. After 3 h, the mixture was 
poured into dH2O (20 mL) and was extracted with diethyl ether (3 x 50 mL). The combined organic layers 
were washed with saturated aqueous NaHCO3, NaCl and dH2O (30 mL each), dried over Na2SO4, filtered 
and concentrated in vacuo. Flash column chromatography (silica, 20 x 10 cm, wet load, gradient; 
iHex/EtOAc = 1:0 → 100:1 → 66:1 → 49:1 → 20:1) yielded the TES-protected ribolactone 83 (7.1 g, 
14.4 mmol, 72%) as a colorless oil. 
Rf (iHex/EtOAc, 9:1) = 0.6. 
1H NMR (599 MHz, CDCl3): δ (ppm) = 4.60 (d, J = 5.1 Hz, 1H, 2´-H), 4.30 (dd, J = 5.1, 0.8 Hz, 1H, 3´-
H), 4.26 (t, J = 2.8 Hz, 1H, 4´-H), 3.83 (dd, J = 11.7, 3.2 Hz, 1H, 5´-H), 3.78 (dd, J=11.6, 2.3, 1H, 5´-H), 
1.02-0.89 (m, 27 H, 3 x Si(CH2CH3)3), 0.73-0.53 (m, 18 H, 3 x Si(CH2CH3)3). 
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 175.3 (1´-C), 85.8 (4´-H), 72.0 (3´-H), 70.4 (2´-H), 
62.1 (5´-C), 6.7 (2 x Si(CH2CH3)3), 6.6 (Si(CH2CH3)3), 4.8 (2 x Si(CH2CH3)3), 4.1 (Si(CH2CH3)3). 
IR (ATR): ν ̃(cm–1) = 2954, 2912, 2877, 1795, 1458, 1414, 1379, 1341, 1239, 1171, 1110, 1086, 1004, 
984, 951, 899, 860, 801, 785, 721, 673. 
MS (EI): calc. for C23H50O5Si3+ [M]+: 490.2960, found: 490.18. 
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(2R,3R,4R,5R)-2-(4-(1,3-Dioxan-2-yl)-3-(triisopropylsilyloxy)phenyl)-3,4-bis(triethylsilyloxy)-5-
((triethylsilyloxy)methyl)tetrahydrofuran-2-yl acetate (86) 
 
 
C44H84O9Si4 
MW: 869.47 g/mol 
The protected salicyl base building block 2 (2.88 g, 6.93 mmol, 1.7 eq) was dissolved in dry diethyl ether 
(20 mL) under an argon atmosphere, degassed and cooled to –78 °C. Then, tBuLi (1.76 M in pentane, 
7.88 mL, 13.86 mmol, 3.4 eq.) was added dropwise within 30 min and the solution was stirred for 2 h at –
78 °C. TES-protected ribolactone 83 (2.00 g, 4.08 mmol, 1.0 eq) dissolved in dry THF (16 mL) was added 
dropwise. After 30 min, acetic anhydride (2.00 mL, 21.2 mmol, 5.2 eq) was added, and the reaction 
mixture was stirred for 15 min at –78 °C before it was allowed to warm to rt. The mixture was poured into 
ice water (120 mL) and was extracted with diethyl ether (3 x 100 mL). The combined organic layers were 
dried over Na2SO4, filtered and concentrated in vacuo (30 °C). Flash column chromatography (silica, 16 x 
5.5 cm, wet load, gradient; iHex/EtOAc = 100:1 → 50:1 → 33:1 → 25:1 → 20:1) afforded the acetylated 
hemiketal 86 (2.56 g, 2.94 mmol, 72%) as a colorless oil. 
Rf (iHex/EtOAc, 9:1) = 0.4. 
1H NMR (300 MHz, CDCl3): δ (ppm) = 7.50 (d, 3J = 8.1 Hz, 1H, 5-H), 7.16 (dd, 3J = 8.1 Hz, 4J = 1.7 Hz, 
1H, 6-H), 6.82 (d, 3J = 1.7 Hz, 1H, 2-H), 5.83 (s, 1H, 7-H), 4.29-4.14 (m, 4H, 4´-H, 3´-H and 8-H), 4.01-
3.87 (m, 3H, 2´-H and 8-H), 3.82 (dd, J = 10.8, 3.4 Hz, 1H, 5´-H), 3.75 (dd, J = 10.8, 4.9 Hz, 1H, 5´-H), 
2.34-2.12 (m, 1H, 9-H), 1.99 (s, 3H, OCOCH3), 1.36-1.21 (m, 4H, Si(CH(CH3)2)3 and 9-H), 1.12 (dd, 
J=7.3, 3.8 Hz, 18H, Si(CH(CH3)2)3), 1.02-0.92 (m, 18H, 2 x Si(CH2CH3)3), 0.92-0.82 (m, 9H, 
Si(CH2CH3)3), 0.68-0.56 (m, 12H, 2 x Si(CH2CH3)3), 0.53-0.43 (m, 6H, Si(CH2CH3)3). 
13C NMR (75 MHz, 1H-decoupled, CDCl3): δ (ppm) = 168.1 (OCOCH3), 152.6 (1/3/4-C)*, 142.0 (1/3/4-
C)*, 128.5 (5-C), 126.9 (1/3/4-C)*, 118.4 (6-C), 115.3 (2-C), 106.3 (1´-C), 97.5 (7-C), 85.8 (4´-C), 80.2 
(2´-C), 71.9 (3´-C), 67.5 (8-C), 67.4 (8-C), 62.4 (5´-C), 25.8 (9-C), 21.9 (OCOCH3), 18.0 (Si(CH(CH3)2)3), 
13.0 (Si(CH(CH3)2)3), 6.8 (Si(CH2CH3)3), 6.70 (Si(CH2CH3)3), 6.67 (Si(CH2CH3)3), 5.0 (Si(CH2CH3)3), 4.8 
(Si(CH2CH3)3), 4.2 (Si(CH2CH3)3). 
IR (ATR): ν ̃(cm–1) = 2953, 2874, 2360, 2341, 1758, 1616, 1579, 1506, 1460, 1415, 1392, 1284, 1236, 
1185, 1150, 1100, 1000, 948, 882, 859, 843, 826, 800, 778, 726, 682. 
HRMS (ESI): calc. for C42H81O7Si4+ [oxocarbenium from M]+: 809.5054; found: 809.5058. 
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((2S,3S,4R,5R)-2-(4-(1,3-Dioxan-2-yl)-3-(triisopropylsilyloxy)phenyl)-5-
((triethylsilyloxy)methyl)tetrahydrofuran-3,4-diyl)bis(oxy)bis(triethylsilane) (82) 
 
 
C42H82O7Si4 
MW: 811.44 g/mol 
To a stirring solution of the acetylated hemiketal 86 (960 mg, 1.10 mmol, 1.0 eq) in dry toluene (8.5 mL) 
was added triethylsilane (0.53 mL, 3.31 mmol, 3.0 eq) at –30 °C. After 5 min stirring the solution was 
warmed to –20 °C, BF3∙OEt2 (0.15 mL, 1.21 mmol, 1.1 eq) was added dropwise and stirring was continued 
for 5 min. The deep dark green solution was quenched with an aqueous saturated solution of NaHCO3 
(12.5 mL), diluted with ddH2O (12.5 mL) and warmed to rt. The mixture was immediately extracted with 
diethyl ether (3 x 50 mL) and the combined organic layers were dried over Na2SO4, filtered and dried in 
vacuo. Flash column chromatography (silica, 18 x 5.5 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 
→ 50:1 → 25:1) afforded the fully protected salicyl nucleoside 82 (322 mg, 0.40 mmol, 36%) as a 
colorless oil. 
Rf (iHex/EtOAc, 9:1) = 0.5. 
1H NMR (300 MHz, CDCl3): δ (ppm) = 7.51 (d, J =7.9 Hz, 1H, 5-H), 7.07 (dd, J = 8.1 Hz, J = 1.3 Hz, 1H, 
6-H), 6.75 (d, J = 1.3 Hz, 1H, 2-H), 5.85 (s, 1H, 7-H), 4.73 (d, J = 5.7 Hz, 1H, 1´-H), 4.23 (dd, J = 11.6, 
4.1 Hz, 2H, 8-H), 4.10 (t, J = 4.1 Hz, 1H, 3´-H), 4.05-3.99 (m, 1H,   4´-H), 3.99-3.89 (m, 2H, 8-H), 3.84 
(dd, J = 5.6, 4.3 Hz, 1H, 2´-H), 3.80-3.67 (m, 2H, 5´-H), 2.36-2.12 (m, 1H, 9-H), 1.45-1.36 (m, 1H, 9-H), 
1.37-1.24 (m, 3H, Si(CH(CH3)2)3), 1.13 (d, J = 7.0 Hz, 18H, Si(CH(CH3)2)3), 1.07-0.91 (m, 18H, 2 x 
Si(CH2CH3)3), 0.86 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.71-0.57 (m, 12H, 2 x Si(CH2CH3)3), 0.53-0.39 (m, 
6H, Si(CH2CH3)3). 
13C NMR (75 MHz, 1H-decoupled, CDCl3): δ (ppm) = 152.9 (1/3/4-C)*, 142.7 (1/3/4-C)*, 128.2 (1/3/4-
C)*, 127.0 (5-C), 119.4 (6-C), 116.0 (2-C), 97.6 (7-C), 84.1 (4´-C), 83.9 (1´-C), 79.4 (2´-C), 73.2 (3´-C), 
67.6 (8-C), 63.3 (5´-C), 25.9 (9-C), 18.1 (Si(CH(CH3)2)3), 18.0 (Si(CH(CH3)2)3), 13.1 (Si(CH(CH3)2)3), 6.9 
(Si(CH2CH3)3), 6.8 (2 x Si(CH2CH3)3), 5.0 (Si(CH2CH3)3), 4.8 (Si(CH2CH3)3), 4.3 (Si(CH2CH3)3). 
HRMS (ESI): calc. for C42H83O7Si4+ [M+H]+: 811.5210; found: 811.5216. 
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4-((2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-
(triisopropylsilyloxy)benzaldehyde (87) 
 
C21H34O6Si 
MW: 410.58 g/mol 
Route A: To a stirring solution of the fully protected salicyl nucleoside 82 (249 mg, 0.31 mmol, 1.0 eq) in 
a mixture of THF/dH2O/AcOH (6:2:1, 4.5 mL) was added aqueous HCl (2 M, 0.3 mL). After stirring for 
15 min at rt the mixture was poured into dH2O (10 mL) and extracted with diethyl ether (2 x 15 mL). The 
combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Flash column 
chromatography (silica, 15 x 2 cm, wet load, gradient; iHex/EtOAc = 3:1 → 1:1 → 0:1) afforded the TIPS-
protected salicylaldehyde nucleoside 87 (116 mg, 0.28 mmol, 91%) as a colorless oil. 
Route B: To a stirring solution of the acetylated hemiketal 86 (2.27 g, 2.61 mmol, 1.0 eq) in dry toluene 
(17.1 mL) was added triethylsilane (1.25 mL, 7.83 mmol, 3.0 eq) at –30 °C. After 5 min stirring the 
solution was warmed to –20 °C, BF3∙OEt2 (0.17 mL, 1.31 mmol, 0.5 eq) was added dropwise and stirring 
was continued for 5 min. The deep dark green solution was quenched with an aqueous saturated solution of 
NaHCO3 (13.0 mL), diluted with dH2O (13.0 mL) and warmed to rt. The mixture was immediately 
extracted with diethyl ether (3 x 60 mL) and the combined organic layers were dried over Na2SO4, filtered 
and concentrated in vacuo. The crude product mixture, which contained the fully protected nucleoside 82 
(about 70% determined by 1H NMR) was dissolved in a mixture of THF/dH2O/AcOH (6:2:1, 13.5 mL) and 
aqueous HCl (2 M, 1.2 mL). After stirring 1 h at rt, dH2O (50 mL) was added and the mixture was 
extracted with diethyl ether (3 x 50 mL). The combined organic layers were dried over Na2SO4, filtered 
and concentrated in vacuo. Flash column chromatography (silica, 17 x 4 cm, wet load, gradient; 
iHex/EtOAc = 3:1 → 1:1 → 0:1) afforded the TIPS-protected salicylaldehyde nucleoside 87 (649 mg, 
1.58 mmol, 60% from acetylated hemiketal 86) as a pale yellow oil. 
Rf (DCM) = 0.5. 
1H NMR (599 MHz, CDCl3): δ (ppm) = 10.48 (d, J = 0.8 Hz, 1H, 4´´-H), 7.76 (d, J = 8.0 Hz, 1H, 5-H), 
7.04 (d, J = 8.1 Hz, 1H, 6-H), 7.00-6.97 (m, 1H, 2-H), 4.72 (d, J = 6.6 Hz, 1H, 1´-H), 4.17-4.12 (m, 1H, 3´-
H), 4.06 (q, J = 4.2, 1H, 4´-H), 3.93-3.86 (m, 2H, 1 x 5´-H and 2´-H), 3.84-3.76 (m, 1H, 5´-H), 1.34 (hept, 
J = 7.5 Hz, 3H, (Si(CH(CH3)2)3), 1.12 (d, J =7.5 Hz, 18H, (Si(CH(CH3)2)3). 
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 190.1 (4´´-C), 159.6 (ipso-C), 148.5 (ipso-C), 
128.5 (5-C), 126.1 (ipso-C), 118.2 (6-C), 116.8 (2-C), 84.5 (4´-C), 83.6 (1´-C), 77.4 (2´-C), 71.8 (3´-C), 
63.0 (5´-C), 17.9 (Si(CH(CH3)2)3), 12.9 (Si(CH(CH3)2)3). 
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IR (ATR): ν ̃(cm–1) = 2952, 2912, 2875, 2360, 1616,1581, 1508, 1460, 1426, 1393, 1273, 1237, 1214, 
1150, 1100, 1044, 1001, 930, 882, 844, 819, 725, 681. 
HRMS (ESI): calc. for  C21H35O6Si+ [M+H]+: 411.2197; found: 411.2199. 
 
4-((2S,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-
2-(triisopropylsilyloxy)benzaldehyde (89) 
 
 
 
C42H52O8Si 
MW: 712.94 g/mol 
TIPS-protected salicylaldehyde nucleoside 87 (800 mg, 1.95 mmol, 1.0 eq) was coevaporated in dry 
pyridine (2 x 30 mL), dissolved in dry pyridine (30 mL) and stirred over molecular sieve (3 Å) for 14 h. 
4,4´-Dimethoxytrityl chloride (706 mg, 2.08 mmol, 1.1 eq) was added to the nucleoside solution and 
stirred for 3 h at rt. Methanol was added (7.5 mL) and stirring was continued for 1 h before the solution 
was filtered and concentrated in vacuo. Flash column chromatography (deactivated silica, 20 x 5 cm, wet 
load, gradient; 1% pyridine in iHex/EtOAc = 9:1 → 5:1 → 3:1) afforded the DMTr-TIPS-protected 
salicylaldehyde nucleoside 89 (947 mg, 1.33 mmol, 68%) as a colorless foam. 
Rf (iHex/EtOAc, 1:1) = 0.7. 
mp.: 46-50 °C. 
1H NMR (599 MHz, CDCl3): δ = 10.51 (d, J = 0.7 Hz, 1H, 4´´-H), 7.78 (d, J = 8.0 Hz, 1H, 5-H), 7.47-7.40 
(m, 2H, 14-H), 7.35-7.31 (m, 4H, 9-H), 7.30-7.27 (m, 3H, 15-H, 16-H), 7.18-7.14 (m, 1H, 6-H), 6.96-6.93 
(m, 1H, 2-H), 6.84-6.78 (m, 4H, 10-H), 4.73 (d, J = 6.6 Hz, 1H, 1´-H), 4.19-4.10 (m, 2H, 3´-H and 4´-H), 
3.97 (dd, J = 6.6, 5.6 Hz, 1H, 2´-H), 3.79 (s, 6H, 12-H), 3.50-3.29 (m, 2H, 5´-H), 1.39-1.24 (m, 3H, 
Si(CH(CH3)2)3), 1.09 (dd, J = 7.5, 3.5 Hz, 18H, Si(CH(CH3)2)3). 
13C NMR (151 MHz, 1H-decoupled, CDCl3): δ (ppm) = 189.9 (4´´-C), 159.4 (3-C), 158.5 (2 x 11-C), 148.7 
(1-C), 144.6 (13-C), 135.8 (2 x 8-C), 130.0 (4 x 9-C), 128.4 (5-C), 128.1 (2 x 14-C), 127.8 (2 x 15-C), 
126.9 (6-C), 126.0 (4-C), 123.8 (16-C), 118.2 (6-C), 117.0 (2-C), 113.1 (4 x 10-C), 86.4 (7-C), 83.4 (1´-C, 
and 4´-C), 77.4 (2´-C), 72.9 (3´-C), 64.0 (5´-C), 55.2 (12-C), 17.9 (Si(CH(CH3)2)3), 12.9 (Si(CH(CH3)2)3). 
IR (ATR): ν ̃(cm–1) = 3413, 3062, 2945, 2867, 2361, 2341, 2043, 1684, 1607, 1568, 1508, 1490, 1462, 
1425, 1391, 1301, 1247, 1174, 1074, 1033, 996, 977, 915, 881, 855, 825, 790, 751, 726, 686, 661. 
HRMS (ESI): calc. for  C42H51O8Si– [M–H]–: 711.3359; found: 711.3376. 
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4-((2S,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-
((triisopropylsilyloxy)methoxy)tetrahydrofuran-2-yl)-2-(triisopropylsilyloxy)benzaldehyde (90a) 
 
 
C52H74O9Si2 
MW: 899.31 g/mol 
To a stirring solution of DMTr-TIPS salicylaldehyde nucleoside 89 (706 mg, 0.99 mmol, 1.0 eq) in dry 
1,2-dichloroethane (4.75 mL) was added DIPEA (674 µL, 3.96 mmol, 4.0 eq), di-tert-butyltin dichloride 
(365 mg, 1.20 mmol, 1.2 eq), and the reaction mixture was stirred at 70 °C for 15 min. After cooling to rt, 
(triisopropylsiloxy)methyl chloride (251 µL, 1.08 mmol, 1.1 eq) was slowly added dropwise and the 
mixture was stirred for 2 h. Methanol (940 µL) was added, the solution was diluted with DCM (20 mL) 
and washed with half-saturated aqueous NaHCO3 and dH2O (10 mL each). The organic layer was dried 
over Na2SO4, filtered and concentrated in vacuo. Flash column chromatography (deactivated silica, 17 x 
4 cm, wet load, gradient; 1% pyridine in iHex/EtOAc = 19:1 → 12:1 → 10:1 → 9:1) afforded a 1:1 
regioisomer mixture (determined by 1H NMR) of 2´- and 3´-TOM-protected DMTr-TIPS salicylaldehyde 
nucleoside 90 (614 mg, 0.68 mmol, 68%). By painstaking repetitive flash column purification this mixture 
could be separated whereby the 3´-protected isomer 90b (273 mg, 0.30 mmol, 30%) eluted first. This 
finally afforded the desired 2´-TOM DMTr TIPS salicylaldehyde nucleoside 90a (278 mg, 0.31 mmol, 
31%) as a colorless foam. 
Data for the 2´-regioisomer 90a: 
Rf (iHex/EtOAc, 3:1) = 0.7. 
mp.: 40-44 °C. 
1H NMR (599 MHz, CDCl3): d (ppm) = 10.51 (d, J = 0.8 Hz, 1H, 7-H), 7.77 (d, J = 8.1 Hz, 1H, 5-H), 
7.48-7.41 (m, 2H, 20-H), 7.37-7.30 (m, 4H, 15-H), 7.32-7.13 (m, 3H, 21+22-H), 7.23-7.18 (m, 1H, 6-H), 
6.93-6.90 (m, 1H, 2-H), 6.83-6.79 (m, 4H, 16-H), 5.14 (d, J = 4.6 Hz, 1H, 10-H), 4.86 (d, 3J = 7.8 Hz, 1H, 
1´-H), 4.78 (d, J = 4.7 Hz, 1H, 10-H), 4.30-4.26 (m, 1H, 3´-H), 4.26-4.21 (m, 1H, 4´-H), 3.80-3.79 (m, 1H, 
2´-H), 3.79 (s, 6H, 18-H), 3.37 (dd, J = 10.0, 4.0 Hz, 1H, 5´-H), 3.33 (dd, J = 10.0, 4.4 Hz, 1H, 5´-H), 
3.06 (d, 3J = 2.0 Hz, 1H, 3´-OH), 1.39-1.21 (m, 6H, 11+8-H), 1.10 (d, 3J = 7.4 Hz, 18H, 9-H), 1.08-1.04 
(m, 18H, 12-H). 
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13C NMR (151 MHz, 1H-decoupled, CDCl3): d (ppm) = 190.0 (7-C), 159.4 (3-C), 158.6 (2 x 17-C), 149.1 
(1-C), 144.9 (19-C), 136.2 (14-C), 136.1 (14-C), 130.2 (4 x 15-C), 128.6 (5-C), 128.4 (2 x 20-C), 127.9 (2 
x 21-C), 126.9 (22-C) 126.2 (4-C), 118.4 (6-C), 117.4 (2-C), 113.3 (4 x 16-C), 91.3 (10-C), 87.0 (2´-C), 
86.4 (13-C), 84.4 (4´-C), 80.8 (1´-C), 72.6 (3´-C), 64.2 (5´-C), 55.4 (2 x 18-C), 18.1 (6 x 9-C), 18.0 (6 x 
12-C), 13.1 (3 x 8-C), 12.0 (3 x 11-C). 
IR (ATR): ν ̃(cm–1) = 3526, 2944, 2892, 2866, 2360, 2341, 1686, 1608, 1569, 1508, 1490, 1462, 1424, 
1390, 1368, 1300, 1248, 1174, 1075, 1034, 1012, 993, 978, 917, 881, 825, 790, 772, 752, 725, 683, 661. 
HRMS (ESI): calc. for  C52H75O9Si2+ [M+H]+: 899.4944; found: 899.4955. 
 
(2R,3R,4S,5S)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(4-formyl-3-
(triisopropylsilyloxy)phenyl)-4-((triisopropylsilyloxy)methoxy)tetrahydrofuran-3-yl 2-cyanoethyl 
diisopropylphosphoramidite (88) 
 
C61H91N2O10PSi2 
MW: 1099.53 g/mol 
A solution of 2´-TOM-DMTr-TIPS salicylaldehyde nucleoside 90a (100 mg, 111 µmol, 1.0 eq) and 
DIPEA (59 µL, 45 mg, 345 µmol, 3.1 eq) in dry DCM (0.52 mL) was degassed (3x) and kept under an 
atmosphere of argon. 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite (38 µL, 40 mg, 167 µmol, 
1.5 eq) was added under stirring at rt. After 2 h, the turbid mixture was directly applied to flash column 
chromatography (deactivated silica, argon, 10 x 2 cm, 1% pyridine in iHex/EtOAc = 6:1) and quickly 
purified to afford the salicylaldehyde ribophosphoramidite 88 (109 mg, 99 µmol, 89%) as a colorless foam. 
31P NMR (81 MHz, 1H-decoupled, CDCl3): δ (ppm) = 151.3, 151.0. 
HRMS (ESI): calc. for  C61H92N2O10PSi2+ [M+H]+: 1099.6023; found: 1099.6023. 
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5.2.5 Synthesis of the Salicylaldehyde Nucleoside and Phosphoramidite 
 
Salicylaldehyde nucleoside 101 and its phosphoramidite 99 were prepared according to the procedures 
reported in G. H. Clever et al. and C. Kaul et al. [12-13] 
5.2.6 Synthesis of dSTP 
[(2R,3S,5R)-5-(4-Formyl-3-hydroxyphenyl)-3- hydroxytetrahydrofuran-2-yl]methyl triphosphate (102) 
 
C12H17O14P3 (hypothetic free acid) 
MW: 478.18 g/mol 
The synthesis of dSTP was performed according to the method described in J. Caton-Williams et al. from 
salicylaldehyde nucleoside 101 with only minor adjustments.[7] The analytical data are in agreement with 
C. Kaul et al. with only minor chemical shift changes due to the salt form and the different external 
references.[8] 
In an argon atmosphere, triphosphate reagent solution (1.77 mL, 336 µmol, 2.0 eq, prepared according to 
general procedure 1, p. 100) was added to the dry salicylaldehyde nucleoside 101 (40 mg, 168 µmol, 1.0 
eq) at rt and stirred for 1 h. After complete conversion (monitored by TLC, DCM/MeOH = 5:1), an iodine 
solution (20 mM I2 in Py/H2O = 9:1) was added until a permanent brown color was observed (approx. 
1.6 mL) and stirring was continued for 15 min. ddH2O (4.1 mL) was added and after 1.5 h stirring, the 
resulting solution was transferred to a 50 mL centrifuge tube. Brine was added to a final concentration of 
0.3 M, followed by addition of EtOH (absolute, 36 mL) and vortexing. After 12 h at       –20 °C, the 
precipitate was collected by centrifugation (10 min, 3200 x g) and the resulting pellet was purified twice by 
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preparative RP-HPLC (0–20% B in 45 min). This afforded the dSTP 102 as a yellow tris- to tetrakis-
triethylammonium salt (21 mg, 26 µmol, 15%) after freeze-drying. 
1H NMR (400 MHz, D2O): δ (ppm) = 9.94 (s, 1H, Haldehyde), 7.73 (d, J = 8.1 Hz, 1H, Har), 7.14 (dd, 
J = 8.1 Hz, 4J = 1.5 Hz, 1H, Har), 7.10 (d, J = 1.5 Hz, 1H, Har), 5.21 (dd, J = 10.5, J = 6.0 Hz, 1H, 1´-H), 
4.55 (d, 1H, J =5.6 Hz, 1H, 3´-H), 4.28-4.17 (m, 1H, 4´-H), 4.18-4.03 (m, 2H, 5´-H), 2.30 (ddd, 
J = 13.5 Hz, J = 5.7 Hz, J = 1.3 Hz, 1H, 2´-H), 2.10 (ddd, J = 13.6 Hz, J = 10.6 Hz, J = 5.7, 1H, 2´-H). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = ‒11.02 (d, 2JPP = 19.8 Hz, 1P, -P), ‒11.31 (d, 
2JPP = 20.2 Hz, 1P, -P), ‒23.47 (t, 2JPP = 20.0 Hz, 1P, -P). 
HRMS (ESI): calc. for  C12H16O14P3– [M–H]–: 476.9758; found: 476.9767. 
UV-Vis (H2O): Abs (nm) = 230, 290, 330. 
Extinction coefficient (H2O):  (260 nm) = 10200 M‒1cm‒1. 
5.2.7 Synthesis of dToTP 
{(2R,3S,5R)-3-Hydroxy-5-{4-[2-(2,2,2-trifluoroacetamido)styryl]phenyl}tetrahydrofuran-2-yl}methyl 
triphosphate (106) 
 
C21H23F3NO13P3 (hypothetic free acid) 
MW: 647.33 g/mol 
In an argon atmosphere, triphosphate reagent solution (2.77 mL, 526 µmol, 2.0 eq, prepared according to 
general procedure 1, p. 100) was added to the dry TFA-protected aniline nucleoside 104 (107 mg, 
263 µmol, 1.0 eq) at 0 °C and stirred for 3 h. An iodine solution (20 mM I2 in Py/H2O = 9:1) was added 
until a permanent brown color was observed (approx. 2.5 mL) and stirring was continued for 15 min. 
ddH2O (6.4 mL) was added and after 1.5 h stirring, the resulting solution was partitioned to two 50 mL 
centrifuge tubes. Brine was added to a final concentration of 0.3 M followed by the addition of EtOH 
(absolute, 24 mL) each and vortexing. After 1 h at –80 °C, the precipitate was collected by centrifugation 
(10 min, 3200 x g) and the resulting pellet was purified twice by preparative RP-HPLC (0–50% B in 
45 min). This afforded the TFA-protected dToTP 106 as a yellow fluorescent tris- to tetrakis-
triethylammonium salt (63 mg, 63 µmol, 24%) after freeze-drying. 
1H NMR (400 MHz, D2O): δ (ppm) = 7.71 (dd, J = 7.5 Hz, J = 1.9 Hz, 1H, Har), 7.46 (d, J = 8.3 Hz, 2H, 
Har), 7.40-7.31 (m, 4H, Har), 7.27 (dd, J = 7.5 Hz, J = 1.8 Hz, 1H, Har), 7.11 (d, J = 16.3 Hz, 1H, CH=CH), 
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7.03 (d, J = 16.4 Hz, 1H, CH=CH), 5.09 (dd, J = 10.5 Hz, J = 5.5 Hz, 1H, 1´-H), 4.60–4.44 (m, 1H, 3´-H), 
4.18–4.11 (m, 1H, 4´-H), 4.09–4.00 (m, 2H, 5´-H), 2.22–2.13 (m, 1H, 2´-H), 2.12–2.01 (m, 1H, 2´-H). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = ‒11.02 (d, 1P, 2JPP = 19.8 Hz, /-P), ‒11.36 (d, 1P, 
2JPP = 20.1 Hz, /-P), ‒23.53 (t, 1P, 2JPP = 18.8 Hz, -P). 
HRMS (ESI): calc. for  C21H22O13NF3P3‒ [M–H]‒: 646.0262; found: 646.0253. 
{(2R,3S,5R)-5-[4-(2-Aminostyryl)phenyl]-3-hydroxytetrahydrofuran-2-yl}methyl triphosphate (105) 
 
C19H24NO12P3 (hypothetic free acid) 
MW: 551.32 g/mol 
Route A: To a freshly prepared aqueous solution of NH4OH (28%) and NH2Me (40%) (50:50, v/v, 3 mL) 
was added the triethylammonium salt of TFA-protected dToTP 106 (63 mg, 63 µmol) and heated to 65 °C. 
For reaction control, aliquots were taken for analytical RP-HPLC (0–70% B in 45 min) in 30 min intervals. 
After 2 h almost complete conversion of the starting material was observed. After cooling to 0 °C, acetic 
acid (approx. 1.8 mL) was added to the yellow solution for neutralization and the filtered sample was 
purified twice by preparative RP-HPLC (0–40% B in 45 min). This afforded the dToTP 105 as a yellow 
fluorescent tris- to tetrakis-triethylammonium salt (22.2 mg, 24.6 µmol, 39%) after freeze-drying. 
Route B: To the excessively dried aromatic amine nucleoside 103 (18.1 mg, 58.0 µmol, 1.0 eq) was added 
the triphosphate reagent solution (0.61 mL, 116.0 µmol, 2.0 eq, prepared according to general procedure 1, 
p. 100) at 0 °C in an argon atmosphere. The reaction mixture was allowed to warm to rt under stirring. 
After 3.0 h, an iodine solution (20 mM I2 in Py/H2O = 9:1) was added until a slight brown color remained 
for 15 min (approx. 0.6 mL), followed by addition of ddH2O (1.5 mL) and stirring for 1.5 h. An aqueous 
solution of NaCl (3 M, 0.5 mL) was added, and the solution was transferred to a 50 mL centrifugation tube, 
vortexed vigorously and mixed with EtOH (absolute, 15 mL). Precipitation was achieved by cooling to –
80 °C for 30 min, followed by centrifugation (5 min, 3200 x g). The supernatant was discarded and the 
pellet was redissolved in buffer A (1.0 mL) and lyophilized. The residue was purified twice by RP-HPLC 
purification (0–40% B in 45 min). This afforded the aromatic amine triphosphate 105 as a yellow 
fluorescent tetrakis-triethylammonium salt (4.7 mg, 4.9 µmol, 8%) after freeze-drying. 
1H NMR (400 MHz, D2O): δ (ppm) = 7.55 (d, J = 8.2 Hz, 2H, Har-A), 7.48 (d, J = 7.4 Hz, 1H, Har-B), 7.41 
(d, J = 8.2 Hz, 2H, Har-A), 7.26 (d, J = 16.2 Hz, 1H, CH=CH), 7.14 (td, J = 7.8 Hz, 1.2 Hz, 1H, Har-B), 7.01 
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(d, J = 16.2 Hz, 1H, CH=CH), 6.86 (t, J = 7.5 Hz, 2H, Har-B), 5.13 (dd, J = 10.5 Hz, 3J = 5.6 Hz, 1H, 1´-H), 
4.59–4.42 (m, 1H, 3´-H), 4.18–4.13 (m, 1H, 4´-H), 4.12–4.05 (m, 2H, 5´-H), 2.24–2.17 (m, 1H, 2´-H), 
2.16–2.06 (m, 1H, 2´-H). 
13C NMR (101 MHz, 1H-decoupled, D2O): δ (ppm) = 143.1 (Car), 139.9 (Car), 137.2 (Car), 129.2 (CH=CH), 
129.0 (CHar-B), 127.1 (2 x CHar-A), 126.6 (2 x CHar-A), 126.3 (CHar-B), 124.3 (Car), 123.4 (CH=CH), 120.3 
(CHar-B), 117.7 (CHar-B), 85.6 (d, 
3JPC = 8.9 Hz, 4´-C), 80.6 (1´-C), 73.0 (3´-C), 66.1 (d, 
2JPC = 5.9 Hz, 5´-
C), 41.8 (2´-C).  
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = ‒10.80 (d, 1P, 2JPP = 19.9 Hz, -P), ‒11.32 (d, 1P, 
2JPP = 20.2 Hz, -P), ‒23.41 (t, 1P, 2JPP = 20.0 Hz, -P). 
HRMS (ESI): calc. for  C19H23O12NP3- [M–H]-: 550.0439; found: 550.0432. 
UV-Vis (H2O): Abs (nm) = 289 (base peak), 233, 330. 
Extinction coefficient (H2O):  (289 nm) = 13500 M‒1cm‒1. 
Fluorescence (H2O): Abs = 289 nm, Em = 481 nm.  
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5.2.8 Synthesis of a Naphthalene Amine Triphosphate 
(4S,5R)-4-(tert-Butyldimethylsilyloxy)-5-((tert-butyldimethylsilyloxy)methyl)dihydrofuran-2(3H)-one 
(91) 
 
 
C17H36O4Si2 
MW: 360.64 g/mol 
The synthesis and the analytical data were in agreement with published data by Y. Cen et al.[224] 
 
((2R,3S)-5-(6-Bromonaphthalen-2-yl)-2-((tert-butyldimethylsilyloxy)methyl)tetrahydrofuran-3-yloxy)(tert-
butyl)dimethylsilane (108) 
 
 
C27H43BrO3Si2 
MW: 551.70 g/mol 
To a stirring solution of 2,6-dibromo-naphthalene (1.00 g, 3.50 mmol, 1.7 eq) in dry THF (13.5 mL) at –
78 °C, nBuLi (1.6 M in hexanes, 2.19 mL, 3.50 mmol, 1.7 eq) was added in one shot. After 20 min, a 
solution of the TBS-protected deoxyribolactone 91 (757 mg, 2.10 mmol, 1.0 eq) in dry THF (13.5 mL) was 
added dropwise to the yellow solution at –78 °C, and stirring continued for 1 h. Then, the solution was 
poured into an ice-cold saturated aqueous NH4Cl solution (60 mL) and was subsequently extracted with 
diethyl ether (3 x 70 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated 
in vacuo. Flash column chromatography (silica, 20 x 4 cm, wet load, gradient; iHex/EtOAc = 100:1 → 
50:1 → 25:1 → 10:1) yielded the hemiketal 109 as a colorless oil (271 mg, 0.48 mmol, 22%) that was 
directly used for the subsequent reduction. 
Rf (iHex/EtOAc, 9:1) = 0.4. 
To a stirring solution of the hemiketal 109 (270 mg, 0.48 mmol, 1.0 eq) in dry DCM (3 mL) at –78 °C, 
triethylsilane (0.23 mL, 168 mg, 1.43 mmol, 3.0 eq) was added and after 5 min was followed by BF3∙OEt2 
(73 µL, 83 mg, 0.57 mmol, 1.2 eq). After 2 h, saturated aqueous NaHCO3 (3 mL), H2O (10 mL) and DCM 
(7 mL) were added and the organic layer was separated after warming to rt. The aqueous layer was 
extracted with DCM (3 x 30 mL) and the combined organic layers were dried over Na2SO4, filtered and 
concentrated in vacuo. Flash column chromatography (silica, 18 x 2 cm, wet load, gradient; iHex/EtOAc = 
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1:0 → 100:1 → 50:1 → 25:1) yielded the bromonaphthalene nucleoside 108 (134 mg, 0.24 mmol, 50% 
from 109) as a colorless oil. 
Rf (iHex/EtOAc, 9:1) = 0.6. 
1H NMR (400 MHz, CDCl3): δ (ppm) = 7.97 (s, 1H, Har), 7.80 (s, 1H, Har), 7.71 (d, J = 8.7 Hz, 1H, Har), 
7.69 (d, J = 8.7 Hz, 1H, Har), 7.53 (d, J = 8.6 Hz, 2H, Har), 5.29 (dd, J = 10.5, 5.3 Hz, 1H, 1´-H), 4.46 (d, 
J = 4.9 Hz, 1H, 3´-H), 4.08–3.96 (s, 1H, 4´-H), 3.82 (dd, J = 10.7, 3.6 Hz, 1H, 5´-H), 3.68 (dd, J = 10.7, 
5.6 Hz, 1H, 5´-H), 2.18 (dd, J = 12.5, 5.5 Hz, 1H, 2´-H), 1.96 (td, J = 12.2, 11.7, 5.3 Hz, 1H, 2´-H), 1.05–
0.78 (m, 18H, 2 x SiC(CH3)3), 0.13–0.08 (m, 12H, 2 x Si(CH3)2). 
13C NMR (101 MHz, 1H-decoupled, CDCl3): δ (ppm) = 140.4 (Car), 134.0 (Car), 131.7 (Car), 129.7 (HCar), 
129.5 (HCar), 129.3 (HCar) 127.1 (HCar), 125.4 (HCar), 124.6 (HCar), 119.5 (Car), 88.2 (4´-C), 80.1 (1´-C), 
74.5 (3´-C), 63.9 (5´-C), 44.4 (2´-C), 25.9 (SiC(CH3)3), 25.8 (SiC(CH3)3), 18.4 (SiC(CH3)3), 18.1 
(SiC(CH3)3), –4.6 (SiCH3), –4.7 (SiCH3), –5.3 (SiCH3), –5.4 (SiCH3). 
HRMS (ESI): calc. for  C27H47O3N81BrSi2+ [M+NH4]+: 570.22574; found: 570.22614. 
 
N-(2-Bromophenyl)-2,2,2-trifluoroacetamide  
 
 
C8H5BrF3NO 
MW: 268.03 g/mol 
 
To a stirring  solution of 2-bromoaniline (6.60 g, 38.4 mmol, 1.0 eq) in anhydrous DCM (75 mL) at 0 °C, 
triethylamine (16.0 mL, 11.65 g, 115.1 mmol, 3.0 eq) was added. After 5 min, trifluoroacetic anhydride 
(16.1 mL, 24.17 g, 115.1 mmol, 3.0 eq) was added dropwise and the reaction mixture was allowed to warm 
to rt. After 2 h, the mixture was poured into H2O (200 mL) and was extracted with DCM (3 x 150 mL). 
The combined organic layers were washed with H2O (1 x 200 mL), saturated aqueous NaHCO3 (1 x 
200 mL), dried over Na2SO4, filtered and concentrated in vacuo. Flash column chromatography (silica, 17 
x 6.0 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 → 50:1 → 25:1) yielded the TFA-protected 2-
bromoaniline (10.1 g, 37.7 mmol, 98% yield) as a colorless solid. 
Rf (iHex/EtOAc, 9:1) = 0.4. 
1H NMR (400 MHz, CDCl3): δ (ppm) = 8.46 (br s, 1H, -NH), 8.32 (d, J = 8.2 Hz, 1H, Har), 7.61 (d, J = 
8.1 Hz, 1H, Har), 7.40 (t, J = 7.8 Hz, 1H, Har), 7.13 (t, J = 7.8 Hz, 1H, Har). 
13C NMR (101 MHz, CDCl3): δ (ppm) = 154.8 (q, 2JC-F = 37 Hz, CO), 133.3 (Car), 132.8 (HCar), 128.9 
(HCar), 127.4 (HCar), 122.2 (HCar), 115.7 (q, 1JC-F = 288 Hz, CF3) , 114.2 (Car). 
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2,2,2-Trifluoro-N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide (110) 
 
 
C14H17BF3NO3 
MW: 315.10 g/mol 
To a stirring mixture of TFA-protected 2-bromoaniline (422 mg, 1.58 mmol, 1.0 eq) in dry dioxane 
(4.0 mL) in a 25 mL sealed tube bis(pinacolato)diboron (800 mg, 3.15 mmol, 2.0 eq) and potassium acetate 
(464 mg, 4.73 mmol, 3.0 eq) were added and the mixture was flushed with argon for 5 min. Then [1,1´-
bis(diphenylphosphino)ferrocene]dichloropalladium(II) (57.6 mg, 78.8 µmol, 5 mol%) was added and the 
mixture was heated to 95 °C for 2 h. After cooling to rt H2O and DCM were added (90 mL each) and the 
organic layer was separated. The aqueous layer was extracted with DCM (3 x 90 mL) and the combined 
organic layers were washed with brine (90 mL), dried over Na2SO4, filtered and concentrated in vacuo. 
Flash column chromatography (silica, 20 x 2.5 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 → 
50:1) yielded the boronate amine 110 (422 mg, 1.34 mmol, 85% yield) as an off-white wax. 
Rf (iHex/EtOAc, 9:1) = 0.6. 
1H NMR (800 MHz, CDCl3): δ (ppm) = 10.57 (s, 1H, -NH), 8.46 (d, J = 8.4 Hz, 1H, Har), 7.81 (dd, J = 7.4, 
1.6 Hz, 1H, Har), 7.53 (td, J = 7.9, 1.6 Hz 1H, Har), 7.20 (td, J = 7.4, 0.9 Hz, 1H, Har), 1.38 (s, 12H, O-C-
(CH3)2). 
13C NMR (201 MHz, 1H-decoupled, CDCl3): δ (ppm) = 154.8 (q, 2JC-F = 37 Hz, CO), 142.4 (Car), 136.5 
(HCar), 133.3 (HCar), 125.0 (HCar), 119.7 (HCar), 116.1 (q, 1JC-F = 287 Hz, CF3), 84.9 (2 x OC(CH3)2), 24.8 
(4 x C(CH3)2). The carbon directly adjacent to the boron residue was not detected. 
19F NMR (376 MHz, CDCl3): δ (ppm) = ‒76.3 (s, 3F). 
HRMS (ESI): calc. for  C14H16BF3NO3– [M–H]–: 314.11808; found: 314.11825. 
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N-(2-(6-((4S,5R)-4-(tert-Butyldimethylsilyloxy)-5-((tert-butyldimethylsilyloxy)methyl)-tetrahydrofuran-2-
yl)naphthalen-2-yl)phenyl)-2,2,2-trifluoroacetamide (111) 
 
 
 
C35H48F3NO4Si2 
MW: 659.93 g/mol 
To a stirring solution of the bromonaphthalene nucleoside 108 (197 mg, 0.36 mmol, 1.0 eq) in DMF/H2O 
(9:1, 2 mL) the boronate amine 110 (170 mg, 0.54 mmol, 1.5 eq) and tripotassium phosphate (227 mg, 
1.07 mmol, 3.0 eq) were added. The mixture was flushed with argon for 5 min before [1,1´-
bis(diphenylphosphino)ferrocene]dichloropalladium(II) (13.1 mg, 17.8 µmol, 5 mol%) was added and the 
mixture was heated to 80 °C for 1 h. After cooling to rt H2O and EtOAc were added (50 mL each) and the 
organic layer was separated. The aqueous layer was extracted with EtOAc (3 x 50 mL) and the combined 
organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Flash column chromatography 
(silica, 20 x 2.5 cm, wet load, gradient; iHex/EtOAc = 1:0 → 100:1 → 50:1 → 100:3) yielded the TFA-
TBS-protected naphthalene amine nucleoside 111 (140 mg, 0.21 mmol, 45% yield) as a pale yellow oil. 
Rf (iHex/EtOAc, 9:1) = 0.6. 
1H NMR (800 MHz, CDCl3): δ (ppm)= 8.32 (dd, J = 8.3, 0.9 Hz, 1H, Har), 8.07 (br s, 1H, NH), 7.95 (d, 
J = 8.4 Hz, 1H, Har), 7.84 (d, J = 8.4 Hz, 1H, Har), 7.60 (dd, J = 8.4, 1.6 Hz, 1H, Har), 7.58–7.56 (m, 1H, 
Har), 7.48–7.45 (m, 1H, Har), 7.45–7.42 (m, 2H, Har), 7.42–7.39 (m, 1H, Har), 7.34 (td, J = 7.5, 1.1 Hz, 1H, 
Har), 5.35 (dd, J = 10.5, 5.4 Hz, 1H, 1´-H), 4.53–4.44 (m, 1H, 3´-H), 4.05 (ddd, J = 5.6, 3.7, 1.9 Hz, 1H, 4´-
H), 3.84 (dd, J = 10.7, 3.7 Hz, 1H, 5´-H), 3.71 (dd, J = 10.7, 5.7 Hz, 1H, 5´-H), 2.22 (ddd, J = 12.6, 5.4, 
1.4 Hz, 1H, 2´-H), 2.01 (ddd, J = 12.7, 10.6, 5.3 Hz, 1H, 2´-H), 0.95 (s, 9H, SiC(CH3)3), 0.93 (m, 9H, 
SiC(CH3)3), 0.14–0.11 (m, 12H, 2 x Si(CH3)2). 
13C NMR (201 MHz, 1H-decoupled, CDCl3): δ (ppm) = 154.7 (q, 2JC-F = 37 Hz, CO), 141.3 (Car), 133.9 
(Car), 133.2 (Car), 133.1 (Car), 132.9 (Car), 132.4 (Car), 130.8 (HCar), 129.5 (HCar), 129.4 (HCar), 128.9 
(HCar), 128.29 (HCar), 126.7 (HCar), 126.5 (HCar), 125.7 (HCar), 121.6 (HCar), 120.6 (HCar), 115.8 (q,  1JC-
F = 289 Hz, CF3), 88.5 (4´-C), 80.3 (1´-C), 74.7 (3´-C), 64.1 (5´-C), 44.6 (2´-C), 26.1 (SiC(CH3)3), 26.0 
(SiC(CH3)3), 18.5 (SiC(CH3)3), 18.2 (SiC(CH3)3), –4.45 (SiCH3), ‒4.49 (SiCH3), ‒5.2 (SiCH3), ‒5.3 
(SiCH3). 
19F NMR (376 MHz, CDCl3): δ (ppm) = ‒76.0 (s, 3F). 
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HRMS (ESI): calc. for  C35H47O4NF3Si2‒ [M–H]‒: 658.30012; found: 658.29999. 
2,2,2-Trifluoro-N-(2-(6-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)naphthalen-2-
yl)phenyl)acetamide (112) 
 
 
 
C23H20F3NO4 
MW: 431.40 g/mol 
To a stirring solution of the TFA-TBS-protected naphthalene amine nucleoside 111 (170 mg, 258 µmol, 
1.0 eq) in EtOAc (4.5 mL) in a polypropylene tube HF∙pyridine (200 µL, 220 mg, 7.7 mmol, 30.0 eq) was 
added. After 15 h at rt Me3SiOMe (5.3 mL, 4.00 g, 38.4 mmol, 150.0 eq) was added dropwise and stirring 
continued for 30 min before the solution was concentrated in vacuo. Flash column chromatography (silica, 
20 x 2 cm, wet load, gradient; DCM/MeOH = 1:0 → 50:1 → 25:1 → 9:1) yielded the TFA-protected 
naphthalene amine nucleoside 112 (77 mg, 178 µmol, 69% yield) as a yellow-orange oil. 
Rf (DCM/MeOH, 9:1) = 0.6. 
1H NMR (400 MHz, CD3OD): δ (ppm) = 7.90–7.77 (m, 4H, Har), 7.56 (dd, J = 8.5, 1.6 Hz, 1H, Har), 7.53–
7.42 (m, 5H, Har), 5.31 (dd, J = 10.5, 5.4 Hz, 1H, 1´-H), 4.38 (dt, J = 5.9, 1.8 Hz, 1H, 3´-H), 4.03 (td, 
J = 5.1, 2.5 Hz, 1H, 4´-H), 3.74 (dd, J = 5.1, 1.7 Hz, 2H, 5´-H), 2.29 (ddd, J = 13.1, 5.5, 1.7 Hz, 1H, 2´-H), 
2.06 (ddd, J = 13.1, 10.5, 5.9 Hz,1H, 2´-H). 
13C NMR (101 MHz, 1H-decoupled, CD3OD): δ (ppm) = 157.8 (q, 2JC-F = 37 Hz, CO), 141.2 (Car), 140.0 
(Car), 137.2 (Car), 134.3 (Car), 133.9 (Car), 133.3 (Car), 132.0 (HCar), 129.4 (HCar), 129.30 (HCar), 129.29 
(HCar), 129.1 (HCar), 128.6 (HCar), 128.3 (HCar), 128.0 (HCar), 125.9 (HCar), 125.6 (HCar), 117.5 (q,    1JC-
F = 287 Hz, CF3), 89.3 (4´-C), 81.7 (1´-C), 74.5 (3´-C), 64.1 (5´-C), 44.8 (2´-C). 
19F NMR (376 MHz, CD3OD): δ (ppm) = ‒77.2 (s, 3F). 
HRMS (ESI): calc. for  C23H19O4NF3‒ [M–H]‒: 430.12717; found: 430.12735. 
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(2R,3S,5R)-5-(6-(2-Aminophenyl)naphthalen-2-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol (107) 
 
C21H21NO3 
MW: 335.40 g/mol 
To a stirring solution of the TFA-protected naphthalene amine nucleoside 112 (45.0 mg, 104 µmol, 1.0 eq) 
in MeOH/H2O (3:1, 0.6 mL) lithium hydroxide hydrate (6.1 mg, 146 µmol, 1.4 eq) was added and the 
solution was warmed to 40 °C for 30 min and then concentrated in vacuo. Flash column chromatography 
(silica, 13 x 1.5 cm, wet load, gradient; DCM/MeOH = 100:1 → 50:1 → 20:1 → 9:1) yielded the 
naphthalene amine nucleoside 107 (27.6 mg, 82 µmol, 79% yield) as a yellow-brown glass. 
Rf (DCM/MeOH, 9:1) = 0.6. 
1H NMR (400 MHz, CD3OD): δ (ppm) = 7.92–7.86 (m, 2H, Har),7.83 (d, J = 8.7 Hz, 2H, Har), 7.54 (dd, J 
= 4.0, 1.8 Hz, 1H, Har), 7.52 (dd, J = 3.9, 1.7 Hz, 1H, Har), 7.15–7.07 (m, 2H, Har), 6.85 (dd, J = 8.5, 
1.2 Hz, 1H, Har), 6.79 (td, J = 7.5, 1.2 Hz, 1H, Har), 5.30 (dd, J = 10.4, 5.4 Hz, 1H, 1´-H), 4.37 (dt, J = 5.9, 
1.8 Hz, 1H, 3´-H), 4.02 (td, J = 5.1, 2.5 Hz, 1H, 4´-H), 3.86–3.55 (m, 2H, 5´-H), 2.27 (ddd, J = 13.1, 5.3, 
1.7 Hz, 1H, 2´-H), 2.05 (ddd, J = 13.1, 10.5, 5.9 Hz, 1H, 2´-H). 
13C NMR (101 MHz, 1H-decoupled, CD3OD): δ (ppm) = 145.4 (ipso-C), 140.8 (ipso-C), 138.7 (ipso-C), 
134.7 (ipso-C), 133.7 (ipso-C), 131.5 (HCar), 129.5 (HCar), 129.4 (HCar), 129.2 (HCar), 129.0 (ipso-C), 
128.6 (HCar), 128.4 (HCar), 125.72 (HCar), 125.66 (HCar), 119.6 (HCar), 117.2 (HCar), 89.3 (4´-C), 81.7 (1´-
C), 74.5 (3´-C), 64.1 (5´-C), 44.9 (2´-C). 
HRMS (ESI): calc. for  C21H22O3N+ [M+H]+: 336.15942; found: 336.15941. 
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((2R,3S,5R)-5-(6-(2-Aminophenyl)naphthalen-2-yl)-3-hydroxytetrahydrofuran-2-yl)methyl triphosphate 
(113) 
 
C21H24NO12P3 (hypothetic free acid) 
MW: 575.34 g/mol 
To the excessively dried naphthalene amine nucleoside 107 (27.6 mg, 82.3 µmol, 1.0 eq) under argon was 
added the triphosphate reagent solution (0.87 mL, 165.3 µmol, 2.0 eq, prepared according to general 
procedure 1, p. 100) at 0 °C and the reaction mixture was allowed to warm to rt under stirring. After 2.5 h 
TLC (DCM/MeOH = 5:1) indicated the presence of unreacted naphthalene amine nucleoside, so more 
triphosphate reagent solution (0.20 mL, 38.0 µmol, 0.47 eq) was added and stirring continued for 30 min. 
The reaction mixture was oxidized with an iodine solution (20 mM I2 in Py/H2O = 9:1) until a slight brown 
color remained for 15 min (approx. 1.0 mL), followed by ddH2O (2.7 mL) and stirred for 1 h. Then an 
aqueous solution of NaCl (3 M, 1.6 mL) was added, and the reaction mixture was transferred to a 50 mL 
centrifugation tube, vortexed vigorously and mixed with EtOH (absolute, 15 mL). Precipitation was 
achieved by cooling to –80 °C for 30 min, followed by centrifugation (5 min, 3200 x g). The supernatant 
was discarded and the pellet was redissolved in buffer A (1.5 mL) and lyophilized. The residue was 
purified twice by RP-HPLC purification (0–35% B in 45 min). This afforded the naphthalene amine 
triphosphate 113 as a slightly yellow tetrakis-triethylammonium salt (16.0 mg, 14.1 µmol, 17%) after 
freeze-drying. 
1H NMR (400 MHz, D2O): δ (ppm) = 7.91–7.84 (m, 2H, Har), 7.82 (d, J = 8.6 Hz, 1H, Har), 7.70 (s, 1H, 
Har), 7.55 (d, J = 8.6 Hz, 1H, Har), 7.38 (d, J = 8.5 Hz, 1H, Har), 7.24 (t, J = 7.7 Hz, 1H, Har), 7.10 (d, 
J = 7.5 Hz, 1H, Har), 7.00 (d, J = 8.0 Hz, 1H, Har), 6.95 (t, J = 7.5 Hz, 1H, Har), 5.27 (dd, J = 10.3, 5.7, 1H, 
1´-H), 4.58–4.52 (m, 1H, 3´-H), 4.23–4.17 (m, 1H, 4´-H), 4.16–4.05 (m, 2H, 5´-H), 2.30–2.11 (m, 2H, 2´-
H). 
31P NMR (162 MHz, D2O): δ (ppm) = –11.02 (d, 2JP-P = 19.8 Hz, -P), –11.33 (dt, 2JP-P = 20.1 Hz, 
3JP-H = 5.9 Hz, -P), –23.46 (t, 2JP-P = 20.0 Hz, -P). 
HRMS (ESI): calc. for  C21H23O12NP3– [M–H]–: 574.04386; found: 574.04393. 
UV-Vis (H2O): Abs (nm) = 230 (base peak), 279.  
Extinction coefficient (H2O):  (279 nm) = 9000 M–1cm‒1.  
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5.2.9 Synthesis of -Alkyne Labeled Nucleotides 
General Procedure 2: In a 1.5 mL reaction tube 300 µL of the nucleoside triphosphate solution (100 mM, 
30 µmol, 1.0 eq) were mixed with 300 µL EDC∙HCl solution (500 mM in ddH2O, pH = 7.5, 150 µmol, 
5.0 eq) and incubated at 25 °C, 1200 rpm (in a thermomixer from EPPENDORF) for 7 min. Then, 600 µL of 
1-aminobut-3-yne solution (55 mM in DMF, 33 µmol, 1.1 eq) were added and incubated for 4.5 h at 25 °C, 
1200 rpm. DMF was removed by extraction with CHCl3 (3 x 600 µL) and the aqueous layer (aprox. 
600 µL) was transferred to a 15 mL reaction tube. Precipitation was achieved by addition of 180 µL NaCl 
(3 M in ddH2O) and 4 mL of abs. EtOH. After vortexing, the mixture was cooled to –80 °C for 1 h 
(alternatively –20 °C overnight). After centrifugation (4000 x g, 10 min) the supernatant was removed, the 
colorless solid was redissolved in H2O (500 µL) and then dried by lyophilization. Purification by 
preparative RP-HPLC yielded -alkyne labeled nucleotides with >95% purity (according to analytical RP-
HPLC at 260 nm detection, 0–20% B in 45 min). 
General Procedure 3: All reactions were performed with magnetic stirring. EDC∙HCl (5.0 eq) was 
dissolved in ddH2O, the nucleoside triphosphate (1.0 eq) was added and the pH was adjusted to 7.5 with 
aqueous NaOH (0.1 M) if necessary. After stirring at rt for 5 min 1-aminobut-3-yne (55 mM in DMF, 
1.1 eq) was added. After complete consumption of the starting material (reactions were monitored by RP-
HPLC at 260 nm detection, 0–20% B in 45 min), the solvent was removed in vacuo and the colorless crude 
product was purified by preparative RP-HPLC to yield the -alkyne labeled nucleotides. 
 
-N-(But-3-yn-1-ylamido)-2´-deoxyadenosine-5´-triphosphate 118 
 
C14H21N6O11P3 (hypothetic free acid) 
MW: 542.27 g/mol 
The synthesis was performed with a 100 mM dATP solution (300 µL, 30.0 µmol) as described in the 
general procedure 2 (5.2.9, p. 130). RP-HPLC purification (0–15% B in 45 min) afforded the tris-
triethylammonium salt of -alkyne labeled dATP 118 (19.9 mg, 23.5 µmol, 78%) as a colorless solid after 
lyophilization.  
1H NMR (400 MHz, D2O): δ (ppm) = 8.56 (s, 1H, 2-H), 8.31 (s, 1H, 8-H), 6.55 (t, 3J = 4.0 Hz, 1H, 1´-H), 
4.84–4.82 (m, 1H, 3´-H), 4.33–4.25 (m, 1H, 4´-H), 4.33–4.10 (m, 2H, 5´-H), 3.10–2.99 (m, 2H, 10-H), 
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2.89–2.83 (m, 1H, 2´-H), 2.67–2.60 (m, 1H, 2´-H), 2.36 (td, 3J = 6.4 Hz, 4J = 2.6 Hz, 2H, 11-H), 2.31 (t, 
4J = 2.4 Hz, 1H, 13-H).  
13C NMR (102 MHz, 1H-decoupled, D2O): δ (ppm) = 155.3 (6-C), 152.5 (2-C), 148.7 (4-C), 140.0 (8-C), 
118.5 (5-C), 85.7 (d, 3JP-C = 9.2 Hz, 4´-C), 83.6 (1´-C), 83.2 (12-C), 72.3 (3´-C), 71.0 (13-C), 65.4 (d,  2JP-
C = 7.1 Hz, 5´-C), 40.4 (10-C), 39.0 (2´-C), 20.8 (d, 3JP-C = 8.2 Hz, 11-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = –2.00 (d, 2J = 19.4 Hz, γ-P), –11.58 (d, 2J = 19.6 Hz, 
α-P), –23.15 (t, 2J = 21.6 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3177, 2982, 2884, 2610, 2471, 1650, 1597, 1570, 1473, 1397, 1330, 1294, 1212, 
1083, 991, 901, 836, 799, 723. 
HRESIMS: calculated for C14H20N6O11P3– [M–H]–: 541.0408, observed: 541.0399. 
 
-N-(But-3-yn-1-ylamido)-2´-deoxycytidine-5´-triphosphate 119 
 
C13H21N4O12P3 (hypothetic free acid) 
MW: 518.25 g/mol 
The synthesis was performed with a 100 mM dCTP solution (300 µL, 30.0 µmol) as described in the 
general procedure 2 (5.2.9, p. 130). RP-HPLC purification (0–10% B in 45 min) afforded the tris-
triethylammonium salt of -alkyne labeled dCTP 119 (18.9 mg, 23.0 µmol, 76%) as a colorless solid after 
lyophilization. 
1H NMR (400 MHz, D2O): δ = 8.04 (d, 3J = 7.53 Hz, 1H, 6-H), 6.37 (t, 3J = 6.92 Hz, 1H, 1´-H), 6.19 (d, 
3J = 7.57 Hz, 1H, 5-H), 4.67–4.64 (m, 1H, 3´-H), 4.25–4.24 (m, 3H, 4´-H, 5´-H2), 3.12–3.06 (m, 2H, 7-H), 
2.69–2.65 (m, 1H, 2´-H), 2.47–2.46 (m, 1H, 2´-H), 2.45–2.40 (m, 2H, 8-H), 2.38–2.36 (m, 1H, 10-H). 
13C NMR (102 MHz, 1H-decoupled, D2O): δ = 166.0 (4-C), 157.3 (2-C), 141.7 (6-C), 96.5 (1´-C), 
85.8 (5-C), 85.4 (d, 3JP-C = 9.6 Hz, 4´-C), 83.3 (9-C), 70.4 (3´-C), 70.1 (10-C), 65.0 (d, 2JP-C = 5.6 Hz, 5´-
C), 40.4 (7-C), 39.4 (2´-C), 20.7 (3JP-C = 8.7 Hz, 8-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ = –1.97 (d, 2J = 20.7 Hz, -P), –11.63 (d, 2J = 19.5 Hz, α-P), –
23.10 (t, 2J = 20.6 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3276, 2973, 2937, 2877, 2437, 1692, 1647, 1524, 1488, 1385, 1223, 1057, 995, 902, 
840, 809, 787, 767. 
HRESIMS: calculated for C13H20N4O12P3– [M–H]–: 517.0296, observed: 517.0296. 
132  Experimental Part 
 
 
-N-(But-3-yn-1-ylamido)-2´-deoxyguanosine-5´-triphosphate 120 
 
C14H21N6O12P3 (hypothetic free acid) 
MW: 558.27 g/mol 
The synthesis was performed with a 100 mM dGTP solution (300 µL, 30.0 µmol) as described in the 
general procedure 2 (5.2.9, p. 130) except that after EDC∙HCl incubation 200 µL of extra H2O were added 
to prevent precipitation upon addition of the DMF solution. RP-HPLC purification (0–15% B in 45 min) 
afforded the tris-triethylammonium salt of -alkyne labeled dGTP 120 (20.3 mg, 23.6 µmol, 78%) as a 
colorless solid after lyophilization. 
1H NMR (400 MHz, D2O): δ (ppm) = 8.11 (s, 1H, 8-H), 6.33 (t, 3J = 4.6 Hz, 1H, 1´-H),  4.81–4.78 (m, 1H, 
3´-H), 4.28–4.25 (m, 1H, 4´-H), 4.20 (t, 3J = 3.6 Hz, 2H, 5´-H), 3.10–3.01 (m, 2H, 10-H), 2.89–2.83 (m, 
1H, 2´-H), 2.53–2.48 (m, 1H, 2´-H), 2.37–2.34 (m, 2H, 11-H), 2.31–2.29 (m, 1H, 13-H). 
13C NMR (150.6 MHz, 1H-decoupled, D2O): δ (ppm) = 158.9 (6-C), 153.8 (2-C), 151.4 (4-C), 137.8 (8-C), 
116.3 (5-C), 85.6 (d, 3JP-C = 9.2 Hz, 4´-C), 83.6 (1´-C), 83.3 (12-C), 71.2 (3´-C), 70.0 (13-C), 65.3 (d, 2JP-
C = 5.7 Hz, 5´-C), 40.4 (10-C), 38.2 (2´-C), 20.7 (d, 3JP-C = 8.4 Hz, 11-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = –1.94 (d, 2J = 21.6 Hz, γ-P), –11.51 (d, 2J = 19.8 Hz, 
α-P), –23.08 (t, 2J = 20.3 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3212, 2986, 2945, 2694, 2497, 1678, 1635, 1602, 1568, 1531, 1478, 1454, 1397, 
1358, 1320, 1225, 1085, 1060, 996, 911, 837, 783, 734, 677.  
HRESIMS: calculated for C14H20N6O13P3– [M–H]–: 557.0358, observed: 557.0346. 
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-N-(But-3-yn-1-ylamido)-2´-deoxythymidine-5´-triphosphate 121 
 
C14H22N3O13P3 (hypothetic free acid) 
MW: 533.26 g/mol 
The synthesis was performed with dTTP sodium salt (13.8 mg, 25.0 µmol, 1.0 eq), EDC∙HCl (24.0 mg, 
125.0 µmol, 5.0 eq) and 1-aminobut-3-yne (1.9 mg, 28.0 µmol, 1.1 eq) in ddH2O (0.5 mL) within 4.5 h as 
described in the general procedure 3 (5.2.9, p. 130). RP-HPLC purification (0–15% B in 45 min) afforded 
the tris-triethylammonium salt of -alkyne labeled dTTP 121 (17.5 mg, 21.0 µmol, 84%) as a colorless 
solid after lyophilization. 
1H NMR (400 MHz, D2O): δ (ppm) = 7.80 (d, 
3J = 7.7 Hz, 1H, 6-H), 6.37 (t, 3J = 6.9 Hz, 1H, 1´-H), 4.70–
4.66 (m, 1H, 3´-H), 4.26–4.18 (m, 3H, 4´-H, 5´-H), 3.11–3.05 (m, 2H, 8-H), 2.44–2.33 (m, 5H, 2´-H, 9-H, 
11-H), 1.96 (s, 3H, 7-H). 
13C NMR (102 MHz, 1H-decoupled, D2O): δ (ppm) = 166.5 (4-C), 151.7 (2-C), 137.3 (6-C), 111.7 (5-C), 
85.4 (d, 3JP-C = 9.1 Hz, 4´-C), 84.8 (1´-C), 83.4 (10-C), 70.7 (3´-C), 70.1 (11-C), 65.3 (d,
 2JP-C = 5.7 Hz, 
5´-C), 40.4 (8-C), 38.5 (2´-C), 20.8 (d, 3JP-C = 8.6 Hz, 9-C), 11.6 (7-C). 
31P NMR (162 MHz, D2O): δ (ppm) = –1.94 (d, 2JP-P = 20.6 Hz, γ-P), –11.85 (dd, 2JP-P = 19.9 Hz, 3JH-
P = 3.8 Hz, α-P), –23.15 (t, 2JP-P = 20.2 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3250, 2914, 2847, 2692, 2493, 1660, 1463, 1399, 1223, 1060, 991, 906, 814, 764, 
717. 
HRESIMS: calculated for C14H21N3O13P3– [M–H]–: 532.0293, observed: 532.0291. 
 
-N-(But-3-yn-1-ylamido)adenosine-5´-triphosphate 122 
 
C14H21N6O12P3 (hypothetic free acid) 
MW: 558.27 g/mol 
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The synthesis was performed with ATP disodium salt (27.6 mg, 50.0 µmol, 1.0 eq), EDC∙HCl (48.0 mg, 
250.0 µmol, 1.0 eq) and 1-aminobut-3-yne (3.8 mg, 55.0 µmol, 1.1 eq) in ddH2O (1.0 mL) within 3 h as 
described in the general procedure 3 (5.2.9, p. 130). RP-HPLC purification (0–15% B in 45 min) afforded 
the tris-triethylammonium salt of -alkyne labeled ATP 122 (36.7 mg, 43.0 µmol, 85%) as a colorless solid 
after lyophilization. 
1H NMR (400 MHz, D2O): δ (ppm) = 8.60 (s, 1H, 2-H), 8.31 (s, 1H, 8-H), 6.18 (d, 
3J = 6.0 Hz, 1H, 1´-H), 
4.84–4.80 (m, 1H, 2´-H), 4.62–4.60 (m, 1H, 3´-H), 4.44–4.43 (m, 1H, 4´-H), 4.30–4.26 (m, 2H, 5´-H), 
3.07–3.03 (m, 2H, 10-H), 2.38–2.26 (m, 3H, 11-H, 13-H). 
13C NMR (102 MHz, 1H-decoupled, D2O): δ (ppm) = 155.4 (6-C), 152.7 (2-C), 149.3 (4-C), 140.0 (8-C), 
118.4 (5-C), 86.6 (1´-C), 84.1 (d, 3JP-C = 9.3 Hz, 4´-C), 83.3 (12-C), 74.2 (2´-C), 70.4 (3´-C), 70.3 (13-C), 
65.2 (d, 2JP-C = 6.1 Hz, 5´-C), 40.4 (10-C), 20.8 (d, 
3JP-C = 8.5 Hz, 11-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = –1.94 (d, 2J = 20.7 Hz, γ-P), –11.58 (d, 2J = 19.6 Hz, 
α-P), –23.03 (t, 2J = 20.2 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3189, 2982, 2680, 2489, 1645, 1600, 1571, 1475, 1399, 1331, 1297, 1215, 1060, 
990, 897, 799. 
HRESIMS: calculated for C14H20N6O12P3– [M–H]–: 557.0358, observed: 557.0355. 
 
-N-(But-3-yn-1-ylamido)cytidine-5´-triphosphate 123 
 
C13H21N4O13P3 (hypothetic free acid) 
MW: 534.25 g/mol 
The synthesis was performed with a 100 mM CTP solution (300 µL, 30.0 µmol) as described in the general 
procedure 2 (5.2.9, p. 130). RP-HPLC purification (0–10% B in 45 min) afforded the tris-
triethylammonium salt of -alkyne labeled CTP 123 (19.2 mg, 23.0 µmol, 76%) as a colorless solid after 
lyophilization. 
1H NMR (400 MHz, D2O): δ (ppm) = 8.08 (d, 3J = 8.0 Hz, 1H, 6-H), 6.22 (d, 3J = 8.0 Hz, 1H, 5-H), 6.03 
(d, 3J = 4.4 Hz, 1H, 1´-H), 4.43–4.41 (m, 1H, 3´-H), 4.37–4.34 (m, 1H, 2´-H), 4.32-4.25 (m, 3H, 4´-H, 5´-
H), 3.08 (dt, 2JP-H = 10.4 Hz,  3J = 6.8 Hz, 2H, 7-H), 2.41 (td, 3J = 6.8 Hz, 4J = 2.6 Hz, 2H, 8-H), 2.37 (t, 
4J = 2.6 Hz, 1H, 10-H). 
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13C NMR (102 MHz, 1H-decoupled, D2O): δ (ppm)  = 165.6 (4-C), 157.2 (2-C), 141.6 (6-C), 96.6 (5-C), 
89.0 (1´-C), 83.3 (9-C), 82.7 (d, 3JP-C = 9.6 Hz, 4´-C), 74.2 (2´-C), 70.0 (10-C), 69.0 (3´-C), 64.4 (d, 2JP-
C = 5.6 Hz, 5´-C), 40.4 (7-C), 20.8 (d, 3JP-C = 8.7 Hz, 8-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm)  = –1.98 (d, 2J = 20.7 Hz, -P), –11.63 (d, 2J = 19.5 Hz, 
α-P), –23.09 (t, 2J = 20.5 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3248, 2994, 2502, 1645, 1489, 1398, 1285, 1220, 1109, 1061, 1011, 903, 902, 787. 
HRESIMS: calculated for C13H20N4O13P3– [M–H]–: 533.0245, observed: 533.0233. 
 
-N-(But-3-yn-1-ylamido)guanosine-5´-triphosphate 124 
 
C14H21N6O13P3 (hypothetic free acid) 
MW: 574.27 g/mol 
The synthesis was performed with a 100 mM GTP solution (300 µL, 30.0 µmol) as described in the general 
procedure 2 (5.2.9, p. 130). RP-HPLC purification (0–15% B in 45 min) afforded the tris-
triethylammonium salt of -alkyne labeled GTP 124 (22.8 mg, 26.0 µmol, 86%) as a colorless solid after 
lyophilization. 
1H NMR (400 MHz, D2O): δ (ppm) = 8.15 (s, 1H, 8-H), 5.94 (d, 
3J = 6.4 Hz, 1H, 1´-H), 4.87–4.82 (m, 1H, 
2´-H), 4.61–4.57 (m, 1H, 3´-H), 4.39–4.35 (m, 1H, 4´-H), 4.30–4.20 (m, 2H, 5´-H), 3.09–3.01 (m, 2H, 10-
H), 2.40–2.34 (m, 2H, 11-H), 2.33–2.31(m, 1H, 13-H). 
13C NMR (102 MHz, 1H-decoupled, D2O): δ (ppm) = 159.0 (6-C), 154.0 (2-C), 151.8 (4-C), 137.7 (8-C), 
116.3 (5-C), 86.7 (1´-C), 83.9 (d, 3JP-C = 9.2 Hz, 4´-C), 82.9 (12-C), 73.4 (2´-C), 70.3 (3´-C and 13-C), 65.2 
(d, 2JP-C = 5.6 Hz, 5´-C), 40.3 (10-C), 20.7 (d, 2JP-C = 8.5 Hz, 11-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = –1.97 (d, 2J = 20.6 Hz, γ-P), –11.64 (d, 2J = 19.6 Hz, 
α-P), –23.12 (t, 2J = 20.2 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3301, 2986, 2948, 2632, 2491, 1678, 1567, 1532, 1477, 1454, 1398, 1223, 1116, 
1061, 1011, 912, 837, 810, 783. 
HRESIMS: calculated for C14H20N6O13P3– [M–H]–: 573.0307, observed: 573.0307.  
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-N-(But-3-yn-1-ylamido)uridine-5´-triphosphate 125 
 
C13H20N3O14P3 (hypothetic free acid) 
MW: 535.23 g/mol 
The synthesis was performed with a 100 mM UTP solution (300 µL, 30.0 µmol) as described in the general 
procedure 2 (5.2.9, p. 130). RP-HPLC purification (0–15% B in 45 min) afforded the tris-
triethylammonium salt of -alkyne labeled UTP 125 (17.6 mg, 21.0 µmol, 70%) as a colorless solid after 
lyophilization. 
1H NMR (400 MHz, D2O): δ (ppm) = 8.02 (d, 
3J = 7.7 Hz, 1H, 6-H), 6.02 (d, 3J = 7.6 Hz, 1H, 5-H), 6.02–
5.99 (m, 1H, 1´-H), 4.46–4.41 (m, 2H, 3´-H, 2´-H), 4.33–4.29 (m, 1H, 4´-H), 4.28–4.25 (m, 2H, 5´-H), 
3.12–3.05 (m, 2H, 7-H), 2.44–2.40 (m, 2H, 8-H), 2.38–2.37 (m, 1H, 10-H). 
13C NMR (102 MHz, 1H-decoupled, D2O): δ (ppm) = 166.1 (4-C), 151.8 (2-C), 141.7 (6-C), 102.7 (5-C), 
88.1 (1´-C), 83.3 (d, 3JP-C = 9.8 Hz, 4´-C), 83.2 (9-C), 73.7 (2´-C), 70.1 (10-C), 69.6 (3´-C), 64.8 (d,     2JP-
C = 5.6 Hz, 5´-C), 40.4 (7-C), 20.8 (d, 
3JP-C = 8.2 Hz, 8-C). 
31P NMR (162 MHz, D2O): δ (ppm) = –1.95 (d, 2JP-P = 21.0 Hz, γ-P), –11.65 (dd, 2JP-P = 19.4 Hz, 3JH-P = 
3.8 Hz, α-P), –23.10 (t, 2JP-P = 21.0 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3259, 2988, 2690, 2504, 1680, 1463, 1390, 1220, 1009, 902, 813, 764. 
HRESIMS: calculated for C13H20N3O14P3– [M–H]–: 534.0085, observed: 534.0074. 
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5.2.10 Synthesis of Fluorophore Azides 
3-Azido-7-hydroxy-2H-chromen-2-one (b) 
 
C9H5N3O3 
MW: 203.15 g/mol 
The synthesis was performed according to the procedure of Sivakumar et al.[216]  
1H NMR (400 MHz, d6-DMSO): δ (ppm) = 10.52 (s, 1H, OH), 7.60 (s, 1H, 3-H), 7.48 (d, 3J = 8.5 Hz, 1H, 
4-H), 6.81 (dd, 3J = 8.5 Hz, 4J = 2.3 Hz, 1H, 5-H), 6.76 (d, 4J = 2.3 Hz, 1H, 7-H). 
13C NMR (102 MHz, 1H-decoupled, d6-DMSO): δ (ppm) = 160.2 (1-C), 157.3 (6-C), 152.7 (8-C), 129.1 
(3-C), 127.8 (4-C), 121.1 (2-C), 113.8 (9-C), 111.3 (5-C), 102.0 (7-C). 
IR (ATR): ṽ (cm–1) = 3204, 2920, 2100, 1739, 1608, 1544, 1505, 1447, 1307, 1243, 1175, 1108, 993, 940, 
837, 761, 661. 
HREIMS: calculated for C9H5N3O3+ [M]+: 203.0331, observed: 203.0321. 
UV-Vis (DMSO): λAbs (nm) = 345. 
 
Synthesis Overview of BODIPY Azide c 
 
Figure 5-1. Synthesis of BODIPY azide c. Note that BODIPY phenol was generously provided by B. 
Hackner. 
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10-(4-(2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethylcarbamoyloxy)-2,6-di-methylphenyl)-5,5-difluoro-
1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:1´,2´-f][1,3,2]diazabo-rinin-4-ium-5-uide (c) 
 
C30H39BF2N6O5 
MW: 612.49 g/mol 
To a stirring solution of BODIPY phenol (200 mg, 0.54 mmol, 1.0 eq) in THF (10 mL), NEt3 (302 µL, 
220 mg, 2.17 mmol, 4.0 eq) was added, followed by the addition of N,N´-di-succinimidyl carbonate 
(278 mg, 1.09 mmol, 2.0 eq). After stirring at rt for 16 h, TLC monitoring indicated quantitative 
conversion. 11-Azido-3,6,9-trioxaundecan-1-amine (480 µL, 514 mg, 2.44 mmol, 4.5 eq) was added and 
stirring at rt was continued for 1 h. H2O (150 mL) was added and the mixture was extracted with EtOAc 
(4 x 100 mL). The combined organic layers were dried over Na2SO4, filtered and the solvent was removed 
in vacuo. Flash column chromatography (iHex/EtOAc = 3:1 → 0:1) afforded the desired BODIPY azide b 
(156 mg, 0.26 mmol, 47%) as a dark red oil. 
1H NMR (400 MHz, CD3OD): δ (ppm) = 7.00 (s, 2H, 13-H and 15-H), 6.07 (s, 2H, 2-H and 8-H), 3.71–
3.64 (m, 10H, linker-CH2), 3.62 (t, 3J = 5.4 Hz, 2H, linker-CH2), 3.42–3.35 (m, 4H, linker-CH2), 2.50 (s, 
6H, 1-H and 9-H), 2.13 (s, 6H, 12-H and 16-H), 1.44 (s, 6H, 3-H and 7-H). 
13C NMR (102 MHz, 1H-decoupled, CD3OD): δ (ppm) = 156.81 (Car), 156.79 (Car) 153.2 (17-C), 143.8 
(Car), 141.9 (Car), 137.9 (Car), 132.1 (Car), 131.7 (Car), 122.6 (13-C and 15-C), 122.1 (2-C and 8-C), 71.69 
(linker-C), 71.67 (linker-C), 71.5 (linker-C), 71.3 (linker-C), 71.1 (linker-C), 70.8 (linker-C), 51.8 (linker-
C), 42.0 (linker-C), 19.6 (12-C and 16-C), 14.6 (1-C and 9-C), 13.7 (3-C and 7-C). 
HRESIMS: calculated for C30H39BF2N6NaO5+ [M+Na]+: 635.2935, observed: 635.2934. 
UV-Vis (H2O): λAbs (nm) = 498. 
Fluorescence (H2O): λEm (nm) = 508. 
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4(5)-(2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)carbamoyl)-2-(6-hydroxy-oxo-3H-xanthen-9-yl)benzoic acid 
(5(6)) (a) 
 
C29H28N4O9 
MW: 576.55 g/mol 
To a stirring solution of 5(6)-carboxyfluorescein (188.2 mg, 0.50 mmol, 1.0 eq) in DMF (1.5 mL), N,N-
diisopropylethylamine (0.26 mL, 1.50 mmol, 3.0 eq), 4-dimethylaminopyridine (6.1 mg, 0.05 mmol, 
0.1 eq), 1-(bis(dimethylamino)methylene)-1H-1,2,3-triazolo-[4,5-b]pyridinium-3-oxid hexafluorophos-
phate (228.1 mg, 0.60 mmol, 1.2 eq) and 11-azido-3,6,9-trioxaundecan-1-amine (120.0 mg, 0.55 mmol, 
0.11 mL, 1.1 eq) were added and stirred at rt for 24 h. The solvent was removed in vacuo and the crude 
product was purified by flash column chromatography (DCM/MeOH = 9:1 → 5:1) to yield 5(6)-a 
(278.4 mg, 0.48 mmol, 97%) as an orange solid.  
5 mg of the regioisomers 5(6)-a were separated by preparative RP-HPLC (0–50% B in 45 min) and one 
regioisomer a was used for click reactions. 
1H NMR (400 MHz, CD3OD, 5(6)-a): δ (ppm) = 8.44 (dd, 4J = 1.6 Hz, J  = 0.7 Hz, 1H, 18-H), 8.25 (dd, 
3J = 8.0 Hz, 4J = 1.6 Hz, 1H, 16-H), 8.19 (dd, 3J = 8.0 Hz, 4J = 1.4 Hz, 1H, 17-H), 8.12 (dd, 3J = 8.0 Hz, 
J = 0.7 Hz, 1H, 18-H), 7.69 (dd, 4J = 1.4 Hz, J = 0.8 Hz, 1H, 15-H), 7.34 (dd, 3J = 8.0 Hz, J = 0.7 Hz, 1H, 
15-H), 6.75–6.71 (m, 2H, 5-H and 8-H), 6.64–6.58 (m, 2H, 2-H and 11-H), 6.54 (ddd, 3J = 8.7 Hz, 
3J = 5.2 Hz, 4J = 2.4 Hz, 2H, 4-H and 9-H), 3.77–3.48 (m, 16H, linker-CH2), 2.15 (s, 1H, OH).  
13C NMR (102 MHz, 1H-decoupled, CD3OD): δ (ppm) = 170.7 (21-C), 168.6 (20-C), 168.4 (20-C), 161.8 
(3-C, 10-C), 154.3 (1-C, 12-C), 142.4 (14-C), 138.0 (13-C), 135.6 (19-C), 130.5 (5-C, 8-C), 130.3 (5-C, 8-
C), 126.4 (16-C)*, 125.9 (17-C)*, 125.1 (18-C)*, 124.2 (15-C)*, 113.9 (4-C, 9-C), 111.1 (6-C, 7-C), 103.8 
(2-C, 11-C), 71.83 (25-C)**, 71.79 (26-C)**, 71.75 (25-C)**, 71.7 (23-C, 26-C)**,***, 71.6 (23-C)***, 
71.5 (24-C)****, 71.3 (24-C)****, 71.2 (27-C)****, 71.2 (27-C)****, 70.6 (28-C), 70.4 (28-C), 51.9 (29-
C), 51.9 (29-C), 41.4 (22-C), 41.3 (22-C). 
IR (ATR): ṽ (cm–1) = 3302, 3051, 2117, 1678, 1621, 1516, 1458, 1373, 1343, 1319, 1260, 1226, 1158, 
1121, 1070, 982, 953, 926, 860, 837, 816, 756, 745, 720. 
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HRESIMS: calculated for C29H27N4O9– [M–H]–: 575.1784, observed: 575.1784. 
UV-Vis (H2O): λAbs (nm) = 495. 
Fluorescence (H2O): λEm (nm) = 520. 
 
5.2.11 Synthesis of -Fluorophore Labeled Nucleoside Triphosphates 
General Procedure 4: In a 0.2 mL PCR tube 8.0 µL of the -alkyne labeled nucleoside triphosphate 
solution (50 mM in ddH2O, 400 nmol, 1.0 eq) was mixed with 10.4 µL of the fluorophore azide solution 
(58 mM, 600 nmol, 1.5 eq) (THF solution for the coumarin b, BODIPY c and carboxyfluorescein a, 
THF/H2O = 1:1 mixture for TAMRA e). 0.64-1.92 µL CuSO4 solution (10 mg/mL in ddH2O, 40 nmol, 0.1-
0.3 eq) and 1.60-4.80 µL of a freshly prepared sodium ascorbate solution (100 mg/mL in H2O, 800 nmol, 
2.0-6.0 eq) were added, mixed and incubated at 0 °C to 25 °C for 1-4 h (exact conditions: Table 3-6, p. 84). 
Purification by semipreparative RP-HPLC (0–40% B in 25 min, 40–60% B from 25-45 min) yielded -
fluorophore labeled nucleotides. 
General Procedure 5: The reactions were performed in glassware under an argon atmosphere and with 
magnetic stirring. The -alkyne labeled nucleoside triphosphate (1.0 eq) was dissolved in ddH2O, the 
fluorophore azide b (1.5 eq) in THF was added at rt and the brownish solution was degassed (5x). Sodium 
ascorbate (2.0 eq) and CuSO4 (10 mol%) were added and after complete consumption of the starting 
material (reactions were monitored by RP-HPLC, 0–40% B in 25 min, 40–60% B from 25-45 min) the 
solvent was removed and the pale brown crude product was purified by preparative RP-HPLC (see below) 
to yield the -fluorophore labeled nucleotides. 
γ-N-(2-(1-(7-Hydroxy-2-oxo-2H-chromen-3-yl)-1H-1,2,3-triazol-4-yl)ethyl-amido)-2´-deoxythymidine-5´-
triphosphate 121b 
 
C23H27N6O16P3 (hypothetic free acid) 
MW: 736.42 g/mol 
The synthesis was performed with 121 (16.9 mg, 20.0 µmol, 1.0 eq), b (6.2 mg, 30.3 µmol, 1.5 eq), sodium 
ascorbate (7.9 mg, 40.0 µmol, 2.0 eq) and CuSO4 (0.3 mg, 10 mol%) in ddH2O/THF = 1:1 (1.0 mL) at 0 °C 
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within 1 h as described in the general procedure 5 (chapter 5.2.11, p. 140). Purification by RP-HPLC (0–
20% B in 45 min) afforded the tris-triethylammonium salt of -fluorophore labeled dTTP 121b (14.6 mg, 
14.0 µmol, 70%) as a bright yellow solid after lyophilization. 
One pot synthesis of 121b from dTTP 
The synthesis was performed with a 100 mM dTTP solution (200 µL, 20 µmol, 1.0 eq) as described in the 
general procedure 2 (chapter 5.2.9, p. 130) within 4.5 h, using adjusted amounts of EDC∙HCl and 1-
aminobut-3-yne in ddH2O/DMF = 1:1 (0.8 mL). After precipitation, the crude -alkyne labeled dTTP 121 
was directly used for the click reaction with fluorophore azide b as described in the general procedure 4 
(chapter 5.2.11, p. 140) using the reagent amounts as described above. Purification by RP-HPLC (0–20% 
B in 45 min) afforded the tris-triethylammonium salt of the -fluorophore labeled dTTP 121b (12.6 mg, 
12.1 µmol, 60%) as a bright yellow solid after lyophilization. 
1H NMR (600 MHz, D2O): δ (ppm) = 8.38 (s, 1H, 11-H), 8.36 (s, 1H, 14-H), 7.63 (d, 3J = 8.6 Hz, 1H, 15-
H), 7.58 (d, 4J = 1.2 Hz, 1H, 6-H), 6.95 (dd, 3J = 8.8 Hz, 4J = 2.4 Hz, 1H, 16-H), 6.87 (d, 4J = 1.9 Hz, 1H, 
18-H), 6.15 (t, 3J = 6.9 Hz, 1H, 1´-H), 4.58–4.52 (m, 1H, 3´-H), 4.18–4.05 (m, 3H, 4´-H, 5´-H), 3.36–3.25 
(m, 2H, 8-H), 3.03 (t, 3J = 7.3 Hz, 2H, 9-H), 2.29–2.24 (m, 1H, 2´-H), 2.22–2.16 (m, 1H, 2´H), 1.85 (s, 3H, 
7-H). 
13C NMR (151 MHz, 1H-decoupled, D2O): δ (ppm) = 166.0 (4-C), 161.9 (12-C), 158.5 (17-C), 154.6 (19-
C), 151.1 (2-C), 145.9 (13-C), 138.1 (14-C), 136.9 (6-C), 131.0 (15-C), 124.3 (11-C), 118.9 (10-C), 114.8 
(16-C), 111.3 (5-C), 110.8 (20-C), 102.6 (18-C), 85.4 (d, 3JP-C = 9.0 Hz, 4´-C), 84.8 (1´-C), 70.7 (3´-C), 
65.2 (d, 2JP-C = 6.0 Hz, 5´-C), 41.2 (8-C), 38.6 (2´-C), 27.2 (d, 3JP-C = 8.9 Hz, 9-C), 11.5 (7-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = –1.78 (d, 
2J = 19.0 Hz, γ-P), –11.81 (d, 2J = 19.2 Hz, 
α-P), –23.04 (t, 2J = 20.5 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3331, 2987, 2692, 2500, 1728, 1695, 1651, 1605, 1475, 1419, 1398, 1327, 1222, 
1116, 1082, 1052, 989, 902, 812, 798, 760, 720. 
HRESIMS: calculated for C23H26N6O16P3– [M–H]–: 735.0624, observed: 735.0620. 
UV-Vis (H2O): λAbs (nm) = 393, 262. 
Fluorescence (H2O): λEm (nm) = 476. 
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γ-N-(2-(1-(7-Hydroxy-2-oxo-2H-chromen-3-yl)-1H-1,2,3-triazol-4-yl)ethyl-amido)adenosine-5´-
triphosphate 122b 
 
C28H39N12O15P3 (hypothetic free acid) 
MW: 876.61 g/mol 
The synthesis was performed with 122 (8.6 mg, 10.0 µmol, 1.0 eq), b (3.0 mg, 15.0 µmol, 1.5 eq), sodium 
ascorbate (4.0 mg, 20.0 µmol, 2.0 eq) and CuSO4 (0.2 mg, 10 mol%) in ddH2O/THF = 1:1 (0.5 mL) at 0 °C 
within 1 h as described in the general procedure 5 (chapter 5.2.11, p. 140). Purification by RP-HPLC (0–
20% B in 45 min) afforded the tris-triethylammonium salt of -fluorophore labeled ATP 122b (8.2 mg, 
7.7 µmol, 77%) as a bright yellow solid after lyophilization. 
1H NMR (600 MHz, D2O): δ (ppm) = 8.28 (s, 1H, 2-H), 8.24 (s, 1H, 13-H), 8.07 (s, 1H, 16-H), 7.90 (s, 
1H, 8-H), 7.40 (d, 3J = 8.6 Hz, 1H, 17-H), 6.80 (dd, 3J = 8.6 Hz, 4J = 2.2 Hz, 1H, 18-H), 6.65 (d, 
4J = 2.2 Hz, 1H, 20-H), 5.91 (d, 3J = 5.4 Hz, 1H, 1´-H), 4.52 (t, 3J = 5.2 Hz, 1H, 2´-H), 4.46 (t, 3J = 4.8 Hz, 
1H, 3´-H), 4.32–4.28 (m, 1H, 4´-H), 4.27–4.15 (m, 2H, 5´-H), 3.33–3.25 (m, 2H, 10-H), 2.99 (t, 3J = 7.4, 
2H, 11-H). 
13C NMR (151 MHz, 1H-decoupled, D2O): δ (ppm) = 161.6 (14-C), 157.7 (19-C), 157.6 (6-C), 154.8 (21-
C), 152.1 (2-C), 148.2 (4-C), 145.6 (15-C), 139.1 (8-C), 136.7 (16-C), 130.6 (17-C), 123.8 (13-C), 118.1 
(5-C)*, 118.0 (12-C)*, 114.6 (18-C), 110.3 (22-C), 102.2 (20-C), 86.9 (1´-C), 83.6 (d, 3JP-C = 8.5 Hz, 4´-
C), 74.6 (2´-C), 70.0 (3´-C), 65.0 (d, 2JP-C = 5.6 Hz, 5´-C), 41.2 (10-C), 27.1 (d, 
3JP-C =  8.3 Hz, 11-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): δ (ppm) = –1.77 (d, 
2J = 19.9 Hz, γ-P), –11.51 (d, 2J = 18.3 Hz, 
α-P), –22.95 (t, 2J = 17.6 Hz, -P). 
IR (ATR): ṽ (cm–1) = 3327, 3172, 2982, 2878, 2733, 2503, 1728, 1700, 1645, 1605, 1513, 1475, 1418, 
1397, 1327, 1218, 1113, 1083, 1060, 988, 899, 846, 811, 798, 758, 718. 
HRESIMS: calculated for C23H25N9O15P3– [M–H]–: 760.0688, observed: 760.0687. 
UV-Vis (H2O): λAbs (nm) = 354, 258. 
Fluorescence (H2O): λEm (nm) = 478. 
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5.2.12 Synthesis of an -Alkyne Labeled Nucleoside Triphosphate 
 
-N-(But-3-yn-1-ylamido)deoxyguanosine-5´-monophosphate 126 
 
 
 
C14H19N6O6P (hypothetic free acid) 
MW: 398.33 g/mol 
To 1.1 mL stirring solution of bis-sodium dGMP (100 mM in ddH2O, 43.0 mg, 110 µmol, 1.0 eq) at rt were 
added 1.1 mL of an EDC·HCl solution (500 mM in ddH2O, 105.4 mg, 550 µmol, 5.0 eq). After 10 min, 
2.2 mL solution of 1-aminobut-3-yne (55 mM in DMF, 8.4 mg, 121 μmol, 1.1 eq) were added and stirring 
continued for 6 h. The reaction was lyophilized, the dry residue was dissolved in buffer A and purified via 
RP-HPLC (0–20% B in 45 min). This afforded the triethylammonium salt of -alkyne dGMP 126 
(23.4 mg, 46.8 µmol, 43%) as a colorless solid after lyophilisation. 
1H NMR (400 MHz, D2O): d (ppm) = 8.11 (s, 1H, 8-H), 6.34 (t, 3J = 6.5 Hz, 1H, 1´-H), 4.79–4.74 (m, 1H, 
3´-H), 4.28–4.20 (m, 1H, 4´-H), 4.04–3.94 (m, 2H, 5´-H), 2.96–2.87 (m, 1H, 2´-H), 2.84–2.76 (m, 2H, 10-
H), 2.63–2.55 (m, 1H, 2´-H), 2.30 (td, 4J = 2.7 Hz, 5J = 0.8 Hz, 1H, 13-H), 2.20 (td, 3J = 7.0 Hz, 4J = 
2.7 Hz, 2H, 11-H).  
13C NMR (101 MHz, 1H-decoupled, D2O): d (ppm) = 158.8 (6-C), 153.8 (2-C), 151.4 (4-C), 137.4 (8-C), 
116.3 (5-C), 85.8 (d, 3JP-C = 9.2 Hz, 4´-C), 83.4 (1´-C), 83.0 (12-C), 71.2 (3´-C), 69.9 (13-C), 64.2 (d,  2JP-C 
= 5.0 Hz, 5´-C), 40.0 (10-C), 38.2 (2´-C), 20.6 (d, 3JP-C = 6.5 Hz, 11-C). 
31P NMR (162 MHz, 1H-decoupled, D2O): d (ppm) = 8.40 (s, -P). 
HRESIMS: calc. for C14H18N6O6P– [M–H]−: 397.1031; found: 397.1026. 
 
-N-(But-3-yn-1-ylamido)deoxyguanosine-5´-triphosphate 130 
 
C14H21N6O12P3 (hypothetic free acid) 
MW: 558.27 g/mol 
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To a solution of the -alkyne dGMP 126 (8.3 mg, 16.6 μmol, 1.0 eq) in dry DMF (408 µL) at 0 °C was 
added DIPEA (13.6 µL, 10.1 mg, 78.1 µmol) and 3-methyl-1-(phenylsulfonyl)-1H-imidazolium triflate 
(127) (7.4 mg, 19.9 µmol, 1.2 eq). The resulting yellow solution was incubated at 0 °C for 20 min and then 
added to a solution of bis-tributylammonium pyrophosphate (25.3 mg, 66.5 µmol, 4.0 eq) in dry DMF 
(408 µL) while maintaining the cooling for 1 min. After warming to rt the reaction was incubated at 25 °C, 
800 rpm for 8 h using a thermomixer (EPPENDORF). The reaction was stopped by addition of diluted buffer 
A (50 mM, 853 µL) and was washed with CHCl3 (3 x 2 mL). The combined aqueous layers were 
lyophilized and the remaining residue was dissolved in buffer A (1.0 mL), filtered and purified by RP-
HPLC (0–20% B in 45 min). This afforded the tris-triethylammonium salt of the -alkyne dGTP 130 
(0.26 µmol, determined by UV-Vis, 2%) as a colorless solid. 
HRESIMS: calc. for C14H20N6O12P3– [M–H]−: 557.0358; found: 557.0348. 
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5.3 Oligonucleotide Synthesis 
All strands without artificial bases were obtained from METABION and were used without further 
purification. This section describes the synthesis of strands containing special bases used for experiments 
described within this thesis. The sequences of the strands can be found in 5.4.3, p. 148. 
DNA oligonucleotide synthesis was performed on an APPLIED BIOSYSTEMS Incorporated 394 automated 
synthesizer. All oligodeoxynucleotides were synthesized on a 1 µmol or 200 nmol scale, using standard 
DNA synthesis conditions (trityl off mode). Phosphoramidites for dA, dC, dG, dT were obtained from 
LINK TECHNOLOGIES. Polystyrene-based supports were purchased from GLEN RESEARCH corporation. Dry 
acetonitrile (<10 ppm H2O, ROTH) was used as solvent for the phosphoramidites. Standard protocols for 
DNA solid-phase synthesis were applied for amine and aldehyde phosphoramidites with only minor 
adjustments. For the phosphoramidites of amine derivatives, the capping step was omitted after addition of 
the special base due to protecting group problems. In addition, coupling times were doubled for all special 
bases.  
RNA oligonucleotide synthesis was performed on an ABI 394 automated synthesizer applying A, C, G and 
U 2’-OTBDMS RNA phosphoramidites from LINK TECHNOLOGIES. For phosphoramidites dry acetonitrile 
(<10 ppm H2O, ROTH) was used as a solvent. Standard protocols for RNA solid-phase synthesis were 
applied for the salicylaldehyde ribophosphoramidite with only minor adjustments. Solutions (0.15 M) of 
the standard phosphoramidites and the salicylaldehyde ribophosphoramidite 88 and 10 equivalents of 
amidite per coupling were utilized. dA-CPG was used as solid support for establishing the synthesis 
protocol. Coupling times of 20 min were applied for the standard and 30 min for the salicylaldehyde 
ribophosphoramidite 88. Monitoring of the trityl cation absorbance (498 nm) during deblocking allowed 
approximation of the coupling efficiency. The synthesizer was equipped with the following solutions and 
reagents:  
Phosphoramidites: 0.10 M (0.15 M, for RNA) in acetonitrile 
Activator: 0.25 M 5-[3,5-bis(trifluoromethyl)phenyl]-1H-tetrazole in acetonitrile (solution from SIGMA-
ALDRICH) 
Deblock: 3% (15% for RNA) (v/v) dichloroacetic acid in toluene 
Oxidation: 25 mM iodine in 65:30:5 (v/v) acetonitrile:H2O:lutidine 
Capping A: 20:50:30 (v/v) acetic anhydride:acetonitrile:lutidine 
Capping B: 20% (v/v) N-methylimidazol in acetonitrile 
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Deprotection and Purification of Oligonucleotides 
DNA strands containing the aromatic amine, the aliphatic amine and the pyridine amine were cleaved off 
the solid support and all protecting groups were removed by incubation in 1 mL of a freshly prepared 1:1 
mixture of 40% aqueous ammonia and 28% aqueous methylamine (AMA) at 65 °C for 1 h. 
Hydrolysis of acetal protecting groups of DNA strands containing aldehyde bases was performed on solid 
support by slow washing with 2% dichloroacetic acid + 1% H2O in DCM at room temperature for 2 h. 
Then, the support was washed with DCM (3 x 3 mL), dried, transferred to a 2 mL reaction tube and 1 mL 
AMA was applied at 65 °C for 10 min. 
After cooling to rt, the supernatant from the AMA deprotection was transferred to a fresh 2 mL reaction 
tube, the pellet was washed with 0.5 mL ddH2O and its supernatant was also transferred. The solvents were 
removed in a SpeedVac concentrator and the resulting pellet was dissolved in ddH2O. Analysis and 
purification were conducted on HPLC systems described in 5.1, p. 98. Prior to HPLC purification of DNA 
strands containing aldehyde bases, the crude mixture was dissolved in 10% aqueous acetic acid. Purified 
fractions were concentrated in a SpeedVac and lyophilized. 
For deprotection of RNA strands three protocols were examined in parallel in 2 mL polypropylene reaction 
tubes: 
a) 1 mL saturated aqueous ammonia:EtOH = 3:1, 18 h, rt; then +10% AcOH. 
b) 1 mL 0.4 M NaOH in MeOH:H2O = 4:1, 18 h, rt; then 600 µL 1 M buffer A (5.1, p. 98). 
c) 1 mL AMA, 10 min, 65 °C. 
The solvents from a)-c) were removed in a SpeedVac concentrator and the pellet was dissolved in 100 µL 
dry DMSO. Then 125 µL TEA∙3HF were added and the mixture was incubated at 65 °C for 2.5 h. After 
cooling to rt, 25 µL 3 M NaOAc was added, vortexed and followed by addition of 1 mL butanol and 
vigorous mixing. Precipitation of the product was achieved by incubation at –70 °C for 30 min and was 
then sedimented by centrifugation (12500 rpm, 5 min). After removal of the supernatant, the pellet was 
washed twice with EtOH (absolute, 2 x 0.75 mL), dried in a SpeedVac concentrator and redissolved in 
1 mL RNase free H2O. Analysis and purification were conducted on the HPLC systems described in 5.1, p. 
98. 
The identity of the obtained oligomers was verified by MALDI-TOF mass spectrometry and the purity was 
assessed by analytical RP-HPLC (5.1, p. 98). 
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5.4 Biochemical Experiments 
5.4.1 Buffers 
Table 5-1. List of buffers and solutions used in biochemical experiments. Note that all compositions correspond to 
the final working concentration. Stock solutions were prepared if necessary. 
Name Composition 
Binding buffer 500 mM NaCl, 20 mM Tris-HCl, pH 8.0 at 25 °C 
Binding buffer TX 500 mM NaCl, 0.05% Tween-20, 20 mM Tris-HCl, pH 8.0 at 25 °C,  
varying imidazole concentrations (20, 30, 200 mM) 
DNA loading dye1 5% glycerine, bromophenol blue 
DNA loading dye2 3.5 M urea, 15% glycerine, 44 mM Tris-HCl, 44 mM boric acid, 1 mM EDTA, 
bromophenol blue 
Hybridization 
buffer1 
10 mM NaCl, 10 mM Tris-HCl, pH 7.6 at 25 °C 
Hybridization 
buffer2 
100 mM NaCl, 25 mM CHES, pH 8.0 at 25 °C 
Hybridization 
buffer3 
50 mM NaCl, 10 mM CHES, pH 9.0 at 25 °C  
KOD XL, pH 8 120 mM HEPES, 10 mM KCl, 6 mM (NH4)2SO4, 0.1% Triton X-100, 
0.001% BSA, pH 8.0 at 25 °C 
LB medium 5 g L–1 yeast extract, 10 g L–1 trypton, 10 g L–1 NaCl,  
NEB 2, pH 8 50 mM NaCl, 10 mM HEPES, 10 mM MgCl2, 1 mM DTT, pH 7.9 at 25 °C 
NEB 4, pH 8 50 mM KOAc, 20 mM TrisOAc, 10 mM Mg(OAc)2, 1 mM DTT, pH 7.9 at 25 °C 
Phusion buffer 50 mM KCl, 1.5 mM MgCl2 10 mM Tris-HCl, pH 8.3 at 25 °C 
RNA loading dye 47.5% formamide, 0.5 mM EDTA, 0.01% SDS, 0.01% bromophenol blue 
RNAP storage buffer 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 20 mM NaH2PO4/Na2HPO4, pH 7.7 at 
25 °C 
SDS buffer 25 mm Tris, 192 mM glycine, 0.1% SDS 
SDS loading dye 25 mM Tris-HCl, 5% glycerine, 1% SDS, 50 mM DTT, 0.01% bromophenol blue 
SOC medium 20 g L–1 vegetable peptone, 5 g L–1 yeast extract, 20 mM glucose, 10 mM NaCl 
10 mM MgCl2, 10 mM MgSO4, 2.5 mM KCl 
T4 ligation buffer 10 mM MgCl2, 1 mM ATP, 10 mM DTT, 50 mM Tris-HCl, pH 7.5 at 25°C 
TAE buffer 40 mM Tris-OAc, 2 mM EDTA, pH 8.3 at 25 °C 
TBE buffer 89 mM Tris-HCl, 89 mM boric acid, 20 mM EDTA, pH 8.0 at 25 °C 
ThermoPol, pH 8.8 20 mM HEPES, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-
100, pH 8.8 at 25 °C 
Transcription buffer 40 mM HEPES, 6 mM MgCl2, 10 mM DTT, pH 7.4 at 25 °C 
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5.4.2 Chemically Competent E. coli Strains 
Table 5-2. E. coli strains used within this work. 
E. coli strain Manufacturer Genotype 
BL21 (DE3) NEW ENGLAND BIOLABS  fhuA2 ompT ΔhsdS (rB- mB-) dcm+ gal λ 
(DE3) i21 ∆nin5 
NEB 5-alpha (High 
Efficiency) 
NEW ENGLAND BIOLABS fhuA2 Φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsd R17 (rK-, mK+) phoA 
glnV44 thi–1 gyrA96 relA1 
5.4.3 DNA Oligonucleotide Sequences 
Table 5-3. Sequences of DNA strands used for mutagenesis and sequencing. Mutated positions are depicted in bold. 
Name 5´-3´ Sequence Length 
TM 
[°C]* 
MW 
[g mol–1] 
T7_F644A_1 GGGTCCAAAGAGGCCGGCTTCCGTCAACAAGTGCTGG 37 mer 71.3 11440.5 
T7_F644A_2 CCAGCACTTGTTGACGGAAGCCGGCCTCTTTGGACCC 37 mer 71.3 11302.3 
T7_H784A_1 pCGCTCCTAACTTTGTAGCCAGCCAAGACG 29 mer 65.8 8901.8 
T7_H784A_2 pATACCAGACTCCTGTTTGTGTGCATCAATCTCG 33 mer 64.2 10133.6 
T7_5000_for GCTGGGCACTAAGGCACTGGC 21 mer 59.7 6472.2 
T7_5700_rev TAGCCAGTACATCACAAGACTCA 23 mer 54.3 6985.6 
*Note that the melting temperature was calculated for 50 mM NaCl applying the nearest neighbor algorithm by the 
online tool: http://www.basic.northwestern.edu/biotools/oligocalc.html (checked July, 2015) 
 
Table 5-4. Sequences of DNA strands used for transcription experiments. 
Name 5´-3´ Sequence Length MW [g mol–1] 
T1a 
T1 
ATAATACGACTCACTATAGGG 
TAGTCACTXCTCGGGATTCCCTATAGTGAGTCGTATTAT 
21 mer 
39 mer 
6438.3 
 
T1b X = T (control) 39 mer 12023.0 
T1c X = S (salicylaldehyde nucleoside) 39 mer 11949.8 
T1d X = Ald (aldehyde nucleoside) 39 mer 11933.8 
T2a ATAATACGACTCACTATAGGCCTTTCACTACTCCTACCT 39 mer 11780.7 
T2b AGGTAGGAGTAGTGAAAGGCCTATAGTGAGTCGTATTAT 39 mer 12190.0 
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Table 5-5. Sequences of 15 mer DNA strands used for melting curve analysis. 
Name 5´-3´ Sequence MW [g mol–1] 
M1 CACATTAXTGTTGTA  
M1a X = To (aromatic amine) 4625.9 
M1b X = S (salicylaldehyde nucleoside) 4553.0 
M1c X = Ald (aldehyde nucleoside) 4537.0 
M1d X = Ali (aliphatic amine) 4578.1 
M1e X = Pyr (pyridine amine) 4627.1 
M1f X = A 4566.1 
M1g X = C 4542.0 
M2 TACAACAXTAATGTG  
M2a X = S 4571.1 
M2b X = Ald 4555.1 
M2c X = A 4584.1 
M2d X = C 4560.1 
M2e X = G 4600.1 
M2f X = T 4575.1 
 
Table 5-6. Sequences of DNA strands used for primer extension experiments. Artificial bases are depicted in bold. 
Name 5´-3´ Sequence Length MW [g mol–1] 
P1a Fluo-TGGTCCGCCTCGCTATAGGGAGA 23 mer 7619.0 
P1b TAGCAAToTCTCCCTATAGCGAGGCGGACCA 30 mer 9244.9 
P1c TAGCAASTCTCCCTATAGCGAGGCGGACCA 30 mer 9171.9 
P1d TAGCAAATCTCCCTATAGCGAGGCGGACCA 30 mer 9185.0 
P1e TAGCAACTCTCCCTATAGCGAGGCGGACCA 30 mer 9161.0 
 
Table 5-7. Sequences of DNA strands used for crystallization experiments. 
Name 5´-3´ Sequence Length MW [g mol–1] 
C1a CACToCGAGTCAGGCT 15 mer 4622.2 
C1b AGCCTGACTCG 11 mer 3317.2 
C1c AGCCTGACTCGS 12 mer 3617.4 
C2a ATGCGACCToTCCCT 14 mer 4243.0 
C2b AGGGASGGTC 10 mer 3104.0 
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5.4.4 Melting Curve Experiments 
Melting profiles were measured on a JASCO V-650 spectrometer using quartz glass cuvettes with 10.0 mm 
path length. Final samples contained 150 mM NaCl, 10 mM buffer (no amine) and 2 μM of each strand in a 
final volume of 250 μL, and depending on the experiment, additionally 1 mM amine (e.g. ethylenediamine) 
and 3-30 µM CuSO4. Measurements were repeated at least three times with independent samples. Before 
the measurement, oligonucleotides were hybridized as a 20 µM solution in hybridization buffer1 (95 °C for 
4 min followed by cooling down to 4 °C over a period of 45 min). For UV-measurements the solutions 
were covered with silicon oil and tightly plugged. Absorbance was recorded in the forward and reverse 
direction at temperatures of 5 °C to 95 °C with diverse slopes, from 0.1 to 5 K/min. At least 3 denaturing 
and renaturing ramps were performed and averaged for evaluation of the melting temperature. TM values 
were calculated as the zero-crossing of 2nd derivate of the 349 nm background-corrected change in 
hyperchromicity at 260 nm. 
5.4.5 Site-Directed Mutagenesis 
For introduction of point mutations in the T7 RNA polymerase DNA sequence, a PCR with primers 
containing mismatches was performed. In a total volume of 50 µL, 50-100 ng plasmid (8 kbp, i.e. about 14 
fmol) were mixed with 20 pmol forward and reverse primer in the phusion reaction buffer (Table 5-1), 
followed by 200 µM dNTPs and 1 unit Phusion® HF DNA polymerase. The components were assembled 
on ice, mixed gently by careful pipetting and were directly transferred into a preheated thermocycler 
(Mastercycler Personal from EPPENDORF). Using adequately designed primers (see Table 5-3) the 
following temperature program was applied: 
98 °C 5 min  
98 °C 15 s  
60 °C 10 s 30 x 
72 °C 180 s (20 s/kbp)  
72 °C 5 min  
After PCR, methylated template plasmid was digested by adding 40 Units DpnI restriction endonuclease 
(NEW ENGLAND BIOLABS) and 8% (v/v) NEB buffer 4 (Table 5-1). After incubation at 37 °C for 1 h, 5 µL 
of the mixture from the T7_F644thA mutation was used to transform 5-alpha cells according to 5.4.6 (p. 
151). Growing colonies were used to inoculate LBCarb preparatory cultures and employed for plasmid 
isolation (5.4.7) and subsequent sequencing (5.4.8). In case of T7_H784A mutation, the DpnI reaction 
mixture was purified by agarose gel electrophoresis (5.4.10). The band between 8-10 kbp was cut from the 
gel and extracted using the NucleoSpin® gel clean-up kit (MACHEREY NAGEL) according to the 
manufacturer’s protocol. Resulting DNA was ligated by T4 DNA ligase (NEB), applying 2 units of ligase 
in T4 ligation buffer (Table 5-1) at 16 °C for 45 min. Then, 5 µL ligation reaction was used to transform 5-
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alpha cells according to 5.4.6 (p. 151). Growing colonies were used to inoculate LBCarb preparatory cultures 
and employed for plasmid isolation (5.4.7) and subsequent sequencing (5.4.8). 
5.4.6 Transformation 
For transformation of chemically competent E. coli cells, 50 μL of BL21 (DE3) or NEB 5-alpha were 
thawed on ice and gently mixed with 5-100 ng vector plasmid. After 30 min incubation on ice, the cells 
were heat shocked for 20 s (30 s for 5-alpha) in a 42 °C water bath and then regenerated on ice for 2 min 
(5 min 5-alpha). Then, 250 μL rt warm SOC medium was added (450 μL rt warm SOC medium for 5-
alpha) and the cell suspension was incubated at 37 °C, 300 rpm for 1 h. Subsequently, 20-100 μL culture 
was spread on LB plates containing 100 µg/mL carbenicillin (LBCarb) as a selection marker and incubated 
overnight at 37 °C. Single colonies were used to inoculate 20 mL LBCarb and incubated overnight at 37 °C, 
200 rpm as preparatory cultures. 
5.4.7 Plasmid DNA Preparation 
Plasmid DNA was isolated using the GeneJET Plasmid Miniprep KitTM (THERMO SCIENTIFIC) according to 
manufacturer’s instructions with one exception: The final elution of DNA from the columns was carried 
out in 30 µL ddH2O. 
5.4.8 DNA sequencing 
DNA sequencing was performed on at least 600 ng of purified plasmid by the Sanger sequencing method 
at the GATC BIOTECH AG. Primer sequences for the analysis of the site- directed mutagenesis can be 
found in Table 5-3. 
5.4.9 Determination of Protein and DNA Concentrations 
Concentration of all mentioned macromolecules was determined by UV absorbance measurements on a 
NanoDrop ND-1000 Spectrophotometer (THERMO SCIENTIFIC) using 1.5 µL sample volume. 
T7 RNA polymerase protein concentration was determined by measuring the UV absorbance at 280 nm. 
Concentrations were calculated according to the Beer-Lambert law, using a protein sequence-based molar 
extinction coefficient ε calculated from the EXPASYProtParam tool (http://web.expasy.org/protparam/, 
checked: July 2015) assuming all cysteines to be in a reduced state. For RNA polymerases T7 (wild-type), 
T7_F644A and T7_H784A  was calculated to 140260 M–1cm–1. 
Concentration of plasmids was determined by measuring UV absorbance at 260 nm using an extinction 
coefficient of 0.02 (ml / µg) cm–1. DNA concentration from synthesized single strands was determined by 
measuring the UV absorbance at 260 nm. Concentrations were calculated according to Beer-Lambert law, 
using a DNA sequence-based molar extinction coefficient  calculated from Oligo Calc 
(http://www.basic.northwestern.edu/biotools/OligoCalc.html, checked: July 2015). For strands containing 
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artificial bases the extinction coefficient of their corresponding control strand was employed without 
corrections. 
5.4.10 Gel Electrophoresis of Proteins, DNA and RNA 
For evaluation of the protein preparation procedure, SDS-PAGE was performed according to Laemmli[225] 
using discontinuous Tris gels with 5% stacking, 12% resolving gel concentration, 0.75 mm thickness and 
SDS loading dye (Table 5-1). Gels were run in SDS buffer at constant voltage (200 V) for 90 min and 
stained in Coomassie staining solution (0.1% (w/v) Coomassie Blue, 10% (v/v) acetic acid and 40% (v/v) 
ethanol in ddH2O) by gentle shaking at rt for several hours and then transferred to destaining solution (10% 
(v/v) acetic acid and 40% (v/v) ethanol in ddH2O).  
Gel composition: 
Component Resolving Gel Stacking Gel 
Rotiphorese® Gel 30 (37.5:1) 8.0 mL 1.7 mL 
ddH2O 6.5 mL 6.8 mL 
1.5 M Tris, pH 8.8  5.0 mL - 
1.0 M Tris, pH 6.8 - 1.25 mL 
10% SDS 200 µL 100 µL 
10% APS 200 µL 100 µL 
TEMED 20 µL 10 µL 
 
DNA plasmids and PCR amplification products of about 8 kbp were analyzed and purified by agarose gel 
electrophoresis. Therefore, gels containing 1% agarose in TAE buffer and 0.01% ethidium bromide were 
prepared. DNA loading dye1 was added to the samples and the gel was run in TAE buffer at 100 V for 2 h. 
Fluorescence of the DNA fragments in the gel upon excitation at 342 nm was examined. 
DNA and RNA strands of 10-30 mer oligonucleotide size were analyzed by 20% denaturing 
polyacrylamide gel electrophoresis on 20 x 20 cm gels of 1 mm thickness. The gels were run in TBE buffer 
(Table 5-1) at 40 °C applying a constant current of 40 mA per gel (maximum 1000 V) for about 3-4 h. The 
gel from RNA samples without fluorophores was stained with SYBR® green II for 15 min (in 0.5 x TBE) 
and then visualized like the fluorescein-containing samples using a LAS-3000 imaging system (RAYTEST). 
Gel composition: 32 mL Rotiphorese® sequencing gel concentrate, 4 mL 8 M urea, 4 mL 10 x TBE buffer, 
200 µL APS, 20 µL TEMED. 
5.4.11 Expression and Purification of T7 RNA Polymerase Mutants 
For expression of T7 RNA polymerases 1 L of LBCarb in a 5 L shaking flask was inoculated with 2 mL 
BL21-T7 overnight preparatory culture. The flask was incubated at 37 °C, 200 rpm until an OD600 of 0.6-
0.7 was reached (about 4 h). Then, IPTG was added to a final 1 mM and incubation continued at 37 °C, 200 
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rpm for 4 h. Cells were harvested by centrifugation (6 min, 6000 x g, 4 °C) and the pellet was frozen at –
20 °C for short term storage. Pellets from protein expression were thawed and resuspended in sevenfold 
wet pellet weight of binding buffer T with additional 750 units endonuclease (Benzonase®, SIGMA 
ALDRICH) and one protease inhibitor cocktail tablet (cOmplete™, EDTA-free, ROCHE). Cells were lysed in 
a French pressure cell press (12000 psi; SLM AMINCO, three passes) and the lysate was centrifuged at 
17000 x g for 45 min at 4 °C. The target protein was purified from the supernatant via His-tag affinity 
chromatography with a 3 mL Ni-NTA batch applying gravity flow at rt. The batch was equilibrated first 
with 5 column volumes (CV, i.e. here 15 mL) binding buffer, then the supernatant was loaded onto the Ni-
NTA beads by stirring for 45 min at 0 °C. Subsequently, the beads were washed with 4 CV of binding 
buffer T, followed by 4 CV binding buffer T20. T7 RNA polymerase was eluted by adding 2.5 CV of 
binding buffer T200 and collected in fractions of 1 mL size, which were analyzed by UV-Vis 
measurements (5.4.9) and by SDS-PAGE (5.4.10). Purified protein-containing fractions were combined 
and the concentration was adjusted to 2.5-4.0 mg/mL by dilution or concentrating. Protein concentrating 
was achieved using Amicon Ultra® (MILLIPORE, regenerated cellulose) ultrafiltration devices with a 30 
kDa molecular weight cut-off (MWCO) and centrifugation (up to 3200 x g). Then, the protein solution was 
dialyzed in a dialysis tubing (SnakeSkin™, THERMO SCIENTIFIC) against at least 100 fold volume of RNAP 
storage buffer (Table 5-1) at 4 °C stirring overnight. The dialyzed protein was filtered through a 0.2 µm 
GHP filter membrane (Acrodisc®), the concentration was adjusted to 2.5-4.0 mg/mL and DTT was added 
to a final concentration of 2 mM. Enzymatic activity was analyzed in a transcription assay and freezer 
stocks were prepared by addition of glycerol to a final 40% (v/v). 
5.4.12 Transcription Assay Conditions 
In vitro transcriptions were performed in a total volume of 10-20 µL using a thermocycler (Mastercycler 
Personal from EPPENDORF) for temperature control. Triphosphates were thawed on ice and the components 
were assembled at rt. 
This section describes transcription experiments for the metal base pair transcription. To the transcription 
buffer (Table 5-1) was added template (2 µM) and the NTPs (400 µM). Varying amounts of the subsequent 
components were provided with the enzyme added last: 
Entry Component   Concentration 
1 Metal cation CuSO4, MnSO4, AgNO3, FeSO4, FeCl3∙H2O 0-4.0 mM 
2 Amine Ethylenediamine, methylamine, 1,2-diaminobenzene 0-140 mM 
3 Nucleotide STP, AldTP 0-1.2 mM 
4 Enzyme T7RNAP, T7RNAP_F644A, T7RNAP_H784A 2 µM 
Transcriptions were usually incubated at 37 °C for 5 h. Alternatively, lower (20, 25 and 30 °C) and higher 
(40 °C) temperatures as well as different incubation times (0.5, 1.0, 2.0, 15 h) were analyzed. After 
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incubation, the reaction was either stopped by heating to 70 °C for 10 min and subsequent MALDI-TOF 
mass spectrometry (after dialysis) or treated with RNA loading dye and applied to PAGE (5.4.10, p. 152). 
Remaining samples were stored at –20 °C for several days without noticeable changes. 
This section describes transcription experiments involving the -alkyne and -fluorophore GTP. To 
transcription buffer (Table 5-1) was added the template (2 µM) and the -alkyne or -fluorophore GTP 
(400 µM). Then, 400 µM ATP, CTP, UTP and 0-400 µM GTP was added and transcription was started by 
addition of the RNA polymerase. In case no natural GTP was provided from the beginning, delayed 
addition after different timepoints was analyzed. Also mutant T7 RNA polymerases F644A and H784A 
were studied. The transcriptions were usually incubated at 37 °C for 3 h. Alternatively, lower (20 °C) 
temperature as well as different incubation times (0.5, 1.0, 15 h) were analyzed. After incubation, the 
reaction was treated as described above. 
5.4.13 Expression and Purification of Bst Pol I 
Bst Pol I was expressed and purified as previously described.[13] 
5.4.14 DNA-Bst Pol I Co-Crystallization 
Prior to crystallization experiments 500 µM of strand CXa was annealed to strand CXb (CXc) (sequences 
Table 5-7) in hybridization buffer3 (Table 5-1) using a thermocycler (Mastercycler Personal from 
EPPENDORF), applying the following temperature gradient: 95 °C for 4 min followed by cooling with 
2 °C/min to 4 °C. Then Bst Pol I and DNA were mixed to a final 5 mg/mL and 250 µM, respectively (about 
1:3 molar ratio). Crystallization trials were performed using the vapor diffusion hanging drop technique at 
18 °C with 500 μL reservoir solution per well. For each well 0.8 µL of reservoir solution was placed with 
0.8 µL of DNA-protein solution in one drop. Well diffracting crystals grew within 10 to 20 days using this 
reservoir solution: 0.1 M MES pH 5.8, 2-3% 2-methyl-2,4-pentanediol, 46-49% (NH4)2SO4 (saturated 
aqueous solution). Crystals were frozen in cryoprotectant solution (24% (w/v) sucrose, 55% (NH4)2SO4 
(sat. aq. sol.), 2-3% 2-methyl-2,4-pentanediol, 0.1 M MES pH 5.8) and stored in liquid nitrogen until data 
collection. 
Data were collected at the beamline PX I (Swiss Light Source (SLS), Villigen, Switzerland) and processed 
with the program XDS.[226] Structure solution was carried out by molecular replacement with PHASER[227] 
using the coordinates of 2XY5.[13] In order to reduce model bias, the temperature factors were reset to 20 
for main chain and 40 for side chain and DNA atoms, respectively. Prior to model building in COOT,[228] a 
random shift of 0.1 Å was introduced with pdbset (CCP4. Collaborative Computational Project, Number 4. 
1994. The CCP4 suite: programs for protein crystallography).[229] Restrained refinement was carried out on 
REFMAC5.[230] All structural figures were prepared with Pymol (SCHRÖDINGER). Data processing and 
refinement statistics are summarized in Table 5-8, p. 156. 
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Accession Numbers: Atomic coordinates and structure factors of the protein in complex with DNA have 
been deposited in the PDB at the EBI Macromolecular Structure Database (http://www.ebi.ac.uk/pdbe) and 
the code is 4uqg.  
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Table 5-8. Data collection and refinement statistics. Statistics for the highest-resolution shell are shown in 
parentheses. 
 Post insertion To-S 
PDB number 
DNA strands 
4uqg 
C2a and C2b 
Data collection statistics  
Wavelength (Å) 1.000 
Resolution range (Å) 70.16 – 2.0 (2.066 – 1.995) 
Space group P 21 21 21 
Cell dimensions  
a, b, c (Å) 87.442 93.996 105.416 
α, β,  () 90, 90, 90 
Total reflections 525616 (49867) 
Unique reflections 59562 (5664) 
Multiplicity 8.8 (8.8) 
Completeness (%) 99.63 (96.34) 
<I/σI> 22.05 (2.59) 
Refinement statistics  
Wilson B-factor 30.57 
Rmerge 0.0846 (0.9151) 
Rmeas 0.08987 
CC1/2 0.08987 
CC* 1 (0.958) 
  
Reflections used for R-free  
R-work 0.1844 (0.2983) 
R-free 0.2165 (0.3176) 
Number of non-hydrogen atoms 5208 
Macromolecules 4955 
Ligands 43 
Water 210 
Protein residues 580 
RMS bonds (Å) 0.018 
RMS angles (°) 1.67 
Ramachandran favored (%) 98 
Ramachandran outliers (%) 0.35 
Clashscore 0.84 
Average B-factor 35.80 
Macromolecules 35.80 
Ligands 48.20 
Solvent 35.10 
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5.4.15 Primer Extension Experiments 
Using a thermocycler (Mastercycler Personal from EPPENDORF) 20 μM of 5’-fluorescein-labeled 23-mer 
primer (P1a, Table 5-6) was annealed to 50% excess of unlabeled 30-mer P1b, P1c, P1d or P1e in 
hybridization buffer2 (Table 5-1) prior to primer extension experiments. Therefore, the following 
temperature gradient was applied: 95 °C for 4 min followed by cooling with 2 K/min to 4 °C. 
Primer extension experiments were performed with the following polymerases: Klenow fragment, Klenow 
fragment exo-, OneTaq, Vent exo-, Geobacillus stearothermophilus Pol I (Bst Pol I), Therminator, Deep 
vent exo- (purchased from NEB) and KOD-XL (bought from MERCK). Modified polymerase buffers had to 
be used to avoid the interference of external amines with the amine-aldehyde base pairs. Primer extensions 
with Klenow fragment and Klenow fragment exo- were carried out in modified NEB buffer 2, for the 
polymerase KOD XL, KOD buffer was applied and Thermo buffer was used for all other polymerases 
(buffer composition see Table 5-1). 
General protocol: In a 10 µL setup 10 pmol of dsDNA was premixed in the adequate buffer (in case that 
two polymerases were used in one setup, both buffers were mixed). Then, 200 µM of dNTPs and 200-
400 µM of RP-HPLC purified dSTP, dToTP or dNaTP were added, followed by the addition of 1-2 units of 
polymerase. Experiments with Klenow polymerases were incubated at 37 °C, Bst Pol I at 60 °C and all 
other polymerases at 70 °C. To allow enzymatic incorporation of the artificial bases the incubation times 
were varied (for the exact conditions see the corresponding primer extension, chapter 3.9, 3.11.2 and 3.13). 
The reaction was stopped by addition of one volume of DNA loading dye2 (Table 5-1) and heating to 
95 °C for 5 min. Samples were analyzed by denaturing PAGE (5.4.10, p. 152). 
Mass analysis of primer extension experiments: A 20 µL primer extension setup containing 20 pmol of 
dsDNA was performed in the case mass analysis was desired. The reaction was stopped by addition of 
20 µL Rotiphenol (Roti® Phenol/Chloroform/Isoamylalcohol, ROTH) and extraction. Then, the aqueous 
layer (top, about 20 µL) was extracted twice with chloroform and concentrated in vacuo. Before MALDI-
TOF mass spectrometry, the residue was redissolved in 3 µL ddH2O and dialyzed on a 0.025 µm VSWP 
membrane (MILLIPORE) against ddH2O for at least 4 h. 0.5 µL from the dialyzed sample and HPA-matrix 
were co-crystallized on a target and then measured (also see 5.1).  
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6 Abbreviations 
 
(d)NTP (Deoxy)nucleoside 5´-triphosphate(s) (natural: A, C, G, T, U) 
(d)XTP (Deoxy)nucleoside 5´-triphosphate(s) (natural and artificial) 
(TBA)2PPi Bis(tri-n-butylammonium) pyrophosphate 
°C  Degree Celsius (temperature) 
A  Adenine/Adenosine (depending on context) 
Å  Ångstrom, 10–10 m 
Ac  Acetyl 
APS Ammonium persulfate 
aq  Aqueous 
BODIPY Boron-dipyrromethene, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
bp  Base pair 
br  Broad 
BuLi Butyllithium 
C  Cytosine/Cytidine (depending on context) 
CD Circular dichroism 
CDI 1,1’-Carbonyldiimidazole  
CHES N-Cyclohexyl-2-aminoethanesulfonic acid 
COSY Correlation spectroscopy (2D NMR) 
CPG Controlled pore glass 
CuAAC Cu(I)-catalyzed alkyne azide cycloadditions 
CV Column volume 
DCM Dichloromethane 
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DFT Density functional theory (quantum mechanical modelling method) 
DIPEA N,N-Diisopropylethylamine 
DMF Dimethylformamide 
DMSO Dimethoxysulfoxide 
DMTr 4,4´-Dimethoxytrityl 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
e.g. Latin “exempli gratia”, meaning: for example 
EDC 1-Ethyl-3-(3-dimethyl-aminopropyl) carbodiimide 
EDTA Ethylenediaminetetraacetate 
EI  Electron impact 
eq  Equivalent(s) 
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ESI Electrospray ionization 
et al. Et alii (latin = and others) 
EtOAc Ethylacetate 
EtOH Ethanol 
Fm 9-Fluorenylmethyl (protecting group) 
g  Gram, 10–3 kg 
G  Guanine/Guanosine (depending on context) 
h  Hour(s) 
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
His Histidine (amino acid) 
HMBC Heteronuclear multiple-bond correlation spectroscopy 
HPA Hydroxypicolinic acid 
HPLC High-pressure liquid chromatography/High-performance liquid chromatography 
HR High-resolution 
HSQC Heteronuclear single quantum coherence/correlation 
Hz  Unit of frequency, s–1 
i. e.  Latin “id est”, meaning: that is 
iHex Isohexane, alkane fraction with a boiling point of 40 °C at 350 mbar 
in vacuo In a vacuum 
IPTG Isopropyl -D-1-thiogalactopyranoside 
IR  Infrared (measurement), light from 700 nm to 1 mm 
J  Coupling constant (NMR) 
K  Kelvin (temperature) 
KF Klenow fragment (polymerase) 
L  Liter(s) 
LC Liquid chromatography 
m  Meter(s) 
M  Molar (c) 
m  Multiplet (NMR) 
m/z Mass to charge ratio 
MALDI-TOF Matrix assisted laser desorption/ionization time-of-flight 
mCPBA meta-Chloroperoxybenzoic acid 
MeOH Methanol 
MES 2-(N-Morpholino)ethanesulfonic acid 
min Minute(s) 
mol Mole(s) 
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mp Melting point 
MPD 2-Methyl-2,4-pentanediol 
MS Mass spectrometry 
n  Normal (isomer) 
Naa Naphthalene aromatic amine (nucleoside) 
Ni-NTA Nickel-nitrilotriacetic acid 
NMR Nuclear magnetic resonance 
PAGE Polyacrylamide gel electrophoresis 
PCR Polymerase chain reaction 
pH The negative decimal logarithm of the hydrogen ion activity 
PhD Doctor of philosophy (university degree) 
pKa Logarithmic acid dissociation constant Ka, pKa = –log10 Ka 
ppm Parts per million 
Py  Pyridine 
q Quartet (NMR) 
Rf  Retention factor (thin-layer chromatography) 
RNA Ribonucleic acid 
RP Reversed-phase 
Rt  Retention time (chromatography) 
rt  Room temperature 
S  Salicylaldehyde (nucleoside) 
s  Second (unit of time) 
s  Singlet (NMR) 
SDS Sodium dodecyl sulfate 
SNI Single nucleotide insertion 
T  Thymine/Thymidine (depending on context) 
t  Triplet (NMR) 
t  Tertiary (isomer) 
TAMRA Tetramethylrhodamine 
TBA Tetrabutylamine/Tetrabutylammonium 
TBAF Tetrabutylammoniumfluorid 
TBS/TBDMS tert-Butyldimethylsilyl  
TBTA Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 
TEA Triethylamine/Triethylammonium 
TEMED Tetramethylethylenediamine 
TES Triethylsilyl 
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TFA Trifluoroacetic (acid)/Trifluoroacetyl 
THF Tetrahydrofuran 
THPTA Tris[(1-hydroxypropyl-1H-1,2,3-triazol-4-yl)methyl]amine 
TIPS Triisopropylsilyl 
TLC Thin-layer chromatography 
TM Melting temperature (DNA double strand) 
To  Aromatic amine (nucleoside) 
Tol Toluene 
TOM [(Triisopropylsilyl)oxy]methyl 
Tris Tris(hydroxymethyl)aminomethane 
Tris Tris(hydroxymethyl)aminomethane 
tRNA Transfer RNA 
UV Ultraviolet range of light, 10-380 nm 
v/v Volume per volume 
vis  Visible range of light, 380-700 nm 
w/v Weight per volume 
δ  Chemical shift (NMR) 
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7 Appendix 
7.1 Protein Sequences 
T7 RNA polymerase protein sequence (without linker and tag); 883 amino acids, the mutated residues are 
marked bold: 
mntiniaknd fsdielaaip fntladhyge rlareqlale hesyemgear frkmferqlk 
agevadnaaa kplittllpk miarindwfe evkakrgkrp tafqflqeik peavayitik 
ttlacltsad nttvqavasa igraiedear fgrirdleak hfkknveeql nkrvghvykk 
afmqvveadm lskgllggea wsswhkedsi hvgvrcieml iestgmvslh rqnagvvgqd 
setielapey aeaiatraga lagispmfqp cvvppkpwtg itgggywang rrplalvrth 
skkalmryed vympevykai niaqntawki nkkvlavanv itkwkhcpve dipaiereel 
pmkpedidmn pealtawkra aaavyrkdka rksrrislef mleqankfan hkaiwfpynm 
dwrgrvyavs mfnpqgndmt kglltlakgk pigkegyywl kihgancagv dkvpfperik 
fieenhenim acaksplent wwaeqdspfc flafcfeyag vqhhglsync slplafdgsc 
sgiqhfsaml rdevggravn llpsetvqdi ygivakkvne ilqadaingt dnevvtvtde 
ntgeisekvk lgtkalagqw laygvtrsvt krsvmtlayg skefgfrqqv ledtiqpaid 
sgkglmftqp nqaagymakl iwesvsvtvv aaveamnwlk saakllaaev kdkktgeilr 
krcavhwvtp dgfpvwqeyk kpiqtrlnlm flgqfrlqpt intnkdseid ahkqesgiap 
nfvhsqdgsh lrktvvwahe kygiesfali hdsfgtipad aanlfkavre tmvdtyescd 
vladfydqfa dqlhesqldk mpalpakgnl nlrdilesdf afa 
7.2 DNA Sequences 
T7 RNA polymerase gene sequence (without linker and tag): 
atgaacacgattaacatcgctaagaacgacttctctgacatcgaactggctgctatcccgttcaacactctggctgaccattacggtgagcgtttagctcgcg
aacagttggcccttgagcatgagtcttacgagatgggtgaagcacgcttccgcaagatgtttgagcgtcaacttaaagctggtgaggttgcggataacgctg
ccgccaagcctctcatcactaccctactccctaagatgattgcacgcatcaacgactggtttgaggaagtgaaagctaagcgcggcaagcgcccgacagc
cttccagttcctgcaagaaatcaagccggaagccgtagcgtacatcaccattaagaccactctggcttgcctaaccagtgctgacaatacaaccgttcaggc
tgtagcaagcgcaatcggtcgggccattgaggacgaggctcgcttcggtcgtatccgtgaccttgaagctaagcacttcaagaaaaacgttgaggaacaa
ctcaacaagcgcgtagggcacgtctacaagaaagcatttatgcaagttgtcgaggctgacatgctctctaagggtctactcggtggcgaggcgtggtcttcg
tggcataaggaagactctattcatgtaggagtacgctgcatcgagatgctcattgagtcaaccggaatggttagcttacaccgccaaaatgctggcgtagta
ggtcaagactctgagactatcgaactcgcacctgaatacgctgaggctatcgcaacccgtgcaggtgcgctggctggcatctctccgatgttccaaccttgc
gtagttcctcctaagccgtggactggcattactggtggtggctattgggctaacggtcgtcgtcctctggcgctggtgcgtactcacagtaagaaagcactga
tgcgctacgaagacgtttacatgcctgaggtgtacaaagcgattaacattgcgcaaaacaccgcatggaaaatcaacaagaaagtcctagcggtcgccaa
cgtaatcaccaagtggaagcattgtccggtcgaggacatccctgcgattgagcgtgaagaactcccgatgaaaccggaagacatcgacatgaatcctgag
gctctcaccgcgtggaaacgtgctgccgctgctgtgtaccgcaaggacaaggctcgcaagtctcgccgtatcagccttgagttcatgcttgagcaagccaa
taagtttgctaaccataaggccatctggttcccttacaacatggactggcgcggtcgtgtttacgctgtgtcaatgttcaacccgcaaggtaacgatatgacca
aaggactgcttacgctggcgaaaggtaaaccaatcggtaaggaaggttactactggctgaaaatccacggtgcaaactgtgcgggtgtcgataaggttcc
gttccctgagcgcatcaagttcattgaggaaaaccacgagaacatcatggcttgcgctaagtctccactggagaacacttggtgggctgagcaagattctcc
gttctgcttccttgcgttctgctttgagtacgctggggtacagcaccacggcctgagctataactgctcccttccgctggcgtttgacgggtcttgctctggcat
ccagcacttctccgcgatgctccgagatgaggtaggtggtcgcgcggttaacttgcttcctagtgaaaccgttcaggacatctacgggattgttgctaagaaa
gtcaacgagattctacaagcagacgcaatcaatgggaccgataacgaagtagttaccgtgaccgatgagaacactggtgaaatctctgagaaagtcaagc
tgggcactaaggcactggctggtcaatggctggcttacggtgttactcgcagtgtgactaagcgttcagtcatgacgctggcttacgggtccaaagagttcg
gcttccgtcaacaagtgctggaagataccattcagccagctattgattccggcaagggtctgatgttcactcagccgaatcaggctgctggatacatggctaa
gctgatttgggaatctgtgagcgtgacggtggtagctgcggttgaagcaatgaactggcttaagtctgctgctaagctgctggctgctgaggtcaaagataa
gaagactggagagattcttcgcaagcgttgcgctgtgcattgggtaactcctgatggtttccctgtgtggcaggaatacaagaagcctattcagacgcgcttg
aacctgatgttcctcggtcagttccgcttacagcctaccattaacaccaacaaagatagcgagattgatgcacacaaacaggagtctggtatcgctcctaact
ttgtacacagccaagacggtagccaccttcgtaagactgtagtgtgggcacacgagaagtacggaatcgaatcttttgcactgattcacgactccttcggtac
cattccggctgacgctgcgaacctgttcaaagcagtgcgcgaaactatggttgacacatatgagtcttgtgatgtactggctgatttctacgaccagttcgctg
accagttgcacgagtctcaattggacaaaatgccagcacttccggctaaaggtaacttgaacctccgtgacatcttagagtcggacttcgcgttcgcgtaa 
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